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Abstract
The main objective of the presented work was to integrate four putative regulatory
virulence genes (vqsR, gltR, 47D7, icsF) of Pseudomonas aeruginosa into regulatory
circuits and pathways using combined approach of functional genomics
(microarrays), genetics in silico and various bioassays. 
vqsR (virulence and quorum sensing regulator) encodes one of the major regulators
of the cell-to-cell communication in P. aeruginosa. Inactivation of vqsR abrogated the
production of the autoinducer molecules, which are known to be involved in the
initiation of P. aeruginosa quorum sensing cascade. GeneChip experiments revealed
downregulation of the whole battery of quorum sensing genes in the vqsR mutant
and correspondingly the mutant was compromised in phenotypic traits that are under
quorum sensing control. According to genome-wide transcriptional analyses, VqsR is
also implicated in the modulation of the broad spectrum of virulence, iron-uptake and
metabolic genes. 
icsF (intracellular survival factor) encodes the key modulator of the expression of
oxidative stress genes in P. aeruginosa. As oxidative stress response genes
represent an effective tool to combat the harsh conditions in the intracellular
compartments, the disruption of icsF inevitably has a negative effect on the
intracellular survival of P. aeruginosa strain TB in polymorphonuclear neutrophils
(PMNs). Besides the intracellular survival, the disruption of icsF also affects cell-to-
cell communication and overall virulence of P. aeruginosa against Caenorhabditis
elegans. 
The preliminary experiments suggested an important role of gltR and 47D7 in P.
aeruginosa virulence; however, complementation of these genes in trans did not
restore the phenotype of the wild type strain, thus revealing that the observed
phenotypes of the respective mutants are caused by a secondary genetic effect
elsewhere in the genome.
Key-words: Pseudomonas aeruginosa, Quorum sensing, Intracellular survival
 
Kurzfassung
Kurzfassung
Primäres Ziel der vorliegenden Arbeit war, vier putativ regulatorische Gene (vqsR,
gltR, 47D7 und icsF) aus dem Genom von Pseudomonas aeruginosa genauer zu
charakterisieren und in regulatorische Systeme einzuordnen. Angewandt wurde dazu
eine Kombination aus funktioneller Genomanalyse (microarrays), in silico Genetik
und verschiedene Bioassays.
vqsR (virulence and quorum sensing regulator) kodiert für einen der wichtigsten
Regulatoren der Zell-Zell-Kommunikation in P. aeruginosa. Durch Inaktivierung
dieses Gens wurde die Produktion der sog. autoinducer ausgeschaltet, die an der
Initiierung der quorum sensing Kaskade in P. aeruginosa beteiligt sind. In microarray
Experimenten wurde gezeigt, dass die Expression von quorum sensing Genen in
einer vqsR-Mutante deutlich vermindert war. Dementsprechend fehlten der vqsR-
Mutante auch charakteristische phänotypische Eigenschaften, die im Wildtyp-Stamm
durch quorum sensing Systeme gesteuert werden. Nach den Ergebnissen einer
genomweiten Transkriptionsanalyse ist das vqsR-Genprodukt zudem in die
Modulation eines breiten Spektrums an Virulenzgenen, Eisen-Aufnahme und
Stoffwechselgenen involviert. 
icsF (intracellular survival factor) kodiert für einen Protein, das eine Schlüsselstellung
in der Modulation der Expression von Genen bei oxidativem Stress einnimmt. Da
Proteine, mit denen die Zelle oxidativem Stress begegnen kann, wirksame
Werkzeuge zur Anpassung an die Umweltbedingungen in intrazellulären
Kompartimenten von Eukaryonten darstellen, vermindert das Ausschalten von icsF
erheblich die Fähigkeit des P. aeruginosa Stammes TB, in polymorphonuklearen
neutrophilen Granulozyten (PMNs) zu überleben. Zusätzlich beeinträchtigt das
Ausschalten von icsF auch die Zell-Zell-Kommunikation von P. aeruginosa und die
generelle Virulenz gegenüber Caenorhabditis elegans. 
Mutanten mit ausgeschaltetem gltR- bzw. 47D7-Gen wiesen ebenfalls deutlich
veränderte phänotypische Eigenschaften auf. Durch Komplementierung dieser Gene
in trans wurde aber nicht der Phänotyp des Wildtyp-Stammes wiederhergestellt. Die
Phänotypen der Mutanten waren also auf Sekundärmutationen an anderen
Positionen im Genom zurückzuführen.
Schlüsselwörter: Pseudomonas aeruginosa, Quorum sensing, intrazelluläres
Überleben
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1. Introduction
1.1. Pseudomonas aeruginosa 
1.1.1. General information 
Pseudomonas aeruginosa is one of the best-known members of the genus
Pseudomonas, which comprises a group of Gram-negative polarly flagellated rods
(Stanier et al., 1966). In contrast to first attempts for taxonomy of pseudomonads,
which were based on morphological properties of individual members, the current
taxonomy of this genus is based on 16S rRNA sequences (Woese Fox, 1977). The
most intensively studied members of genus Pseudomonas as for instance P. putida,
P. fluorescens, P. syringae as well as P. aeruginosa belong to the group of -
proteobacteria (Olsen et al., 1994).  
P. aeruginosa has a length in the range of 1.5-3 m and a diameter of about 0.5-0.8
m (Palleroni, 1986). One of the most noteworthy properties of this common aquatic
organism is its ability to adapt and thrive in many ecological niches, from water and
soil to plant and animal tissues (Hardalo and Edberg, 1997). In humans, this
organism can colonize virtually any mucosal surface and can invade tissues and
blood (Kulasekara and Lory, 2004). The exceptional competence of P. aeruginosa to
colonize a wide variety of ecological niches is based on the ability of this bacterium to
utilize a broad spectrum of organic compounds as food sources and its capability to
survive for a long time under extremely harsh conditions where nutrients are limited.
The emergence of P. aeruginosa as a major opportunistic human pathogen during
the past century may be a consequence of its resistance to the antibiotics and
disinfectants that eliminate other environmental bacteria. P. aeruginosa is now a
significant source of bacteraemia in burn victims, urinary-tract infections in
catheterized patients, and hospital-acquired pneumonia in patients on respirators
(Bodey et al., 1983). It is also the predominant cause of morbidity and mortality in
cystic fibrosis (CF) patients, whose abnormal airway epithelia allow long-term
colonization of the lungs by P. aeruginosa. These infections are impossible to
eradicate, in part because of the natural resistance of the bacterium to antibiotics,
and ultimately lead to pulmonary failure and death (Stover et al., 2000).
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1.1.2. Genome organisation of P. aeruginosa 
The ability of P. aeruginosa to thrive in the broad range of ecological niches was
expected to be matched by a complex, highly regulated genomic repertoire. Not
surprisingly, early estimates of the genomic size suggested a relatively large genome
exceeding 6 million base pairs (Mb) (Schmidt et al., 1996).  
Few years ago, the complete genome of P. aeruginosa strain PAO1 was sequenced
and published by Stover et al., 2000 (http://www.pseudomonas.com), which
confirmed the previous hypotheses about the large genome of this bacterium. At 6.3
Mb, the P. aeruginosa genome is markedly larger than most of the sequenced
bacterial genomes. In fact, with 5,570 predicted open reading frames (ORFs), the
genetic complexity of P. aeruginosa resembles that of the simple eukaryote
Saccharomyces cerevisiae, whose genome encodes about 6,200 proteins (Ball et al.,
2000). In contrast, P. aeruginosa has only 30-40 % of the number of predicted genes
present in the simple metazoans Caenorhabditis elegans and Drosophila
melanogaster (Ewing and Green, 2000). The completion of the sequencing project of
the P. aeruginosa PAO1 genome in 2000 and the results from the second P.
aeruginosa genome sequencing of the strain PA14 clearly demonstrate that the
ecological diversity is indeed reflected in the gene content (Kulasekara and Lory,
2004).
Analysis of the complete genome sequence of P. aeruginosa revealed that this
bacterium possesses numerous genes for transport, metabolism and growth on
organic substrates, numerous iron-uptake systems as well as genes implicated in the
enhanced ability to export various compounds (for instance enzymes and antibiotics)
and four potential chemotaxis systems (Stover et al., 2000). Consistent with its large
genome and environmental adaptability, P. aeruginosa possesses one of the highest
proportion of regulatory genes observed for a bacterial genome, which presumably
modulate the diverse genetic and biochemical capabilities of this bacterium in
changing environmental conditions. The number and variety of genes that allow P.
aeruginosa to thrive in a wide range of environments places this organism as being
truly ubiquitous, arguably one of the most developed bacterial species in terms of
range of habitats it can occupy (Kulasekara and Lory, 2004).  
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1.1.3. P. aeruginosa and cystic fibrosis
P. aeruginosa is an opportunistic pathogen, which causes infections only in certain
individuals with impaired host defenses as for instance in patients undergoing
immunosuppressive therapies (cancer treatment), patients suffering from human
immunodeficiency virus infections, patients with an extensive damage of primary
barriers (burn wounds), and those with cystic fibrosis (CF) (Govan and Deretic,
1996). CF is an autosomal recessive disorder caused by mutations in a single gene
on the long arm of chromosome 7 that encodes the cystic fibrosis transmembrane
conductance regulator (CFTR) (Riordan et al., 1989). After identification of the CF
gene in 1989, the next years were associated with rapid expansion of knowledge
regarding the structure and function of the CF gene product and the molecular
mechanisms underlying the various phenotypic manifestations of the disease. CFTR
protein was shown to interfere with chloride ion transport in CF patients thus resulting
in the decreased secretion of mucins (Bear et al., 1992; Tümmler and Kiewitz, 1999;
Knowles and Boucher, 2002). This genetic defect leads to a number of medical
problems and complications for the patients with CF, including infections of the lung
with a broad spectrum of pathogens.
Chronic airway infection and the accompanying inflammatory response are clearly
the major clinical problems for CF patients today. CF has a unique set of bacterial
pathogens, including Staphylococcus aureus, P. aeruginosa, Burkholderia cepacia,
Haemophilus influenzae, Stenotrophomonas maltophilia and Achromobacter
xylosoxidans, that are frequently acquired in an age-dependent sequence (Gibson et
al., 2003).
P. aeruginosa is by far the most significant pathogen in CF. P. aeruginosa isolates
from the lungs of CF patients are quite different from those causing infections in other
settings. Their typical characteristics are not present in isolates causing initial
infections but appear to be selected within CF airways. Whereas early isolates
appear much like environmental isolates, later isolates are more resistant to
antibiotics and are frequently mucoid (Burns et al., 2001). Additional phenotypic
changes in CF isolates of P. aeruginosa include the loss of flagella dependent
motility (Luzar and Montie, 1985) and increased auxotrophy and tendency to form
biofilms (Singh et al., 2000; Thomas et al., 2000).  It has recently been reported that
antibiotic-resistant phenotype variants of P. aeruginosa with an enhanced ability to
Introduction
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form biofilms arise at high frequency in the lungs of patients with CF (Drenkard and
Ausubel, 2002). 
A large genome of P. aeruginosa offers a potential for a tremendous ability of this
bacterium to adapt to a wide variety of different environments, including the CF
airway. P. aeruginosa isolated from CF sputa have even larger genomes than the
laboratory strain, PAO1, suggesting that they have acquired new genes during their
adaptation, in addition to alterations in those already present (Spencer et al., 2003).
A high frequency of hypermutability has been identified in P. aeruginosa isolates from
patients with CF. This is likely caused by the milieu of the CF airway with large
numbers of infecting organisms and compartmentalization of infection, combined with
ineffective host defenses and ongoing antibiotic selective pressure (Oliver et al.,
2000, Gibson et al., 2003). 
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1.2. Pathogenic lifestyle of P. aeruginosa 
Just as varied as the clinical diseases caused by P. aeruginosa, this typical
nosocomial pathogen possesses a large variety of both cell-associated and
extracellular virulence factors. It is important to realize that the pathogenesis of P.
aeruginosa is not related to a single virulence factor, but to the precise and delicate
interplay between different factors, leading from efficient colonization and biofilm
formation, to tissue necrosis, invasion and dissemination through the vascular
system, as well as activation of both local and systemic inflammatory responses (Van
Delden, 2004).
1.2.1. Cell-associated virulence factors 
The first step in P. aeruginosa infections is the adherence to and colonization of host
epithelial surfaces. The primary P. aeruginosa adhesins for respiratory mucins are
the flagella cap protein (Arora et al., 1998) and flagellin (Feldman et al., 1998; Lillehoj
et al., 2002). Flagellum driven motility has been reported to enhance the efficiency of
surface colonization by P. aeruginosa (O´Toole and Kolter, 1998a) as well as P.
fluorescens (O´Toole and Kolter, 1998b). However, many P. aeruginosa strains
isolated from chronically infected CF airways do not produce flagella, thus indicating
that flagella plays a role only in the early step of infection and longer term
maintenance of the organism in this milieu involves other factors (Mahenthiralingam
et al., 1994). The other factors implicated in the adherence of P. aeruginosa to host
epithelium include type IV pili, covered by galactose-binding or mannose-binding
lectins, which account for 90 % of the adherence capacity (Ramphal et al., 1984; de
Bentzmann et al., 1996; Hahn, 1997), fimbrias (Vallet et al., 2001) the outer
membrane porin OprF (Azghani et al., 2002), lipopolysaccharide and alginate
(Gilboa-Garber, 1996; D´Argenio, 2004). The ability of P. aeruginosa to attach to
abiotic surfaces, to host tissues, or to each other, and the subsequent differentiation
of the microorganisms into biofilm, can be considered a major virulence trait in a
variety of infections (Watnik and Kolter, 2000). 
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1.2.2. Extracellular virulence factors
P. aeruginosa produces several extracellular products that after the initial
colonization can cause extensive tissue damage, bloodstream invasion, and
dissemination. In vivo studies have shown that P. aeruginosa mutants defective in
the production of individual factors are less pathogenic; however, the relative
contribution of a given factor may vary with the type of infection (Nicas and Iglewski,
1985). 
Alkaline protease is an important extracellular virulence factor implicated in the
corneal infections (Howe and Iglewski, 1984), degradation of the components of the
complement (Hong and Ghebrehiwet, 1992) and hydrolysis of fibrin and fibrinogen
(Shibuya et al., 1991). 
Exotoxin A catalyses the ADP-ribosylation and inactivation of elongation factor 2,
leading to inhibition of protein biosynthesis and cell death (Wick et al., 1990). Purified
exotoxin A is lethal for laboratory animals, thus confirming its role as a major
virulence factor of P. aeruginosa (Woods and Iglewski, 1983). 
LasA and LasB elastases are responsible for destruction of protein elastin, which
accounts for a significant part of human lung tissue and is an important component of
blood vessels (Galloway, 1991). Both elastases, LasB and LasA, have been found
and their transcription has been demonstrated in vivo in the sputum of CF patients
(Storey et al., 1992, Jaffar-Bandjee et al., 1995). LasB elastase is implicated not only
in the degradation of elastin and another tissue components (Heck et al., 1986), but it
also interferes with host defense mechanisms (Van Delden, 2004). 
Phospholipase C, which represents one of the two P. aeruginosa hemolysins, has
been shown to induce vascular permeability, organ damage and death in animal
models as well as to contribute to the release of inflammatory mediators (Berk et al.,
1987; Konig et al., 1996). Rhamnolipid, which is the second P. aeruginosa hemolysin
is a rhamnose-containing glycolipid biosurfactant with detergent-like structure
believed to be responsible for dissolving of the lung surfactant phospholipids, making
them more accessible to cleavage by phospholipase C (Liu, 1974). It is hypothesized
that both hemolysins, phospholipase C and rhamnolipid, may act synergistically to
breakdown lipids and lecithin and both contribute to tissue invasion by their cytotoxic
effects (Van Delden, 2004).
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Protease IV is a serine protease implicated in the degradation of complement
components as well as fibrinogen, plasmin and plasminogen (Engel et al., 1998a)
and plays an important role during corneal infections (Engel et al., 1997; Engel et al.,
1998b). 
P. aeruginosa produces two lipases, LipA and LipC, which were shown to enhance
the induction of inflammatory mediators by phospholipase C (Konig et al., 1996). It
has therefore been hypothesized that the simultaneous production of phospholipase
C and lipases might be dangerous to the host by inducing significant inflammation
(Konig et al., 1996; Van Delden, 2004).                  
Another exoproteins, including exoenzyme S, exoenzyme T, exoenzyme Y and
exotoxin U require close contact with host cells and are secreted via the type III
secretion pathway, using a complex secretion and translocation machinery to inject
the effector proteins directly into the cytoplasm of target cells (Frank, 1997; Yahr et
al., 1997). Exoenzyme S, which is produced by about 40 % of clinical isolates
(Sokurenko et al., 2001), does not contribute to initial colonization but it has been
postulated that it is responsible for tissue destruction and for bacterial dissemination
(Nicas et al., 1985a; Nicas et al., 1985b). Exoenzyme S is a bifunctional cytotoxin,
which disrupts actin filaments in eukaryotic cells with its amino terminus, whereas its
carboxyl terminus comprises an ADP-ribosyltransferase domain (Coburn et al.,
1989). Exoenzyme T together with exoenzyme S plays a role in the ribosylation of
ADP (Nicas and Iglewski, 1984; Barbieri, 2000), thus inhibiting wound healing,
exocytosis and cell cycle progression (Krall et al., 2000). The role of exoenzyme Y in
the pathogenesis of P. aeruginosa infections remains an enigma. Exotoxin U is
expressed in most isolates from corneal infections, in 40 % of isolates from acute
respiratory tract infections in non-CF and 10 % of CF isolates (Finck-Barbancon et
al., 1998; Hauser et al., 1998; Dacheux et al., 2000). The secretion of ExoU clearly
results in cytotoxicity in mammalian cells and current research suggests that it may
have a phospholipase activity (Rabin and Hauser, 2003), thus contributing to
degradation of eukaryotic cell membranes and subsequent cell death (Sato et al.,
2003).     
Pyocyanin is a blue redox active phenazine pigment that generates reactive oxygen
species, thus exposing host cells to oxidative stress (Britigan et al., 1999; Muller,
2002). It induces apoptosis and inhibits generation of superoxide by neutrophils and
inhibits proliferation of lymphocytes (Usher et al., 2002).
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Two P. aeruginosa siderophores, pyoverdine and pyochelin play a role in the uptake
of iron and regulation of virulence factors and were shown to be therefore required
for full expression of virulence of P. aeruginosa in animal models (Takase et al.,
2000; Lamont et al., 2002).
Hydrogen cyanide is a poison involved in the blockade of cytochrome oxidase and
subsequent inhibition of mitochondrial respiration and was shown to be responsible
for rapid paralytic killing of the nematodes C. elegans. 
Exopolysaccharides and alginate play an essential role in the formation of biofilms.
Alginate produced P. aeruginosa strains were proven to be more resistant to
antibiotics and disinfectants (Govan and Deretic, 1996). 
Due to its major role in the control of extracellular virulence factor production, the
quorum sensing circuit of P. aeruginosa could be also considered a virulence
determinant (Van Delden, 2004).     
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1.3. Quorum sensing: the power of cooperation in
the world of Pseudomonas
For many years, researchers thought of bacteria as individual cells designed to
proliferate under various conditions but unable to interact with each other and to
collectively respond to environmental stimuli, as it is typical for multicellular
organisms. This view began to change few decades ago with the discovery of the
cooperative regulation of luminescence in the Gram-negative marine bacterium
Vibrio fischeri (Nealson et al., 1970) and regulation of the genetic competence in the
Gram-positive bacterium Streptococcus pneumoniae (Tomasz, 1965). These bacteria
were shown to coordinate their behaviour via the secretion of specific signalling
molecules in a population density-dependent manner. During growth the bacteria
secrete these molecules, which accumulate in the surrounding environment as the
population density increases until a critical threshold concentration is reached, which
then triggers expression of certain sets of genes (Figure 1.1). This type of cell-to-cell
communication was termed “quorum sensing” in order to emphasize the fact that a
sufficient number of bacteria, the bacterial “quorum”, is needed to induce or repress
expression of target genes (Fuqua et al., 1994). The signalling molecules utilized by
quorum sensing systems are often acylated homoserine lactones (AHL) in the case
of Gram-negative bacteria (Figure 1.1), small peptides in the case of Gram-positive
bacteria or autoinducer-2 (AI-2), which has been found in both Gram-negative as well
as Gram-positive bacteria and therefore considered to be a universal bacterial
language, the “bacterial esperanto” (Winans, 2002). 
Since the discovery of population density dependent regulation of bioluminescence in
marine bacteria, cell-to-cell communication has been proven to play an important role
in the life of various bacterial species. Work of the past few years provided evidence
that bacteria not only form well-organised communities but also exchange
information with the other members of the community in order to coordinate their
activities. This allows a group of bacteria to launch a unified, coordinated response to
environmental stimuli and to accomplish tasks which would be difficult, if not
impossible, to achieve for a single bacterial cell. Furthermore, evidence has
accumulated that some bacterial signal molecules are used not only as population
density sensors in one species but also for communication between bacteria of
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different species or genera occupying the same ecological niche and even to interact
with their eukaryotic hosts. Beside bioluminescence and genetic competence,
quorum sensing is also involved in the regulation of a wide variety of different
physiological processes including antibiotic biosynthesis, swarming, swimming and
twitching motility, plasmid conjugal transfer, biofilm development or the production of
bacterial virulence factors in plant, animal or human pathogens (for recent reviews
see Miller and Bassler, 2001; Whitehead et al., 2001; Camara et al., 2002; Fuqua
and Greenberg, 2002; Lazdunski et al., 2004; Pappas et al., 2004).       
Fig. 1.1. The quorum sensing in Gram-negative bacteria. Quorum sensing in Gram-negative
bacteria involves two regulatory components: the transcriptional activator protein (R protein) and the
autoinducer molecule produced by autoinducer synthase. Accumulation of autoinducer occurs in a
population density dependent manner until a threshold concentration is reached. Subsequently the
autoinducer binds to and activates the R protein, which in turn induces or represses the expression of
target genes (de Kievit and Iglewski, 2000).  
One of the most extensively studied AHL-dependent cell-to-cell communication
system is the one of the opportunistic human pathogen Pseudomonas aeruginosa.
This bacterium, well known for its resistance against a variety of antibiotics, causes
serious infections in immunocompromised patients or individuals with cystic fibrosis
and is one leading source of nosocomial infections (Tümmler et al., 1991). Work of
the past few years showed that the quorum sensing circuitry that is operating in P.
aeruginosa is essential for the expression of virulence factors as well as for biofilm
Introduction
11
formation (Table 1.1). It has been speculated that quorum sensing dependent
regulation of pathogenic traits is a highly effective strategy to establish an infection,
as it gives the pathogen enough time to grow and inhabit its niche without displaying
itself to the immune system of the host. Virulence factors are expressed in concert
only when sufficient number of invading bacteria has accumulated, thus minimizing
the threat of eradication by host immune system and increasing greatly the chance
for successful infection (de Kievit and Iglewski, 2000; Greenberg, 2003).     
Table 1.1. Functions controlled by the quorum sensing circuitry in P. aeruginosa. 
Phenotypic traits under the control of quorum sensing in P. aeruginosa
Acyl homoserine lactone synthesis
Adhesins (lectins) biosynthesis
Biofilm formation
Exotoxin A biosynthesis
Hydrogen cyanide synthesis
Neuraminidase
Synthesis of the oxidative-stress responsive enzymes (catalase, superoxide dismutase)
Protease biosynthesis
Proteins of the type III secretion system
Pyocyanin synthesis
PQS synthesis
Rhamnolipid synthesis
Swarming motility
1.3.1. Paradigm of quorum sensing: bioluminescence in V.
fischeri
Quorum sensing was first described approximately 35 years ago in the early 1970s in
the marine luminescent bacterium V. fischeri (Nealson et al., 1970). This bacterium
lives in symbiosis with certain marine fish and squid species and provides them with
light in exchange for nutrients (Graf and Ruby, 1998). The best-characterized model
system of such a symbiotic relationship is the one between V. fischeri and the squid
Euprymna scolopes (Ruby, 1996). E. scolopes posses a specialized light organ,
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which is colonized from the early stages of development by V. fischeri  (Montgomery
and McFall-Ngai, 1994). V. fischeri can be found at low population densities as a
free-living organism in seawater (102 cells ml-1). However, only when the bacteria are
living within the light organ of the squid, where the population density is very high
(1010 – 1011 cells ml-1) the cells emit detectable amounts of light (Boettcher and Ruby,
1995) (Figure 1.2). It was shown that during growth, V. fischeri synthesizes an
extracellular factor, which was originally named autoinducer because expression of
bioluminescence was found to be positively feedback-regulated, and whose structure
was later identified as N-(3-oxohexanoyl)-L-homoserine lactone (3-oxo-C6-HSL). This
molecule, which is synthesized from S-adenosylmethionine (SAM) and carrier protein
(acyl-ACP) via LuxI, was shown to freely diffuse through the bacterial cell membrane
(Eberhard et al., 1981; Kaplan and Greenberg, 1985; Moré et al., 1996). After
reaching a critical threshold concentration, molecules of the autoinducer bind to their
cognate receptor protein, LuxR, which in turn activates the expression of genes
responsible for the luminous phenotype (the lux regulon) (Figure 1.2). 
Fig. 1.2. Quorum sensing paradigm: The LuxR-LuxI quorum sensing system of V. fischeri.
Autoinducer synthase, encoded by luxI, synthesizes N-(3-oxohexanoyl)-L-homoserine lactone (3-oxo-
C6-HSL), which diffuses across the cell envelope and accumulates intracellularly only at high
population density. After reaching a critical threshold concentration, it binds to the LuxR receptor
protein and LuxR-3-oxo-C6-HSL complex in turn activates transcription of the luxICDABE operon
which is responsible for bioluminescence (Pappas et al., 2004). 
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The lux regulon comprises eight genes, organised into two divergently transcribed
transcription units, which are separated by an intergenic regulatory region
(Engebrecht et al., 1983; Engebrecht and Silverman, 1984). The leftward
transcription unit consists of luxR, which encodes the autoinducer-binding LuxR. The
binding of 3-oxo-C6-HSL to LuxR results in a complex that activates transcription of
the rightward lux operon. This operon contains the luxI gene, encoding the 3-oxo-C6-
HSL synthase (LuxI), followed by five genes crucial for light production (luxCDABE).
The LuxR protein is modular in structure with the C-terminal domain necessary for
DNA binding and the N-terminal region required for autoinducer binding. It is believed
that binding of 3-oxo-C6-HSL to the N-terminal domain of the LuxR induces
conformational changes, which then allow the C-terminal region of the protein to bind
to a 20 bp inverted repeat sequence, designated the lux box, in the lux intergenic
region, which in turn activates the expression of the luxICDABE operon (Stevens et
al., 1994; England and Greenberg, 1999; Fuqua et al., 2001). Due to the fact that
LuxI itself is encoded by this operon a positive-feedback regulatory loop is created
once the quorum sensing is triggered. 
1.3.2. Hierarchical control of quorum sensing in P.
aeruginosa   
AHL-dependent cell-to-cell communication systems similar to the one of V. fischeri
(Figure 1.2) have been identified recently in various bacterial species, including P.
aeruginosa. The analysis of the fully sequenced P. aeruginosa genome revealed that
more than 9% of the assigned open reading frames (ORFs) encode known or
putative transcriptional regulators and two-component systems (Stover et al., 2000).
It is hypothesized that such a large amount of regulators gives this bacterium an
opportunity to adapt to a wide variety of different environments and thus represents a
key feature for the understanding of its enormous metabolic versatility. 
When investigating the regulation of quorum sensing in P. aeruginosa, two pairs of V.
fischeri LuxR and LuxI homologues have been identified, which are the major
components of two quorum sensing systems operating in this organism: the las
system, which consists of the transcriptional activator LasR and the AHL synthase
LasI, which directs the synthesis of N-3-oxo-dodecanoyl-homoserine lactone (3-oxo-
C12-HSL) and the rhl system, which consists of the transcriptional regulator RhlR and
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the AHL synthase RhlI (Figure 1.3), which directs the synthesis of N-butanoyl-
homoserine lactone (C4-HSL) (Passador et al., 1993; Latifi et al., 1995; Pearson et
al., 1995). 
While P. aeruginosa cells are freely permeable to C4-HSL, active transport via the
MexAB-OprM multidrug efflux pump is involved in the secretion of 3-oxo-C12-HSL
(Pearson et al., 1999). The las system was shown to be involved in the regulation of
various virulence factors, as well as lasI itself, thereby creating a positive regulatory
feedback loop. Likewise, the rhl system affects the expression of a broad spectrum of
genes. Some of the quorum sensing regulated genes are under control of both
quorum sensing systems, and others are regulated specifically by either the las or
the rhl system. However, the two systems do not operate independently as the LasR-
3-oxo-C12-HSL complex is also positively regulating transcription of RhlR and RhlI
(Latifi et al., 1996; Pesci et al., 1997). A recent study on the transcriptional regulation
of rhlR revealed that expression of this gene is not only dependent on LasR but also
on Vfr (see below) and RhlR itself, indicating that the gene is subject to negative
autoregulation (Medina et al., 2003a). Furthermore, RhlR was shown to form a
homodimer that can be dissociated into monomers by 3-oxo-C12-HSL (Ventre et al.,
2003). In conclusion, these data provide strong evidence that the quorum sensing
systems in P. aeruginosa are hierarchically arranged with the las system being on
top of the signalling cascade. 
In a recent study the transcriptional regulation of the promoter region of the rhlAB
operon, which encodes the enzyme rhamnosyltransferase 1, an enzyme involved in
the biosynthesis of the surfactant rhamnolipid, was studied in detail (Medina et al.,
2003b). This study showed that RhlR binds to specific sequences upstream of rhlAB
independently of the presence or absence of C4-HSL. However, in the former case
transcription is activated, whereas in the latter case RhlR represses transcription.
Such dual activator-repressor activities of LuxR-type regulators appear to be
important for fine tuning of quorum sensing in P. aeruginosa.    
1.3.3. Additional layers of quorum sensing regulation  
The P. aeruginosa quinolone signal 2-heptyl-3-hydroxy-4-quinolone (PQS), produced
maximally during the late stationary phase of growth adds a further level of
complexity to the quorum sensing network, as it provides a link between the las and
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rhl systems by modulating expression of rhlRI and lasRI (McKnight et al., 2000). The
direct precursor of PQS, 4-hydroxy-2-heptylquinoline (HHQ), is first released from
and then taken up again by the cells, before it is eventually converted into PQS by
the action of PqsH, whose expression is controlled by the las system (Gallagher et
al., 2002; Déziel et al., 2004). Recent work has shown that the PQS signal molecule
is able to overcome the cell-density-dependency of quorum sensing and can also be
produced in the absence of LasR (Diggle et al., 2003). The transcription of genes
required for PQS synthesis is not only positively regulated by the las quorum sensing
system but also under negative control of the rhl system. As a consequence, PQS
production is dependent on the ratio of 3-oxo-C12-HSL and C4-HSL, suggesting a
delicate balance between the two quorum sensing systems (McGrath et al., 2004). 
The quorum sensing cascade of P. aeruginosa is subject to regulation by a number
of additional regulatory factors (Figure 1.3). One important factor is the two-
component response regulator gacA, a highly conserved gene primarily responsible
for the control of virulence factors and antibiotics production in fluorescent
pseudomonads, but also shown to be involved in the regulation of C4-HSL production
in P. aeruginosa. A model has been proposed that places GacA upstream of LasR
and RhlR (Reimmann et al., 1997). Likewise, the global transcriptional regulator
AlgR2 (AlgQ) was suggested to play a role in modulating quorum sensing in P.
aeruginosa. Although originally implicated in alginate production, recent studies have
shown that AlgR2 specifically binds to the LasR and RhlR promoter regions thereby
downregulating the entire quorum sensing cascade (Ledgham et al., 2003a).
Furthermore, an important role in the quorum sensing circuitry was suggested for the
RsaL repressor, as it competes with the LasR-3-oxo-C12-HSL complex for the binding
to the lasI promoter, thus negatively regulating lasI transcription (de Kievit et al.,
1999; Fagerlind et al., 2004). Polyphosphate kinase, encoded by ppk, was shown to
have a positive impact on 3-oxo-C12-HSL and C4-HSL synthesis and subsequently on
the overall virulence of P. aeruginosa (Rashid et al., 2000). Recent work identified a
gene mvaT, which, when mutated, led to increased and premature expression of
quorum sensing regulated genes, indicating that MvaT is required for the appropriate
timing of expression of the quorum sensing regulon (Diggle et al., 2002). Moreover,
quorum sensing is regulated at the posttranscriptional level by the RsmA/RsmZ
system (Pessi et al., 2001; Heurlier et al., 2004) as well as by DksA (Jude et al.,
2003). The quorum sensing signalling network of virulence is linked with the cAMP-
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signalling network of virulence (Wolfgang et al., 2003) via the transcriptional regulator
Vfr (Albus et al., 1997), a member of the cAMP receptor protein family. Vfr is
important for the regulation of exotoxin A and protease, which is due in part to its
influence on the expression of lasR/lasI. In addition, Vfr positively regulates the
expression of over a hundred genes (Wolfgang et al., 2003), including those
encoding the type III secretion system that delivers toxic effector proteins directly into
host cells. In P. aeruginosa cAMP is primarily synthesized by CyaB, a class III
membrane-associated adenylate cyclase, which together with Vfr have been shown
to act as a master regulator of virulence gene expression in P. aeruginosa (Wolfgang
et al., 2003; Smith et al., 2004). 
Bioinformatic analyses of the P. aeruginosa PAO1 genome revealed that, in addition
to the two AHL signal receptors LasR and RhlR, the P. aeruginosa genome encodes
additional LuxR homologue, termed QscR. The LuxR homologue, QscR, whose
synthesis is regulated by GacA, has been shown to modulate the timing of quorum
sensing gene expression by repressing transcription of lasI (Chugani et al., 2001). In
the absence of AHLs, QscR forms multimers interacting with itself and heterodimers
with LasR or RhlR, thus offering an another possibility of fine tuning the quorum
sensing circuitry in concert with other regulatory proteins (Lendgham et al., 2003b).
The alternative sigma factor RpoN was shown to negatively affect quorum sensing in
P. aeruginosa, as mutation of rpoN was found to elevate levels of both signal
molecules (Heurlier et al., 2003; Thompson et al., 2003). Furthermore, the stationary
sigma factor RpoS was demonstrated to be involved in the modulation of expression
of a large number of quorum sensing genes as well as the type III secretion system
and anti-host effector proteins (Hogardt et al., 2004; Schuster et al., 2004). All the
regulatory systems mentioned add additional levels of complexity to quorum sensing
circuitry of P. aeruginosa (Figure 1.3). 
According to genome-wide microarray-based transcriptome analyses, approximately
5 % of all P. aeruginosa genes are quorum sensing regulated. Comparing the
expression profiles of wild type strains with those of respective QS mutants by the aid
of DNA microarrays not only confirmed the quorum sensing dependent expression of
many genes previously described as quorum sensing regulated but also allowed the
identification of a large number of novel genes. Quorum sensing in P. aeruginosa
was shown to modulate expression of a broad spectrum of extracellular proteins,
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secondary metabolites, regulatory proteins as well as many proteins belonging to the
class of conserved hypotheticals of unknown function (Hentzer et al., 2003; Schuster
et al., 2003; Wagner et al., 2003).
Fig. 1.3. The quorum sensing network in P. aeruginosa. For each circuit in the cell the interactions
between the different QS systems are indicated by arrows. Signals from the environment, the
intracellular metabolic status and other regulators, such as RpoS, RsmA and MvaT, also interface with
this cellular circuitry (Lazdunski et al., 2004). 
 
Introduction
18
1.3.4. Role of quorum sensing in host-pathogen
interactions
Quorum sensing was found to modulate the expression of a wide variety of bacterial
virulence genes (Passador et al., 1993). The multiple extracellular pathogenic traits
regulated by quorum sensing in P. aeruginosa include elastases, alkaline protease,
exoenzyme S, neuraminidase, hemolysin, lectins, pyocyanin, rhamnolipids, hydrogen
cyanide or oxidative stress-responsive enzymes catalase and superoxide dismutase
(Passador et al., 1993; Latifi et al., 1995; Pearson et al., 1997; Hasset et al., 1999;
Pessi and Haas, 2000; Winzer et al., 2000) (Table 1.1). 
All these extracellular virulence factors are crucial for the competence of P.
aeruginosa to establish and maintain the infection. Mutants defective in quorum
sensing are typically compromised in their ability to establish a successful infection.
The importance of quorum sensing for the pathogenicity of P. aeruginosa has been
demonstrated in a number of animal models. Mutants defective in quorum sensing
were substantially less pathogenic than their parental strains in the burned mouse
model, the mouse agar bead model or in the neonatal mouse model of pneumonia
(Tang et al., 1996; Rumbaugh et al., 1999; Wu et al., 2000a). Quorum sensing
mutants also showed reduced virulence in a number of non-mammalian infection
models, including Caenorhabditis elegans, Dictyostelium discoideum and
Arabidopsis thaliana (Rahme et al., 1995; Tan et al., 1999; Cosson et al., 2002).                          
Direct involvement of quorum sensing in the host infection process was also
confirmed by experiments analyzing sputum samples from CF patients colonized with
P. aeruginosa (Middleton et al., 2002). CF sputum was shown to contain mRNA for
the major regulators of quorum sensing in sufficient amounts to drive heterologous
expression of AHL-dependent fusion reporter genes (Singh et al., 2000; Erickson et
al., 2002). Similar experiments, exploiting mice infected with P. aeruginosa together
with an E. coli AHL reporter strain, confirmed in vivo production of AHLs in the lungs
of the host (Wu et al., 2000b).
The quorum sensing system of P. aeruginosa contributes to its pathogenesis not only
by regulating expression of virulence factors, but also by inducing inflammation.
Dermal injections in mice stimulated the production of proinflammatory cytokines and
arachidonic acid metabolites (Smith et al., 2002). 3-oxo-C12-HSL exerts numerous
immunomodulatory activities on lymphocytes, macrophages and antibody production,
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influences the balance between Th1 and Th2 cells (Telford et al., 1999) and strongly
promotes the production of interleukin 8 (Smith et al., 2001). On the other hand, if the
human host is infected with P. aeruginosa, his innate defence is able to inactivate
quorum sensing signal molecules. Airway epithelium and body fluids can inactivate 3-
oxo-C12-HSL but not C4-HSL (Chun et al., 2004).
  
1.3.5. Involvement of quorum sensing in the biofilm
formation      
Since van Leeuwenhoek’s discovery that bacteria tend to attach and form organised
communities or biofilms on surfaces, this field of microbiology has attracted much
attention. Biofilms can be characterised as assemblages of surface associated
microorganism enclosed in a slime-like extracellular polymeric substance matrix. The
ability of P. aeruginosa to form biofilms has severe implications for infected patients,
as cells grown in biofilms are much more resistant against host defense systems and
exhibit increased resistance against a variety of antibiotics (Greenberg, 2003). 
Intriguingly, P. aeruginosa biofilms are often not just flat layers of bacterial cells but
rather complicated structures consisting of tower-and mushroom-shaped
microcolonies. An involvement of the quorum sensing circuitry in the regulation of
biofilm formation was originally reported by Davis et al., 1998 (Figure 1.4). In this
study it was shown that a lasI mutant of P. aeruginosa only forms flat and
undifferentiated biofilms when compared with the wild type, which formed
characteristic microcolonies separated by water channels. Importantly, the lasI
mutant biofilm exhibited greater sensitivity to the biocide dodecyl sulphate than did
the wild type biofilm. On the basis of this observation is has been suggested that the
las system is required for the development of a typical biofilm architecture (Figure
1.4). In other studies, using slightly changed experimental settings, no differences
between the biofilms of the wild type and those formed by signal negative mutants
were observed (Stoodley et al., 1999; Heydorn et al., 2002). Interestingly, Purevdorj
et al. (2002) reported minor structural differences between wild type and mutant
biofilms, but these differences were only apparent when particular hydrodynamic
conditions were used for growing the biofilms. Finally, in a very recent study on the
effects of the two quorum sensing systems on biofilm structures using advanced
image analysis tools evidence was presented that in fact both quorum sensing
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systems of P. aeruginosa participate in the regulation of biofilm development but that
the differences were only apparent in rather old biofilms, i.e. after 5 to 7 days of
incubation (Hentzer et al., 2004). In conclusion, these data suggest that the
experimental settings have a major impact on the structural development of P.
aeruginosa biofilms and that under certain conditions yet unidentified quorum
sensing regulated factors are required for biofilm maturation.
a)
b)
Fig. 1.4. Quorum sensing and biofilms. Development of P. aeruginosa biofilms involves a
programmed pathway, with quorum sensing playing an important role in the last step of conversion of
microcolonies on a surface into a mature biofilms with cells enclosed in a slime-like extracellular
polymeric substance matrix (Fuqua and Greenberg, 2002). 
a) The steps involved in biofilm development.
b) Confocal-microscope images of a P. aeruginosa biofilm developing over time on a microscope
slide. The cells are producing the green fluorescent protein. The mushroom and tower-like
structures that appear by 8 days are 100 m high. 
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1.3.6. Exploiting quorum sensing for antimicrobial therapy       
Many studies warn before the threat of emerging bacterial strains, which are partially
or completely resistant against a broad spectrum of classical antibiotics. The rapidly
increasing frequency of the occurrence of multidrug resistant strains is demanding
novel therapeutic approaches. Given that that the quorum sensing circuitry in P.
aeruginosa plays an important role in controlling pathogenicity as well as biofilm
formation, it represents a highly attractive target for the development of novel
antimicrobial agents (Passador et al., 1993; Davies et al., 1998; Hartman and Wise,
1998). It has been suggested that the use of AHL antagonists that specifically inhibit
expression of pathogenic traits without affecting growth of the bacterium has the
advantage of minimizing the possibility of selecting resistant mutants. Although such
mutants may eventually arise, they would not have a selective growth advantage and
thus would not out-compete the parental strain (Hentzer and Givskov, 2003).
Disruption of quorum sensing may be accomplished in several ways: (i) blockade of
AHL synthesis, (ii) AHL signal molecule degradation, and (iii) inhibition of AHL
receptor activation. Although previous work has provided evidence that S-adenosyl
methionine analogs can inhibit quorum sensing in P. aeruginosa because of
blockage of AHL synthesis (Parsek et al., 1999), no specific inhibitors, i.e.
compounds that would not also affect bacterial growth, have yet been derived on this
basis. Dong et al., 2001 isolated the first enzyme (AiiA) from Bacillus sp. that
inactivates AHLs by hydrolysing the lactone bond of the molecules, a process that
was named quorum quenching. Work of the past few years identified a large number
of additional genes from various organisms that encode enzymes exhibiting AHL-
inactivating activities. More importantly, it was also shown that heterologous
expression of these enzymes in P. aeruginosa not only reduces production of
virulence factors but also attenuates the pathogenicity of the organism (Reimmann et
al., 2002; Lin et al., 2003). However, whether AiiA or a related enzyme is applicable
for treatment of human infections remains to be seen. 
At present, the most promising strategy for quorum sensing disruption appears to be
the blockage of the AHL receptor protein. In 1996 Givskov et al. demonstrated that
the macroalgae Delisea pulchra produces compounds, commonly known as
halogenated furanones, which have the ability to interfere with AHL-regulated
processes. While the exact mode of action of the furanones remains to be elucidated,
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it was shown that these compounds not only block cell-to-cell communication in a P.
aeruginosa biofilm but, upon prolonged incubation, also cause the sloughing of the
biofilm (Hentzer et al., 2002). More recently, DNA microarrays were used to provide
unambiguous evidence that a certain furanone compound specifically interferes with
the expression of quorum sensing regulated genes (Hentzer et al., 2003). More
importantly, this study also showed that this compound can clear P. aeruginosa lung
infections in a mouse model, indicating that furanone compounds indeed are very
promising candidates for the development of novel agents for treatment of
pseudomonads infections (Hentzer and Givskov, 2003). Evidence has accumulated
over the past few years that inhibition of quorum sensing is a commonly used
strategy of eukaryotic organisms for battling undesired bacteria. In fact, production of
AHL antagonists was demonstrated for different higher plants (Teplitski et al., 2000)
as well as the animal Flustra foliacea (Peters et al., 2003). 
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1.4. Hidden and dangerous: Intracellular pathogens 
To establish and maintain a successful infection, microbial pathogens have evolved a
variety of strategies, including intracellular lifestyle, which allow them to invade the
host, avoid or resist the innate immune response, damage the cells, and multiply in
specific and normally sterile regions (Cossart and Sansonetti, 2003). Some bacteria
are obligate intracellular parasites that can only replicate inside their host cells. Other
bacteria can replicate extracellularly, but choose an intracellular lifestyle to obtain a
favourable niche within the host (Gruenheid and Finlay, 2003). 
During phagocytosis by phagocytes, bacteria play a passive role. In contrary, some
invasive bacteria as for instance Yersinia pseudotuberculosis, Listeria
monocytogenes, Shigella or Salmonella can actively induce their own uptake by
phagocytosis in normally nonphagocytic cells and then to establish a protected niche
within which they survive and replicate, or disseminate from cell to cell by means of
an actin-based motility process (Isberg and Barnes, 2001; Cossart et al., 2003;
Galan, 2001; Sansonetti, 2001; Yoshida et al., 2002; Finlay and Cossart, 1997).
Once inside a host cell, an intracellular pathogen must use a strategy to avoid or
withstand or suppress the maturation of its vacuole into a phagolysosome. Some
pathogens as for instance Coxiella burnetii have adapted to resist and thrive in the
harsh phagolysosomal environment, others (Listeria, Shigella, Rickettsia) lyse their
vacuole and escape to the cytoplasm and the members of the last group
(Mycobacterium tuberculosis, Salmonella) are able to actively modify the vacuole to
suit their needs (Méresse et al., 1999; Gruenheid and Finlay, 2003). M. tuberculosis
was shown to interfere with intracellular trafficking events, thus preventing the fusion
of a phagosome containing the internalised bacterium with the host cell’s lysosomal
system (Russel, 2003; Stewart et al., 2003). 
Furthermore, the apoptosis, cell cycle-and inflammation-related signalling pathways
were also shown to be manipulated by intracellular pathogens in order to take over
the fate of their host cells (Hilbi et al., 1998; Hersh et al., 1999; Orth et al., 1999;
Muller et al., 1999; Tran Van Nhieu et al., 2003). However, the ultimate success of an
infection in all cases depends on the messages that the two players-the bacterium
and the cell send to each other (Cossart and Sansonetti, 2003). 
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1.4.1. Intracellular survival in PMN
Macrophages and polymorphonuclear neutrophils (PMNs) are “guards” that seek and
destroy invading pathogens. The PMN is a small leukocyte, about 10 µm in diameter,
which is well-known as a first line of defence against invading pathogens (König et
al., 1992). PMNs can be found in the bloodstream or attached to the epithelium and
are capable of active moving towards the site of inflammation (Lala et al., 1992;
Smith, 2000). Moreover, PMNs possess an extensive array of antibacterial weaponry
(Elsbach, 1998; Gudmundson and Agerberth, 1999). Elimination of invading
microorganisms is caused by phagocytosis, a process whereby the pathogens are
engulfed into a plasma-derived phagosome (Scott et al., 2003). Following formation,
the phagosome sequentially fuses with a series of endomembrane compartments
and thereby acquires microbicidal and degradative properties (Beron et al., 1995;
Aderem and Underhill, 1999; Tjelle et al., 2000). Prior to phagocytosis of target
microorganism, the PMN begins to consume oxygen, a process known as oxidative
or respiratory burst. This oxidative burst is a consequence to the assembly of a
membrane-associated NADPH oxidase from membrane components gp91phox and
gp22phox and cytosolic components p67phox and p47phox with the participation of
several auxiliary proteins, including the small GTP binding protein, rac2 (Rosen,
2004). The NADPH oxidase transfers electrons from NADPH to dissolved molecular
oxygen thus allowing formation of superoxide anions and reactive antimicrobial
oxygen species in the phagolysosomes which contributes greatly to intensification of
the antimicrobial features of these compartments. 
Intracellular survival in host defence cells is the typical lifestyle of a few obligatory
pathogens; however, few pathogenic bacteria have developed successful
mechanisms to modify host cell metabolism, that enable them to survive and
replicate within potentially lethal PMNs. Among the most interesting bacterial
mechanisms are the type III and type IV secretion systems, which represent a hollow
tube structures penetrating the eukaryotic cell membranes and serve as a conduit for
the injection of bacterial exoproducts into the host cytosol (Hueck, 1998; Cornelis,
2002; Fischer et al., 2002; Sexton and Vogel, 2002; Nagai and Roy, 2003). The
injected effector molecules, variable from species to species and even among strains
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of the same species, modify the metabolism of the host cell in the fashion that
presumably benefits the survival and replication of the microorganism (Rosen, 2004).
Human pathogenic Yersinia species (Y. pestis, Y. enterocolitica, Y.
pseudotuberculosis) evade phagocytosis by adhesion to the surface of PMNs or
opsonization and by subsequent injection of the Yop (Yersinia outer proteins) into the
cytosol of PMNs, which results in disorganization of actin polymerisation that
suppress active phagocytosis (Grosdent et al., 2002). In contrary, an obligate
intracellular pathogen, Anaplasma phagocytophilum needs to be phagocyted by
PMNs, but is able to actively suppress oxidative burst by PMNs thus not allowing
them to generate antimicrobial oxygen species, dioxygen and hydrogen peroxide
(Wang et al., 2002). Furthermore, Anaplasma was shown to be able to facilitate its
intracellular survival in PMNs by suppression of the fusion of phagosomes with
lysosomes and reduction of PMN apoptosis (Gokce et al., 1999; Scaife et al., 2001).
Salmonella typhimurium exploits one of its pathogenicity islands, SPI-2 (Salmonella
pathogenicity island 2) which encodes type III secretion system and which, when in
close contact with phagocytes, prevents assembly or misdirects the localization of
the phagocyte NADPH oxidase to the phagosome (Vazquez-Torres et al., 2000;
Gallois et al., 2001; Vazquez-Torres and Fang, 2001). Interestingly, Escherichia coli
is able to mount a defensive response to the reactive oxygen species generated by
PMNs by increasing synthesis of antioxidant enzymes which are under the control of
an oxidant-sensing transcription factor, OxyR (Staudinger et al., 2002). 
PMN-mediated phagocytosis is also known as the host’s most proficient
antipseudomonal weapon (Döring et al., 1995). Even though, around 20% of
analyzed P. aeruginosa isolates from the lungs of CF patients were shown to be able
to overcome this defense mechanism by increased cytotoxicity towards PMNs, which
leads to oncosis and lysis of PMNs. (Dacheux et al., 2000). Investigation of this
phenomenon has led to the identification of a novel regulatory system for type III
secretion and subsequent cytotoxicity towards PMNs (Dacheux et al., 2002). P.
aeruginosa strain TB (TBCF10839) capable of survival and replication in PMNs
irrespective of whether they were isolated from patients with CF or healthy donors,
that combats PMNs by other, type III-independent mechanisms has been detected in
the late 1980s (Tümmler, 1987). 
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1.4.2. Intracellular survival of P. aeruginosa TB in PMN
TB (TBCF10839 isolate) is a highly virulent strain of P. aeruginosa, which was
isolated in 1983 from the sputum of a CF patient who had suffered from an acute and
chronic infection with P. aeruginosa. The patient was severely ill and this P.
aeruginosa strain had been eradicated from his airways only by the high-dose
antipseudomonal chemotherapy (Tümmler, 1987). TBCF10839 was the most virulent
isolate from strain TB isolates that were frequently identified in CF patients and burn
patients at the Medizinische Hochschule Hannover in the 1980s (Tümmler et al.,
1991; Kiewitz and Tümmler, 2000). 
While examining the survival rate of different P. aeruginosa strains in freshly isolated
PMNs, the reason for the high virulence of strain TB (TBCF10839) has been
uncovered. Whereas the genetic reference strain PAO1 was efficiently phagocytosed
and lysed under standard conditions, the cfu of TBCF10839 initially declined within
the first 30 minutes but continuously increased thereafter indicating cell growth
(Miethke, 1985).  Electron microscopy revealed that after 30 minutes only cell debris
was visible from P. aeruginosa PAO1 in the phagolysosomes (Figure 1.5).
Fig. 1.5. Electron micrograph of P. aeruginosa strain PAO1 incubated with granulocytes.
Bacteria were added at a multiplicity of infection (MOI) 20 and incubated at 37 oC for 30 min.
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In contrast, P. aeruginosa strain TB (TBCF10839) in phagolysosomes was still intact,
thus confirming its increased survival ability in PMNs as observed by Miethke, 1985
(Figure 1.6).
Fig. 1.6. Electron micrograph of P. aeruginosa strain TBCF10839 incubated with granulocytes.
Bacteria were added at a multiplicity of infection (MOI) 20 and incubated at 37 oC for 30 min.
Interestingly, by 60 minutes and thereafter the TBCF10839 bacteria were shown to
multiply in the phagolysosomes (Wiehlmann, 2001). 
Fig. 1.7. Electron micrograph of P. aeruginosa strain TBCF10839 incubated with granulocytes.
Bacteria were added at a multiplicity of infection (MOI) 20 and incubated at 37 oC for 60 min.
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Live P. aeruginosa TBCF10839 bacteria as well as debris from another bacterial cells
were shown to be present in the same vacuole, thus revealing that the uptake of the
bacteria by the PMN does not prevent the subsequent maturation of phagosomes
resulting in their fusion with lysosomes (Figure 1.7). Moreover, the lysis of the
phagolysosomal membrane was observed at higher magnification, thus allowing the
bacteria to escape to the cytosol of the PMN. Therefore, the TBCF10839 bacteria
were shown to reside not only in the phagolysosomes of the PMNs but also in the
extracellular space and in the cytosolic compartment. These experiments showed
that the resistance of P. aeruginosa TBCF10839 to the harsh conditions in the PMN
phagolysosomes and thus its survival ability in PMNs is much higher than that of the
common P. aeruginosa strains.    
The enhanced resistance of P. aeruginosa TBCF10839 towards PMNs is not limited
to those of CF patients. PMNs from 40 tested healthy donors consistently showed all
the same phenotype of bacterial growth in the phagocytosis assay under standard
conditions of a tenfold excess of bacteria over PMNs. This shows that the
opportunistic pathogen P. aeruginosa can convert into a highly virulent
microorganism (Wiehlmann et al., 2002). 
Generally, the intracellular growth in PMNs is very rare amongst bacteria and has yet
not been reported for P. aeruginosa. Interestingly, as shown above, P. aeruginosa
TBCF10839 not only survives but also replicates in PMNs. Moreover, P. aeruginosa
TBCF10839 does not need a lag phase for replication in PMNs that is typical for
other intracellular pathogens to adapt to harsh conditions in phagolysosomes
(Philpott et al., 2001). All known evidence indicates that some novel mechanisms
operate in the P. aeruginosa TBCF10839 allowing this bacterium to thrive in PMNs. 
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1.5. DNA microarray technology
We are witnessing a remarkable change in the scale of molecular microbiological
research and we are entering an era of “big science”. In the past decade we have
moved from a time when entire research papers were based on the sequencing of a
single gene or operon to a single paper describing the sequence of the whole
genome. The completion of microbial genomes is continuing fastly
(http://www.tigr.org/tdb/mdb/mdbcomplete.html) and the availability of this level of
genetic information has spawned the terms “functional genomics”, “transcriptomics”
(Velculescu et al., 1997) and “proteomics” (Wasinger et al., 1995), which describe the
large-scale application of mass mutagenesis, gene expression profiling and global
protein analysis. Assessment of transcription at the genomic scale has been
achieved with DNA microarrays, which are glass slides containing an ordered mosaic
of the entire genome as a collection of either oligonucleotides (high-density
oligonucleotide microarrays) or polymerase chain reaction (PCR) products
representing individual genes (commonly referred as cDNA microarrays or spotted
microarrays). In the spotted microarray, presynthesized single-stranded or double-
stranded DNA is bound or 'printed' onto glass slides. The DNA can be generated
from cloned, synthesized or PCR-amplified material. Because of the technical
simplicity of this approach, spotted microarrays can be produced in house as well as
purchased from commercial providers. High-density oligonucleotide arrays are
constructed by synthesizing short (25-mer) oligonucleotides in situ on glass wafers
using a photolithographic manufacturing process and are thus available only from
commercial vendors (Lipshutz et al., 1999). 
Since the first report of DNA microarray technology in 1995 (Schena et al., 1995) the
potential of DNA microarrays has certainly captured the imagination of biologists
worldwide. The major advantage of microarrays is their ability to measure
simultaneously the presence of tens of thousands of different nucleic acid
sequences. The recent innovative robotic techniques facilitated the construction of
microarrays containing up to 50 000 genes on a single slide (DeRisi et al., 1996;
Shalon et al., 1996). This allows a single hybridisation to be performed against
multiple replicates of a single bacterial genome, or against copies of several
unrelated genomes on a single glass slide (Lucchini et al., 2001). Thus, this
technique permits the quantification of specific genes and their expression patterns in
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a comprehensive genome-wide framework. Although expensive relative to other
quantitative hybridization and amplification methods, the high-throughput capacity
makes it a cost-effective technique for a variety of applications (Kato-Maeda et al.,
2001). 
The application of microarray technology is only limited by our imagination. Thus
microarrays have been already used with success to identify targets for novel drugs
(Braxton and Bedilion, 1998; Anzick and Trent, 2002), to study genetic polymorphism
of pathogenic bacteria (Gingeras et al., 1998; Troesch et al., 1999; Salama et al.,
2000; Kato-Maeda et al., 2001; Fitzgerald et al., 2003), as well as to study microbial
evolution (Winzeler et al., 1998; Gingeras et al., 1998; Behr et al., 1999) and to
analyze gene expression in vivo (Lochkart et al., 1996; Luo et al., 1999; Wang et al.,
2000). Moreover, DNA microarrays can be also used to analyze the host-pathogen
interactions (Manger and Relman, 2000; Schoolnik, 2002; Brooks et al., 2003). A
robust microarray database with microbial response profiles from a wide variety of
well-characterized environmental conditions can allow more insightful interpretation
of transcription patterns recorded in novel host environments. Finally the integration
of host response data with bacterial response can provide a more complete
understanding of the two-way conversation between host and pathogen (Relman,
2002).  
One of the most impressive examples of the use of microarrays for bacterial research
is implicated with the investigation of the whole regulons. The definition of important
regulons by the use of appropriate regulatory mutants provides the framework for a
better understanding of complex cellular responses (Lucchini et al., 2001). 
Introduction
31
1.6. Objectives 
During the last decades we have witnessed an explosion of information about the
organisation of many bacterial genomes, including that of the opportunistic human
pathogen P. aeruginosa (Stover et al., 2000). Thus, one of the greatest challenges of
the future as well as of the presented thesis is the functional analysis of putative
ORFs identified in this genome sequencing project and their integration into
regulatory networks and metabolic pathways.  
Besides the availability of the complete genome sequence, the construction of the
signature tagged mutagenesis (STM) library of P. aeruginosa strain TB by a previous
Ph.D. student in the group (Wiehlmann, 2001) provided an important basis for
completion of the presented work. When screening this STM library comprising
minitransposon Tn5 non-auxotrophic isogenic mutants, four putative regulatory
virulence genes were identified: vqsR, gltR, 47D7 and icsF. These four genes should
be integrated into regulatory circuits and pathways in the presented thesis using
combined approach of up-to-date technologies of functional genomics, genetics in
silico and bioassays, thus helping to pave the way to comprehensive understanding
of the complex phenotypes of P. aeruginosa pathogenicity.    
To achieve this objective, the following tasks will be accomplished: 
1. Extensive in silico analysis of the investigated putative ORFs will be performed
in the first step, which should provide valuable hints about the function of
respective genes.   
2. Examined ORFs with no homologues in the sequenced P. aeruginosa strain
PAO1 will be sequenced. 
3. The investigated ORFs will be complemented in trans to ensure that the
observed phenotypes of mutants are caused by the transposon inactivation of
the respective genes and not by any other secondary genetic event.
4. The mutants will be investigated for the ability to produce quorum sensing
autoinducers and for the phenotypic traits that are known to be under the
control of quorum sensing, as it is for instance the ability to secrete many
extracellular virulence factors.
5. The mutants in the investigated genes will be tested for their ability to survive
intracellularly in PMNs.
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6. The nematode Caenorhabditis elegans infection model will be used to
examine the global impact of the investigated genes on pathogenicity.
7. Differences in gene expression will be examined by Northern blot growing
bacteria under various stress conditions.
8. DNA microarrays comprising the whole genome of the sequenced P.
aeruginosa strain PAO1 (Affymetrix) will be exploited to examine the impact of
the investigated genes on the global gene expression pattern.
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2. Materials and methods
2.1. Materials
2.1.1. Consumables and equipment 
Balance        BP3100 S
                     BP210 S Sartorius
Bio-Rad Pulser
Centrifuge Hettich Universal
Eppendorf centrifuge 5415C Eppendorf
Eppendorf centrifuge 5417R Eppendorf
Eppendorf tubes (0.5 ml, 1.5 ml, 2 ml) Sarstedt
Filter Cellulose ester HA 0.45 M pore size Millipore
Filter Cellulose acetate 0.2 & 5 M pore size Sartorius
Filter paper GB003 Schleicher and Schuell
Heating block DR-block DB-3 Techne
Hybridization oven 400 HY Bachofer
Hybridization oven Biometra
Incubator Heraeus
Minifold I Vacuum blotter Schleicher and Schuell
Pasteur pipette Sarstedt
Petri plates 9 cm Ø Sarstedt
Pipette tips (10 l, 200 l, 1 ml) Sarstedt
pH meter 766 Calimatic Knick
Plastic tubes (15 ml, 50 ml) Greiner
Polaroid film 667 Polaroid
Spectrophotometer U3000 Hitachi
Thermocycler Landgraf
Thermomixer Eppendorf
TLC plate Merck
UV-Transilluminator Bachofer
UV Stratalinker 1800 Stratagene
Vacuum concentrator Bachofer
Voltage supply power pack 300 Bio-Rad
X-ray film Kodak, AGFA
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2.1.2. Chemicals and enzymes
Affymetrix Enzo BioArray Terminal Labelling Kit, Oligonucleotide B2, P.
aeruginosa GeneChip
Amersham Pharmacia
Biotech 
Deoxynucleotides, Hybond N+ nylon membrane, OnePhorAll-buffer,
RNase-free DNase l, TEMED
Ambion SUPERaseIn (RNase Inhibitor)
Becton Dickinson Columbia blood agar
Blood bank MHH AB serum
Biozym SeaKem GTG Agarose
Die & Bernsten (DK) Formalin buffer
Difco Agar, Bacto-Peptone, Beef extract
Gibco BRL Agar, Agarose, DMEM medium, FCS, Fetal calf serum, Lymphocyte
separation medium, PBS Tablets, RPMI 1640 medium
In ViTec Taq-Polymerase & buffers 
Invitrogen Bromophenol blue, Bovine serum albumin, Gentamicin, MOPS buffer,
Random Primers, RNA-standard, Serva Blue G-250, SuperScript II
Reverse Transcriptase, Xylene cyanol FF
Merck Formaldehyde 35 %, Hydrogen peroxide 30 %, Liquemin (Heparin),
Uranyl acetate
Molecular Probes Streptavidine-Phycoerythrine, SYBRGreen 
MWG-Biotech Oligodeoxynucleotides, Primers
New England Biolabs DNA-ladder standards, Restriction enzymes + buffers, T4-DNA-Ligase
Pierce Chemical Streptavidine
Promega Herring-Sperm DNA, RNase Inhibitor
Qiagen Plasmid Spin Kit, Qia-Mini, Midi, Maxi and Giga Prep plasmid kits,
QIAquick Gel Extraction Kit, RNeasy Kit, Rnase A
Roche Molecular
Biochemicals
Alkaline Phosphatase, Anti-Dioxigenin AP fab fragment, DNA
Labelling and Detection Kit, Klenow Polymerase I, RNase-free DNase
I, Terminal Transferase + Buffers, Blocking reagent
Roth Acrylamide solution (Rotiphorese-Gel 40), Ethidium bromide, Phenol
(Rotiphenol) solutions, DEPC
Serva Gentamicin
Sigma Chelex-100 (iminodiacetic acid), Ethidium bromide, Proteinase K,
Propidium iodide, Tween 20, H2SO4, Gold star polymerase, Elastin-
Congo red
Tropix CDP-Star, DEA
Vector Laboratories Biotin anti-Streptavidine
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2.1.3. Media and solutions
2.1.3.1. Media
ABC minimal medium:
A: (NH4)2SO4 20 g/l (0.15 M)
Na2HPO4 ·2H2O 60 g/l (0.33 M)
KH2PO4 30 g/l (0.22 M)
NaCl 29 g/l (0.5 M)
B: MgCl2 ·6H2O 0.4 g/l (2 mM)
CaCl2 ·2H2O 0.014 g/l (0.1 mM)
FeCl3 ·6H2O 0.008 g/l (0.003 mM)
C: Sodium citrate 10 mM
pH 5.5
B was filter-sterilized, while A and C were sterilized by
autoclaving. Subsequently all components were mixed together. 
Columbia blood agar (Becton Dickinson): 
This complex agar, which is used frequently in microbiology, was
exploited for the analysis of hemolytic activity of the investigated
P. aeruginosa strains. 
King’s A medium:
Pepton 20 g/l
KOH 20 g/l
H2SO4 5.5 ml
MgCl2  x 6 H2O 3.3 g/l
Glycerin 10 g/l
pH 7.2
LB Medium:
Peptone 15 g/l
Yeast extract 5 g/l
NaCl 10 g/l (0.17 M)
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LB Agar:
LB medium
Agar 15 g/l
LB T-selective:
LB medium
Tetracycline  50 g/ml or 200 g/ml
M9-Medium (10X):
Na2HPO4 68.14 g/l (0.48 M)
KH2PO4 30 g/l (0.22 M)
NaCl 5 g/l (85 mM ) 
NH4Cl 10 g/l (0.18 M)
M9-Agar:
The M9 medium (10x) and water agar (15 g/l water) were
autoclaved separately. Casein (0.75 % w/v) was dissolved in a
50 ml of M9 (10x) medium by heating, cooled to the temperature
of about 60 oC and subsequently added to the 450 ml of melted
water agar.      
Vogel-Bonner minimal medium:
A (10x): Citrate x H2O 21 g/l
NaNH2PO4 x 4H2O 58.6 g/l
K2HPO4 x 3 H2O 84.4 g/l
pH 7.2
B (5x): Kalium-D-Gluconate 250 g/l
C (50x): MgSO4 x 7 H2O 41 g/l
The solution B was sterile-filtrated, while A and C were
autoclaved. The ready-to-use Vogel-Bonner medium was
obtained via mixing all three components A, B and C and
addition of required volume of the didestilled H2O.  
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SOB:
A:  Bactotryptone 20 g/l
Yeast Extract 5 g/l
NaCl 0.58 g/l (10 mM)
KCl 0.185 g/l (2.5 mM)
pH  7.0
B: MgCl2 1 g/l (10 mM )
C: MgSO4 1.2 g/l (10 mM)
The filter-sterilized stock solutions B and C were added to the
autoclaved A mixture.
SOC:
SOB 
Glucose 3.6 g/l (20 mM) 
2.1.3.2. Solutions 
TBE-Buffer (10X): 
Tris 108 g/l (0.9 M)
 Boric Acid 55 g/l (0.9 M)
EDTA 7.7 g/l (0.02 M)
pH 8.3-8.5
Loading Buffer (6X):
Ficoll 400 15 % v/v
Bromophenol Blue 0.25 % w/v
Xylene cyanol 0.25 % w/v
EDTA 146 g/l (0.5 M) 
pH 8.0
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PBS (10X):
NaCl 80 g/l (1.37 M)
KCl 2 g/l (27 mM )
Na2HPO4 ·7H2O 11.5 g/l (4.3 mM)
KH2PO4 2 g/l (1.4 mM)
pH 7.3
 TB Buffer:
PIPES 3 g/l (10 mM)
CaCl2 1.6 g/l (15 mM)
KCl 18.6 g/l (250 mM)  
MnCl2 (9.58 g/l (50 mM)
pH 6.7  
Sterilized by filtration and stored at 4 oC.
TE Buffer:
Tris-HCl 1.2 g/l (10 mM)
EDTA 0.38 g/l (1 mM)
pH 8.0 
Bradford solution:
Coomassie brilliant blue 70 mg
Ethanol 50 ml/l (96 % w/v)
H3PO4 100 ml/l (85 % w/v)
After the preparation, the solution was incubated at room
temperature for 24 hours, filtrated and kept in a dark flask.
 
Lysis Buffer:
Tris-acetate 4.84 g/l (40 mM)
Sodium acetate 20 mM
EDTA 0.38 g/l (1 mM)
SDS 1 % w/v
pH 7.8
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Plasmid DNA isolation:
Solution I: Tris-Cl 6 g/l (50 mM )
EDTA 3.8 g/l (10 mM)
DNase free RNase A 100 g/ml
pH 8.0
Solution II: NaOH 16 g/l (0.4 M) 
SDS 1 % w/v
Solution III: Potassium acetate 294 g/l (3 M)
Acetic acid 115 ml/l (2 M)
Fixation solution:
PBS 1x
Paraformaldehyde 1 % v/v
CaCl2 0.11 g/l (1 mM)
pH 7.2-7.4
Colour solution for gel filtration:
Dextran Blue 0.8 % w/v (2x 106 g/mol)
Phenol red 0.5 % w/v (376 g/mol)
RNA Lysis buffer:
SDS 2 % w/v
Sodium acetate 3 mM      
EDTA 0.1 % w/v
pH 5.5
DNase buffer (10 x):
Sodium acetate 500 mM  
MgCl2 ·6H2O 20.3 g/l (100 mM)
CaCl2 ·2H2O 2.94 g/l (20 mM)
pH  6.5
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MOPS buffer (10 x):
MOPS 41.8 g/l (200 mM)  
Sodium acetate 100 mM
EDTA 2.9 g/l (10 mM)
pH 7.0
RNA loading buffer:
Glycerol 50 % v/v
EDTA 0.29 g/l (1 mM)      
Bromophenol blue 0.25 % w/v
pH 6.0
SSC buffer (20 x):
NaCl 175 g/l (3 M)
Sodium citrate 0.3 M
pH 7.0
Northern hybridization solutions:
Pre-hybridization buffer:
Formamide 50 % v/v
Denhardt’s solution 5x
SSC 5x
SDS 1 % w/v
Herring sperm DNA 100 µg/ml
Prior to adding to hybridisation solution the Herring sperm DNA
was subjected to fragmentation by ultrasound sonication and
denaturation for 10 min at 95 oC. 
Denhardt’s solution:
Ficoll (Type 400) 2 % v/v
Polyvinylpyrrolidine (PVP-40) 2 % v/v
Bovine serum albumin (BSA) 2 % v/v
Materials and methods
41
Buffer I:
NaCl 175 g/l (3 M)
Tris-HCl 12 g/l (0.1 M)      
Tween 20 0.3 % v/v
pH 8.0
Buffer II:
Buffer I 
Blocking reagent 0.5 % w/v
Buffer III:
Tris-HCl 12 g/l (100 mM)  
NaCl 5.8 g/l (100 mM)
MgCl2 4.8 g/l (50 mM)
pH 9.5
Solutions for GeneChip experiments:
cDNA Reaction mixture:
1st Strand buffer 5 x
DTT 10 mM
dNTPs 0.5 mM
SUPERaseIn 0.5 U/l
SuperScript II 25 U/l 
MES hybridization buffer: 
MES 100 mM
NaCl 58 g/l (1 M)
EDTA 5.84 (20 mM)
Tween 20 0.01 % v/v
Light-protected and stored at 2-8 oC.
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Non-stringent buffer:
SSPE 6 x
Tween 20 0.01 % v/v
Steril-filtered.
Stringent wash buffer:
MES 100 mM
NaCl 5.8 g/l (0.1 M)
Tween 20 0.01 % v/v
Steril-filtered, light-protected and stored at 2-8 oC.
Primary stain solution (Streptavidin solution mix):
MES 100 mM
NaCl 58 g/l (1 M)
Streptavidin 10 g/ml
BSA 2 mg/ml
Tween 20 0.05 % v/v
Secondary stain solution (Biotin Anti-streptavidin solution mix):
MES 100 mM
NaCl 58 g/l (1 M)
Biotin Anti-streptavidin 5 g/ml
Goat IgG 0.1 mg/ml
BSA 2 mg/ml
Tween 20 0.05 % v/v
Tertiary stain solution (Streptavidin-Phycoerythrin solution mix):
MES 100 mM
NaCl 58 g/l (1 M)
Streptavidin-Phycoerythrin 10 g/ml
BSA 2 mg/ml
Tween 20 0.05 % v/v
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Non radioactive detection:
Hybridization wash buffer:
NaH2PO4 ·2H2O 6.3 g/l (40 mM)
SDS 1 % w/v
EDTA 0.38 g/l (1 mM)
pH 7.2
Buffer I:
Tris-HCl 12 g/l (100 mM)
NaCl 8.7 g/l (150 mM) 
pH 7.5
Buffer II:
Buffer I 
Blocking reagent 0.5 % w/v
Antibody solution:
1:5000 dilution of Anti-Digoxigenin AP Fab-alkaline phosphatase
conjugate in buffer II.
Buffer III:
Tris-HCl 12 g/l (100 mM)
NaCl 5.8 g/l (100 mM)
MgCl2 4.8 g/l (50 mM)
pH 9.5
Wash solution:
NaOH 8 g/l (0.2 M)
SDS 0.1 % w/v
Sucrose solution:
Sucrose 171 g/l (0.5 M)
Tris-HCl 12 g/l (0.1 M)
pH 8.0
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TET buffer:
Tris-HCl 1.2 g/l (10 mM) 
EDTA  1.9 g/l (5 mM)
Triton-X100 0.1 % v/v
pH 8.0
2.1.4. Infection models, bacterial strains and plasmids
2.1.4.1. Infection models
Caenorhabditis elegans
Bristol N2 (wild type), provided by the Caenorhabditis Genetics Centre (University of
Minnesota, St Paul’s, MN, USA) was used throughout this study. 
2.1.4.2. Bacterial strains
Pseudomonas aeruginosa strains
TB:
Cystic fibrosis airways isolate Tümmler et al. (1991)
892:
Clonal variant of the strain TB Tümmler et al. (1991)
PAO1:
Wound isolate, genetic reference strain Holloway et al. (1994)
TBvqsR:
Tn5::vqsR mutant of TB Wiehlmann et al. (2001)
TBicsF:
Tn5::icsF mutant of TB Wiehlmann et al. (2001)
TBgltR:
Tn5::gltR mutant of TB Wiehlmann et al. (2001)
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TB47D7:
Tn5::47D7 mutant of TB Wiehlmann et al. (2001)
TBvqsR(pME6010vqsR):
Tn5::vqsR mutant of TB complemented with pME6010(vqsR)
Juhas et al. (2004)
TBicsF(pME6010icsF):
Tn5::icsF mutant of TB complemented with pME6010(icsF)
This study
TBgltR(pME6010gltR):
Tn5::gltR mutant of TB complemented with pME6010(gltR)
This study
TB47D7(pME6010(47D7):
Tn5::47D7 mutant of TB complemented with pME6010(47D7)
This study
Pseudomonas putida strain
F117:
AHL negative derivate of P. putida IsoF, ppuI- Steidle et al. (2001)
Escherichia coli strains
MT102:
araD139 (ara-leu)7697 lac thi hsdR Leo Eberl, lab. collection
JM105:
 F' traD36 lacIq (lacZ)M15 proA+B+/thi rpsL(Strr) endA sbcB15 sbcC hsdR4(rK
mK) (lac-proAB) Yanisch-Perron et al. (1985)
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One Shot TOP10 Chemically competent E. coli
 F' mcrA (mrr-hsdRMS-mcrBC) 80lacZ M15 lacX74 deoR recA1 araD139
(ara-leu)7697 galU galK rpsL (StrR)endA1 nupG 
Invitrogen Life technologies
2.1.4.3. Plasmids
pJBA89:
AHL monitor plasmid; pUC18Not-luxR-PluxI-RBSII-gfp (ASV) -T0-T1; Apr
Andersen et al. (2001)
pKR-C12:
AHL monitor plasmid; pBR1MCS-5 carrying PlasB-gfp(ASV) Plac- lasR; Gmr
Steidle et al. (2001)
pSB403:
broad-host-range AHL monitor plasmid; Tcr Winson et al. (1998)
pME6010:
Shuttle vector replicable in Gram-negative bacteria; Tcr
Heeb et al. (2000)
pME6010vqsR:
pME6010 carrying the vqsR gene This study
pME6010icsF:
pME6010 carrying the icsF gene This study
pME6010gltR:
pME6010 carrying the gltR gene This study
pME601047D7:
pME6010 carrying the 47D7 gene This study
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2.2. Methods
2.2.1. Microbiological methods
2.2.1.1. General bacterial growth conditions 
All bacterial cultures and strains were cultivated at 37 oC in Luria broth (LB) medium
unless specified otherwise. Strains carrying pME6010, pME6010vqsR,
pME6010icsF, pME6010gltR or pME601047D7 were grown in LB medium containing
50 µg/ml tetracycline. Alternatively, a single bacterial colony was inoculated in a 15
ml Falcon tube containing 4-5 ml of LB medium with or without antibiotic and
incubated at 250 rpm on a rotatory shaker for approximately 16 h at 37 oC.
Alternatively, to achieve higher cell yields, 1 ml of bacteria were inoculated in
Erlenmeyer flasks containing 400 ml LB medium and incubated at 250 rpm on a
rotatory shaker for approximately 16 h at 37 oC.  
2.2.1.2. Bacterial growth for RNA isolation (LB medium) 
In this condition, as well as in all other used for RNA isolation, bacteria were grown in
125 ml Capsenberg flasks to achieve the same aeration rate for all bacterial samples. 
1. Bacterial cultures were grown in 15 ml of LB medium in 125 ml Capsenberg flasks
at 300 rpm on a rotatory shaker at 37 oC up to the optical density of 1.5 for early
exponential phase or alternatively of up to 3.5 for late exponential phase at 600
nm.
2. Afterwards, the bacteria were harvested by centrifugation at 3800 g for 2 min and
subjected to RNA isolation.
2.2.1.3. Bacterial growth for RNA isolation (ABC minimal medium) 
1. Bacterial cultures were grown in 15 ml of ABC minimal medium in 125 ml
Capsenberg flasks at 250 rpm on a rotatory shaker at 30 oC up to an optical
density of 1.0 at 600 nm.
2. Afterwards, the bacteria were harvested by centrifugation at 3800 g for 2 min and
subjected to RNA isolation.
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2.2.1.4. Bacterial growth for RNA isolation (H2O2) 
1. Bacterial cultures were grown in 15 ml of LB medium in 125 ml Capsenberg flasks
at 300 rpm on a rotatory shaker at 37 oC up to the optical density 5.0 at 600 nm
(stationary phase). In order to measure OD this highly dense bacterial culture was
diluted 1:10 with LB. 
2. 3 x 1010 cells from this stationary phase culture were resuspended in 5 ml of LB
and added into a 6 cm long dialysis tube (14 kDa cut-off, 25 mm width).
3. The dialysis tube containing bacteria was incubated in 1L Erlenmeyer flasks
containing 10 mM hydrogen peroxide in 600 ml of LB medium at 200 rpm on a
rotary shaker at 37 oC for 2 h. Erlenmeyer flasks containing only pure LB medium
without the addition of hydrogen peroxide served as control.
4. Afterwards, the bacteria were quickly recovered from the dialysis tube, harvested
by centrifugation at 3800 g for 2 min and subjected to RNA isolation.     
2.2.1.5. Bacterial growth for RNA isolation (Serum) 
1. Bacterial cultures were grown in 15 ml of LB medium in 125 ml Capsenberg flasks
at 300 rpm on a rotatory shaker at 37 oC up to the optical density 5.0 at 600 nm
(stationary phase). In order to measure OD this highly dense bacterial culture was
diluted 1:10 with LB.  
2. 2 x 1010 cells from this stationary phase culture were resuspended in 2 ml of
RPMI1640 medium and added into a 3 cm long dialysis tube (300 kDa cut-off).
3. The dialysis tube containing bacteria was incubated in 125 ml Capsenberg flasks
containing 15 ml of 10 % v/v human blood serum in RPMI1640 medium at 200
rpm on a rotatory shaker at 37 oC for 2 h.
4. Afterwards, bacteria were quickly recovered from the dialysis tube, harvested by
centrifugation at 3800 g for 2 min and subjected to RNA isolation.
2.2.1.6 Bacterial growth for RNA isolation (PMNs) 
1. Bacterial cultures were grown in 15 ml of LB medium in 125 ml Capsenberg flasks
at 300 rpm on a rotatory shaker at 37 oC up to the optical density 5.0 at 600 nm
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(stationary phase). In order to measure OD this highly dense bacterial culture was
diluted 1:10 with LB.
2. 2 x 1010 cells from this stationary phase culture were resuspended in 2 ml of
RPMI1640 medium and added into a 3 cm long dialysis tube (300 kDa cut-off).
3. Simultaneously, PMNs were isolated from 30 ml of freshly drawn blood from a
healthy donor. One aliquot of isolated PMNs was kept intact, whereas the second
aliquot was lysed and subsequently both parts were resuspended in 15 ml of
RPMI1640 medium containing 10 % v/v human blood serum (see chapter 2.6.1).
4. Then the dialysis tube containing bacteria was incubated in 125 ml Capsenberg
flasks containing 15 ml of PMNs mixture at 200 rpm on a rotatory shaker at 37 oC
for 2 h.
5. Afterwards, bacteria were quickly recovered from the dialysis tube, harvested by
centrifugation at 3800 g for 2 min and subjected to RNA isolation.
2.2.1.7. Bacterial cell density determination 
The optical density (OD) for the examined bacterial strains was measured
spectrophotometrically at 600 nm (OD600). The correlation between optical density
and colony forming units (cfu) was adjusted according to Wiehlmann (2001): 
Pseudomonas aeruginosa strains:  OD 0.6     1 x 109 cfu/ml
Escherichia coli strains: OD 1.0     0,8 x 109 cfu/ml
2.2.1.8. Maintenance of bacterial cultures
Bacterial cultures were typically maintained on LB agar plates and stored for a limited
period of 2-4 weeks at 4 oC. For long-term storage all bacterial cultures were kept in
LB medium containing 15 % glycerol v/v and stored at -80 oC. 
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2.2.2. Isolation of DNA
2.2.2.1. Isolation of genomic DNA 
The genomic DNA from P. aeruginosa was isolated according to the protocol by
Chen and Kuo (1993). 
1. The bacteria were harvested from 1.5 ml of overnight grown culture in LB medium
by centrifugation at 14. 000 g for 3 min. 
2. The pellet of harvested bacterial cells was resuspended in 300 l of Lysis buffer. 
3. 100 l of 5 M NaCl were added to the suspension and the whole volume was
mixed thoroughly.
4. Cell debris was separated by centrifugation at 14. 000 g for 60 min at 4 oC and
the supernatant was transferred into a fresh eppendorf tube.
5. RNA was removed by incubation of the supernatant with 3 l of RNase (10
mg/ml) at 37 oC for 30 min.
6. Proteins were removed by mixing of the supernatant with equal volumes of
phenol, phenol:chloroform:isoamyl alcohol (25:24:1) and chloroform:isoamyl
alcohol (24:1) and separation of the phases by centrifugation at 14. 000 g for 15
min.  
7. DNA was precipitated by addition of an equal volume of isopropanol and
subsequent centrifugation at 14.000 g for 15 min.
8. Finally the pellet of the genomic DNA was washed with 70 % v/v ethanol, dried
and resuspended in 50 l of TE buffer.  
2.2.2.2. Isolation of plasmid DNA
To isolate ultra-pure plasmid DNA for sequencing, Qiagen Mini-Midi-Maxi and Giga
Prep kits were used according to the manufacturer’s protocol. The plasmid DNA from
the transformed E. coli was isolated by the modified alkaline lysis method (Birnboim
& Doly, 1979).  
1. The bacteria were harvested from 3 ml of the overnight grown culture in LB
medium by centrifugation at 5.000 g for 5 min.
2. The pellet of harvested bacterial cells was resuspended in 300 l of solution I. 
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3. Then 300 l solution II were added to the suspension, the whole volume was
mixed thoroughly by inverting the eppendorf tube and incubated for 5 min at room
temperature. 
4. Afterwards, 300 l solution III was added, mixed thoroughly and incubated on ice
for 15 min. 
5. The precipitate was centrifuged at 10.000 g for 10 min at 4 oC and the
supernatant was transferred into a fresh eppendorf tube. 
6. Proteins and lipids were removed by mixing of the supernatant with an equal
volume of phenol:chloroform:isoamyl alcohol (25:24:1) and separation of the
phases by centrifugation at 14000 g for 2 min at 4 oC. The aqueous phase was
mixed with an equal volume of chloroform:isoamyl alcohol (24:1) and centrifuged
at 10.000 g for 10 min at 4 oC. 
7. Plasmid DNA was precipitated from the solution by addition of an equal volume of
isopropanol and subsequent centrifugation at 14.000 g for 15 min at room
temperature.
8. Finally, the pellet of the plasmid DNA was washed with 70 % v/v ethanol, dried
and resuspended in 50 l of TE buffer.
 
2.2.3. Separation of DNA by agarose gel electrophoresis
1. The 0.8-1.5 % w/v agarose gel was prepared by solubilizing agarose in a proper
volume of TBE buffer. 1x TBE buffer was used as a running buffer.
2. The DNA was mixed with 1/5th volume of loading buffer and loaded on an agarose
gel. Lambda phage DNA digested with BstEII restriction endonuclease was used
as molecular size standard.
3. 8.5 V/cm field strength was applied and the gel was run until the front of the dye
reached approximately 2/3rd of the gel length. Alternatively for overnight run, only
2.0 V/cm field strength was applied. 
4. Afterwards, the gel was stained with 0.5 g/ml ethidium bromide for 20-30 min
and subsequently destained twice in water for 2x 20-30 min.
5. Finally the DNA was visualized and photographed on a UV transilluminator at 312
nm.
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2.2.4. Quantification of DNA 
If DNA is free of contaminants, spectrophotometric measurement of UV absorbance
is used as a common method to quantify its amounts. The absorption was measured
at 260 nm in a 1 cm thick quartz cuvette (Ausubel et al., 1988; Sambrook et al.,
1989). Double distilled water was used as a control. The ratio of OD260 / OD280
provides the estimation of DNA purity and for the ultra-pure DNA equals 1.8.   
Optical density (OD) of 1.0 at 260 nm corresponds to:
50 g/ml of double stranded DNA
33 g/ml of single stranded DNA
Therefore the concentration of the DNA can be easily calculated: 
Concentration of DNA (g/ml) = OD260  X 50 X dilution factor
2.2.5. Restriction digestion of DNA
The DNA was digested with the required restriction enzymes according to the
manufacturer’s protocols. Usually 10 U of the restriction enzyme were used per g of
DNA and digested for 3-24 h depending on the enzyme and the length of the DNA
sequence at recommended temperature. Digestion with two different enzymes was
performed in a buffer in which both restriction enzymes had their optimal intensity.
Restriction enzymes were inactivated by heating or phenol-chloroform extraction. 
Restriction digestion of the target sequences was pre-designed in silico with the
webcutter 2.0 software (http://www.firstmarket.com/cutter/cut2.html).
2.2.6. Polymerase chain reaction 
Polymerase chain reaction (PCR) is a simple and efficient method that exploits
knowledge of the principles of DNA replication for amplification of target DNA
sequences. When using this technique, the DNA segment between two regions of
known sequence is amplified by the polymerase if the specific primers and template
are added to the reaction (Mullis et al., 1986). In this work, PCR was used for the
amplification of target sequences of P. aeruginosa genes for the preparation of
probes for Northern hybridisation and for the amplification of whole ORFs of the
analysed P. aeruginosa regulatory genes.
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2.2.6.1. Construction of the primers for PCR
1. The primer was constructed to be solely complementary to the target DNA
sequence so that it could not hybridise to any other sequence in the genome.
2. Care was taken that the primer was not self-complementary to avoid formation of
hairpin structures.
3. The melting temperature (Tm), calculated as Tm= 4 oCx (GC) + 2 oCx (AT) for
each primer constructed was higher than 60 oC to avoid non-specific
amplification.
4. The length of the primers was approximately 20-25 base pairs.
5. Primers ended with at least two G-C bases to ensure stable hybridisation.
6. Primer 3 software was usually used to construct primers (http://www-
genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi).
7. Two different restriction sites (one in each primer from the respective primer pair)
were incorporated into the primers used for the PCR of the whole ORFs used for
complementation.
2.2.6.2. Reaction mixtures used for PCR
Standard reaction mixtures used for PCR: 
0.5 l Template DNA (50- 100 ng/l)
2.5 l Primer 1 (5 M)
2.5 l Primer 2 (5 M)
2.5 l 10x Buffer (InViTek)
1.25 l DMSO
0.75 l MgCl2  (50 mM)
2.5 l dNTPs (8 mM)
0.2 l Taq-DNA Polymerase (5 U/l)
12.3 l Double distilled water
Gold star polymerase was used for the amplification of long ORFs.  
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2.2.6.3. Program used for PCR
The following program was usually used for the DNA amplification:
Denaturation at 98 oC for 10 min
Amplification (30-40 cycles)
Denaturation at 98 oC for 30 s
Primer extension at Tm for for 60 s
DNA synthesis at 72 oC for 60 s 
Incubation at 72 oC for 10 min 
Maintenance at 4 oC
For the amplification of long ORFs, the program was slightly modified:
Denaturation at 98 oC for 10 min
Amplification (30-40 cycles)
Denaturation at 98 oC for 90 s
Primer extension at Tm for for 60 s
DNA synthesis at 72 oC for 120- 140 s 
Incubation at 72 oC for 10 min 
Maintenance at 4 oC
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2.3. Genetic complementation 
A library of oligonucleotide-tagged mini-Tn5 transposon mutants of P. aeruginosa
strain TB was constructed by a modified signature tagged mutagenesis protocol
(Wiehlmann et al., 2002) and screened for increased susceptibility to human serum
and PMNs or for loss of quorum sensing. Four virulence-attenuated mutants with
predicted strong impact on the expression of other genes were selected for the future
experiments. Subsequently these pre-selected regulatory genes were complemented
in trans to ensure that the observed striking phenotypes were caused by the
transposon inactivation of the respective genes and not by any other secondary
genetic event. 
2.3.1. Preparation of the ORFs for ligation 
1. The open reading frames (ORFs) intended to be cloned into a suitable vector
were first amplified by PCR (see chapter 2.2.6). 
2. The concentration of the PCR product was estimated with 5 l by agarose gel
electrophoresis (see chapter 2.2.3).
3. Optional: The PCR product was purified using Qiaquick GelExtraction Kit
(Qiagen) or PCR purification Kit (Qiagen) according to the manufacturer’s
instruction to remove polymerase enzyme which might block the restriction sites.
4. The ORFs were subjected to restriction digestion (see chapter 2.2.5). 20 l of the
PCR amplificate of the respective gene, together with 2x 2 l of both restriction
enzymes, 4 l of the recommended buffer and 12 l of double distilled water were
incubated at 37 oC for 3 hours.
5. The digested ORFs were purified using Qiaquick GelExtraction Kit (Qiagen) or
PCR purification Kit (Qiagen) according to the manufacturer’s instruction to
remove restriction enzymes, which might block the ligation sites of the DNA. 
2.3.2. Preparation of the vector for ligation 
Plasmid pME6010 was used as a vector for the complementation. This shuttle vector
was chosen due to its ability to replicate in both Esccherichia coli and P. aeruginosa
(Heeb et al., 2000). pME6010 maintains the tetracycline resistance genes so the
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successful complementants could be easily detected. The multi cloning site (MCS) of
pME6010 is following the kanamycin promoter which was used to induce the
expression of the cloned genes (Figure 2.1). 
Fig. 2.1. The restriction map of the pME6010. This plasmid was used as a vector for the
complementation of investigated genes (http://www.acaclone.com).   
1. The pME6010 was isolated from the E. coli culture (see chapter 2.2.2.2) and
concentrated 10 times by isopropanol concentration: the plasmid was precipitated
from the solution by addition of the equal volume of isopropanol and subsequent
centrifugation at 14.000 g for 15 min at room temperature, washed with 70 %
ethanol v/v, dried and resuspended in double distilled water or TE buffer. 
2. The plasmid was subjected to restriction digestion (see chapter 2.2.5). 20 l of the
10 times concentrated vector with 2x 2.5 l of both restriction enzymes, 5 l of the
recommended buffer and 20 l of double distilled water was incubated at 37 oC
for at least 16 hours.
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3. The restriction enzymes were removed from the plasmid by phenol/ chloroform/
isoamylalkohol extraction:  Suspension from the step 2. was mixed with equal
volumes of phenol and chloroform:isoamylalkohol (24:1) and the phases were
separated by centrifugation at 14. 000 g for 10 min. The aqueous phase with
pME6010 plasmid was transferred into a fresh eppendorf tube.
4. The plasmid was dephosphorylated by addition of 4 l of alkaline phosphatase
and 6 l of alkaline phosphatase buffer to the 50 l of the suspension and
subsequent incubation at 37 oC for 1 hour. 
5. Optional: second phenol/ chloroform/ isoamylalkohol extraction of the plasmid
(see step 3).
6. Optional: second dephosphorylation of the vector (see step 4). 
7. Optional: third phenol/ chloroform/ isoamylalkohol extraction of the plasmid (see
step 3).
8. The plasmid was purified using Qiaquick GelExtraction Kit according to the
manufacturer’s instruction. 
2.3.3. Ligation
Different vector: insert molar ratios were tested to obtain maximal ligation.
Standard ligation mixtures: 
1 l T4 ligase 
1 l T4 ligase buffer
1- 4 l Insert
1- 6 l Vector
1- 4 l Double distilled water
Optional: The successfulness of the ligation was checked with 2 l of the ligation
mixture by agarose gel electrophoresis (see chapter 2.2.3). Lower agarose
concentrations (0.5 % - 1 %) were used to separate the fragments with higher
molecular weights (Figure 2.2). 
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Fig. 2.2. Testing successfulness of the ligation by agarose gel electrophoresis. Different vector:
insert molar ratios were examined to obtain maximal quantities of the recombinant plasmid.   
2.3.4. Transformation of E. coli 
One Shot TOP10 Chemically competent E. coli (Invitrogen) were used for the
transformation.
1. 3 l of the ligation product were added to 10 l of E. coli cells, mixed gently and
incubated for 30 min on ice.
2. The tubes were incubated at 42 oC for exactly 30 s and subsequently placed on
ice.
3. 100 l of the pre-warmed S.O.C medium was added to the tube and incubated at
250 rpm at 37 oC for 1 hour.
4. The mixture was spread on LB plate containing Tc, the plate was inverted and
incubated at 37 oC overnight. 
5. Colonies were analysed for the presence of the constructed recombinant plasmid
by plasmid isolation (see chapter 2.2.2.2).
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2.3.5. Electroporation of P. aeruginosa
A modified protocol for the electroporation of freshly plated P. aeruginosa cells was
used (Enderle and Farwell, 1998).
1. P. aeruginosa strains to be complemented were cultivated in 4 ml of LB medium
at 250 rpm at 37 oC overnight and pelleted by centrifugation at 13. 000 g for 3
min. 
2. To achieve successful electroporation, the amount of exopolysaccharides in the
culture needs to be as low as possible so they were removed from the pellet with
repeated washing with double distilled water and centrifugation at 13. 000 g for 3
min.   
3. Bacterial cells were resuspended in 200 l of double distilled water.
4. 90 l of this suspension was mixed with 1-5 l of the constructed recombinant
plasmid isolated from E. coli using Qiagen Mini Prep kit according to the
manufacturer’s protocol.
5. The mixture was poured in the electroporation cuvette and the P. aeruginosa cells
were electroporated with the Bio-Rad pulser (400 , 25 FD, 2.5 V, time constant
5 ms).
6. 0.5 ml of the LB medium was added in the cuvette and the whole volume was
transferred into the fresh eppendorf tube.
7. Bacteria were incubated at 300 rpm at 37 oC for 3 hours.
8. Afterwards, 50-200 l of the bacterial culture were spread on LB plate containing
Tc, the plate was inverted and incubated at 37 oC overnight.
9.  P. aeruginosa colonies were analysed for the presence of the recombinant
plasmid by plasmid isolation (see chapter 2.2.2.2). 
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2.4. RNA-working techniques 
2.4.1. RNA storage and handling 
Special care was taken when working with RNA to avoid degradation by RNases. 
1. All solutions used in the RNA-working techniques were prepared from double
distilled water and treated with 0.05 % v/v Diethylpyrocarbonate (DEPC). After
addition of DEPC, solutions were incubated overnight at 37 oC and subsequently
autoclaved to inactivate DEPC. Those solutions containing Tris or Acetate which
can cause undesired cross-reactions with DEPC were prepared directly from the
already autoclaved DEPC treated double distilled water.     
2. The majority of the devices used in the RNA-working techniques was autoclaved
at 121 oC for 60 min. Glass wares were sterilized at 250 oC for 5 h. Metal devices
such as scalpels or scissors were cleaned with 70 % v/v ethanol and flame-
sterilized. 
3. Heat-sensitive devices were first cleaned with sterile double distilled water and
afterwards with 70 % v/v ethanol.
4. Gel chambers for electrophoresis of RNA samples were first filled with 3 % v/v
H2O2 and afterwards with 70 % v/v ethanol. 
5. For long-term storage, RNA was dissolved in DEPC treated water or in RNase-
free buffer and stored in the –80 oC freezer. During work, RNA samples were kept
on ice and treated with RNase inhibitors when required. 
6. Fresh stocks of plasticware, such as eppendorf tubes or pipette tips were used
every time. 
2.4.2. Quantification of RNA
If RNA is free of contaminants, spectrophotometric measurement of UV absorbance
is used as a common method to quantify its amounts. The absorption was measured
at 260 nm in a 1 cm thick quartz cuvette (Ausubel et al., 1988; Sambrook et al.,
1989). Double distilled water was used as a control. The ratio of OD260 / OD280
provides the estimation of RNA purity and for the ultra-pure RNA equals 2.0.  
Optical density (OD) of 1.0 at 260 nm corresponds to:  40 g/ml of RNA
Therefore the concentration of the RNA can be easily calculated: 
Concentration of RNA (g/ml) = OD260  X 40 X dilution factor
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2.4.3. RNA isolation
The protocol used for the isolation of total RNA was based on the modified hot
phenol method (Oelmüller et al., 1990; Tao et al., 1999). All steps were performed at
4 oC
1. Approximately 3 x 1010 of bacterial cells were harvested by centrifugation at 3800
g for 2-4 min at 4 oC. 
2. Harvested cells were quickly resuspended in 0.5 ml distilled water and lysed at 65
oC in 7.5 ml of preheated 5 ml phenol/ 2.5 ml RNA lysis buffer mixture (pH 5.5) by
vigorous shaking for 10 min. 
3. The cell lysate was centrifuged at 3800 g for 20 min and the supernatant was
purified by subsequent phenol/chloroform (3-5 of phenol:chloroform:isoamyl
alcohol mixture, 25:24:1 v/v) and chloroform (chloroform:isoamyl alcohol, 24:1 v/v)
extractions. 
4. Nucleic acids were precipitated overnight at -20 oC in 0.1 volume of 3 M sodium
acetate (pH 5.2) and 2.5 volumes of ethanol and centrifuged at 3800 g for 30 min. 
5. The pellet was washed with 5 ml of 70 % v/v ethanol and resuspended in 175 µl
of DEPC-treated water. 
6. DNA was digested by the addition of 40 U DNase I and 20 U SUPERaseIn in
DNase I buffer in a total volume of 200 µl for 30 min at 37 oC. 
7. RNA purification with RNeasy columns (Qiagen) was performed according to the
manufacturer’s instructions and was followed by quantification of its total yield by
the UV absorption spectrometry at 260 nm. 
8. RNA integrity was monitored by formaldehyde agarose gel electrophoresis.  
2.4.4. Formaldehyde agarose gel electrophoresis 
Only denatured RNA can be separated as a function of its length by gel
electrophoresis. To keep RNA in denaturated state during electrophoresis, the gel
solution as well as the running buffer were treated with formaldehyde. (Ausubel et al.,
1988; modified). To monitor RNA integrity electrophoresis was performed in mini gel
chambers (5 x 7 cm) with the gel volume of 40 ml. If the RNA was transferred to a
nylon membrane for hybridisation afterwards, large blot gel chambers (8 x 11 cm)
with the gel volume of 220 ml were used. The chambers were first cleaned with 3 %
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(SeaKemGTG, Biozym) was used to prepare gels: 1.2 % w/v and 2 % w/v for mini
gels and blot gels, respectively. Due to the toxicity of formaldehyde, electrophoresis
was running in a fume hood. 
Table 2.1. Sample preparation for formaldehyde gel electrophoresis of RNA.
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2   µl 10   µg RNA
x     µl Double distilled water
0.5  µl Ethidium bromide (10 mg/ml)
2   µl 10   µl Formaldehyde (37 %, w/v)
5   µl 25   µl Formamide
2   µl 9.5  µl RNA-loading buffer
1   µl 5     µl MOPS-buffer (10 x)
12   µl 60   µl62
agarose was autoclaved for 30 min at 121 oC in 1x MOPS buffer and cooled
n to approximately 50 oC. 
l or 13.3 ml of formaldehyde (0.7 M final concentration) were added to mini
ot gel, respectively.   
RNA samples were denatured at 65 oC for 10 min, cooled down on ice and
rifuged at 14.000 g for 30 s at 4 oC. 
ples (Table 2.1), together with the 5 µg of RNA molecular weight standard
 loaded on the formaldehyde agarose gel with 1x MOPS buffer used as
ing buffer after the pre-electrophoresis running for 5 min at 60 V.
stant field strength 5 V/cm was applied for mini gels, thus running for
oximately 1 h and 3 V/cm for blot gels, thus running for approximately 5 h.
electrophoresis of the blot gels was finished when the bromphenol blue dye
moved to the two-thirds of the gel length.
mini gels were stained for 15 min with 10 µg/ml ethidium bromide, destained
 for at least 15 min and photographed under the UV transilluminator.   
 the electrophoresis, the blot gel was photographed under UV
illuminator with a molecular weight standard using 16S and 23S ribosomal
dards as a reference for the RNA integrity checking (Figure 2.3).
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Fig. 2.3. Formaldehyde agarose gel electrophoresis of RNA isolated under different growth
conditions. The molecular weights of 23S and 16S rRNA are 2985 & 1536 bp respectively (Stover et
al., 2000). Isolated RNA was subsequently transferred to a positively charged nylon membrane for
hybridisation. LE: late exponential phase, M: ABC minimal medium, H2O2: presence of 10 mM H2O2,
Ser: presence of 10 % serum, PMNs: presence of PMNs.
2.4.5. Northern blotting 
To detect the intensity of the gene expression via RNA-DNA hybridisation procedure,
total RNA, completely denatured and separated by formaldehyde agarose gel
electrophoresis was transferred on a positively charged nylon membrane (Hybond
N+) (Ausubel et al., 1988). Capillary blotting is the most frequently used procedure of
the transfer and immobilization of the RNA fragments. In this approach, the
formaldehyde agarose gel is held on the porous paper (Whatman filter paper), which
is emerged into a reservoir containing transfer buffer. This procedure is also called
the sandwich method, because the membrane is localized between the gel and filter
papers, which soaks buffer through the gel. The RNA is transferred from the gel and
immobilised on the membrane by the flow of transfer buffer. 
1. The blot gel was washed with the double distilled water for 20 min and
subsequently with 20x SSC buffer for 20 min prior to blotting apparatus assembly.  
2. A Blotting apparatus: The gel was placed upside down on the Whatman filter
paper bridge. The positively charged nylon membrane was kept between the gel,
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another Whatman filter paper and the pile of papers. Nylon membrane, Whatman
filter paper and the pile of papers used were the same size as the gel. The iron
plate (500 g) was placed on the top of the apparatus and the 20x SSC buffer was
added in the bath to serve as a transfer buffer.
3. Blotting was performed at room temperature for at least 20 h. 
4. Afterwards the position of the wells on the gel was marked on the membrane and
the membrane was removed and washed with 2x SSC buffer for 1 min to remove
residual gel traces.
5. The membrane was placed in the filter paper and aluminium foil and dried at room
temperature for 10 min and subsequently at 65 oC for 20 min.
6. Finally the membrane was crosslinked from both sides with UV 254 nm and used
immediately for hybridisation or stored at -20 oC for future use.
2.4.6. Construction of the DNA probes for Northern blotting
The DNA probes for Northern blot hybridisation were constructed by PCR
amplification. The primers for PCR amplification were constructed so that they
resulted in the amplification of approximately 500-600 bp long DNA fragments from
the ORFs of investigated genes. 
The PCR reaction mixture containing the amplified sequence was separated by
agarose gel electrophoresis and the target sequence was recovered from the gel by
the method described by Qiagen (Hilden, Germany). All the centrifugation steps were
carried out at 10.000 g at room temperature.
1. At least 45 l of the PCR mixture were loaded in the each well of the gel and the
DNA was separated by agarose gel electrophoresis.
2. Afterwards, the gel was stained with ethidium bromide, destained and the DNA
fragments were visualized under the UV transilluminator.
3. The desired DNA fragment was excised from the gel with the scalpel and placed
in the eppendorf tube. 
4. Three volumes of solubilization buffer QG (Qiagen) were added to 1 volume of
the excised gel fragment and the eppendorf tubes were incubated at 50 oC for 10
min or until the gel slice completely dissolved.
5. One volume of isopropanol was added to the mixture and the contents of the tube
was mixed by inverting the tube for several times.
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6. The whole volume of this mixture was afterwards applied to a MiniElute column
(Qiagen) and centrifuged for 1 min. Maximum 800 l can be applied on the
column at once so if I had higher volumes of the mixture, the flow-through was
discarded and the same column was re-used for the same sample.
7. The column was washed with 500 l of solubilization buffer QG and subsequently
with 750 l of wash buffer PE (Qiagen).
8. Then the column was centrifuged for an additional 1 min to remove residual wash
buffer PE.
9. 10 l of elution buffer EB (Qiagen) were applied in the centre of the membrane of
the column and finally the DNA was eluted by centrifugation of the column for 1
min.
2.4.7. Random primer labelling and purification of the
probes
Random primer labelling (Feinberg and Vogelstein, 1983) exploits the ability of the
E.coli DNA polymerase I-Klenow fragment to synthesize a new DNA strand
complementary to the template DNA strand starting from a free 3' hydroxyl end in
order to label both strands simultaneously. The hexanucleotides, which bind with
statistical efficiency to the DNA and thus serve as starting primers for the Klenow
fragment of the DNA polymerase I, are exploited in the random primer labelling.
Digoxigenin-labelled nucleotides added in the reaction are then incorporated into the
DNA strands. This procedure ensures uniform labelling of the DNA probes and is
widely used due to its high efficiency requiring only small amount of the template
DNA. The DNA was labelled by using the kit supplied by Roche Molecular
Biochemicals.
1. Prior to starting labelling the DNA fragments were denaturated by boiling at 95 oC
for 10 min and cooled down on ice.
2. To label the DNA, the following components were added to the reaction:
 15 l Denatured DNA  
  2 l DIG DNA labelling mix (10x)
  2 l Hexanucleotide mix (10x)
     1 l Klenow enzyme
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3. The reaction mixture was incubated overnight at 37 oC. 
4. To purify the labelled DNA, a Sephadex G50 column was prepared in a 1 ml
syringe and equilibrated with TE buffer and subsequently centrifuged at 1000 g
for 45 s to remove the residual buffer.
5. 72 l of TE buffer and 8 l of the colour solution for gel filtration were added to the
labelled DNA mixture and loaded on the Sephadex column. The eppendorf tube
was placed at the bottom of the column. 
6. The column was centrifuged at 1000 g for 30 s and the labelled and purified DNA
was recovered in the eppendorf tube at the bottom of the column.
7. The DNA was used immediately for Northern blotting or stored at -20 oC for the
future use.
2.4.8. RNA-DNA hybridisation
1. Northern hybridisation was performed in a hybridisaton oven (Biometra) in a big
glass tubes (Biometra) or alternatively in 50 ml plastic Falcon tubes. The
membrane was placed into the tube with the RNA adhered side facing inward of
the tube. The prehybridization buffer was preheated to 42 oC prior to the
procedure.
2. 25 ml or 10 ml of the prehybridisation buffer for the glass and for the 50 ml plastic
tubes, respectively were added in the tube and prehybridised 42 oC for 2 h. 
3. The Dig labelled DNA probe for Northern blotting was denatured by boiling at 95
oC for 10 min in a 10 ml of prehybridization buffer and subsequently added into
tube containing membrane.  
4. The hybridisation was carried out for at least 16 hours at 42 oC.
5. After hybridization, the probe was saved for future use at -20 oC and the
hybridisation signals on the membrane were detected. 
2.4.9. Detection of Northern blot hybridisation signals 
After hybridization, the hybridisation signals on the membrane were detected by
immunological reaction with an anti-fluorescein alkaline phosphatase conjugate
(Engler-Blum, 1990). The DIG labelled DNA probe exhibit fluorescence signals with
the help of anti-Dioxigenin-dUTP antibodies. The Alkaline Phosphatase catalyzes a
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chemo-luminescence reaction with CDP Star(TM) and emitted light (480nm) can be
detected by exposing of the membrane to X-ray film.   
1. To remove non-specifically bound probe, the membrane was washed for 5 min
with 6 x SSC + 3 % w/v SDS at room temperature, for 20 min with 2 x SSC + 3 %
w/v SDS at 42 oC and for 20 min with 0.2 x SSC + 3 % w/v SDS at 42 oC
subsequently.
2. After these washes, the membrane was removed from the tube and equilibrated
in buffer I for 5 min. 
3. To remove non-specific bound probe, the membrane was incubated on a shaker
in 170 ml of buffer II containing 0.5 % w/v of Blocking reagent for 30 min.
4. Then, the membrane was incubated in 30 ml of buffer II containing 0.5 % w/v of
Blocking reagent and 1:10.000 dilution of Anti-fluorescein-AP conjugate for 30
min.
5. To remove the unbound conjugate, the membrane was washed 3 times for 15 min
in buffer I.
6. The membrane was equilibrated in a filtered buffer III for 2 min and subsequently
incubated with 1: 500 v/v diluted CDP star in 10 ml of filtered buffer III for 5 min.
7. X-OMAT or Bio-MAX (Kodak) films were used to detect chemoluminescence. The
maximum signal intensity was usually detected after approximately 30 min of
exposition of the X-ray film to luminescent signals, but generally the time of
exposure was adjusted depending upon the signal intensity (Bronstein et al.,
1989).  
2.4.10. Regeneration of the membranes 
The hybridised Northern blot membranes can be re-used after washing by SSC and
SDS solutions, even though the quality of this regeneration is not ideal and therefore
it is recommended to use fresh membrane for each hybridisation.  
1. The hybridised membranes were washed with double distilled water for 5 min. 
2. Then the membranes were incubated in 5 x SSC for 20 min and subsequently
washed with nearly boiling (95 oC) 0.1 % SDS solution for 5 min.  
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2.5. P. aeruginosa microarrays (Affymetrix) 
2.5.1. P. aeruginosa GeneChip 
The P. aeruginosa microarray (GeneChip) from Affymetrix used in this work was
designed by the Cystic Fibrosis Foundation Therapeutics Inc. (CFFTI, USA). The
construction of the chip was based on the information from the P. aeruginosa
genome-sequencing project (Stover et al., 2000) financed by CFFTI. There are
probes for 5549 open reading frames on the P. aeruginosa GeneChip (Affymetrix),
and additional probes for one out of four rRNA operons (23S, 16S, 5S rRNA), 18
tRNA genes and for 199 selected intergenic regions exceeding 600 base pairs from
the completely sequenced and annotated genome of P. aeruginosa PAO1 (Stover et
al., 2000). Moreover, probes from 117 open reading frames of other P. aeruginosa
strains are also present on the GeneChip. All in all, 5986 different P. aeruginosa
genome sequences can be analyzed on the GeneChip. 
As a control, the GeneChip also contains 14 genes from Bacillus subtilis,
Saccharomyces cerevisiae and Arabidopsis thaliana. The probes present on this
GeneChip are based on the sequences from the GENE BANK database available at
http://www.ncbi.nlm.nih.gov. The detailed information for the construction of the
GeneChip can be also obtained from the NETAFFX database available at
http://www.affymetrix.com/analysis/index.affx.  
Sequences on the GeneChip from Affymetrix which can be examined are
represented by a varying number of 25-mer oligonucleotides correspondingly to their
lengths (Lipshutz et al., 1999). Each protein-coding gene on the P. aeruginosa
Genechip represent 8-13 of such oligonucleotides, while tRNA genes are covered
with 8-16 and intergenic regions with 13-122 oligonucleotides. 
Exploiting special photo-lithographic technology in combination with solid phase
combinatorial chemistry each oligonucleotide is synthesized as a probe cell in situ on
a glass surface of 20 µm x 20 µm (Fodor et al., 1991). The probe cell complementary
with the analysed sequence (perfect match oligo) is synthesized right beside the
oligonucleotide, which has incorporated a non-complementing base pair in the
position 13 (mismatch oligo). Perfect match and mismatch oligo constitute the probe
pair. The signal intensity of the mismatch oligo represents the background signal of
the specific hybridisation, therefore it is subtracted from the signal intensity of the
perfect match oligo in the following step of an in silico hybridisation analysis. All
probe pairs on the GeneChip representing specific sequence are called the probe set
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(Figure 2.4). The probe pairs of the same probe set are distributed randomly on the
1.28 cm x 1.28 cm surface of the Gene Chip, thus minimizing the negative effect of
the possible local irregularities (non-uniform hybridization and staining or mechanical
damages, e.g. scratches) caused during hybridization.
Fig. 2.4. The construction of the probe set on the GeneChip. 
A single gene on the GeneChip is represented by the probe set of 25-mer oligonucleotides. Each
probe pair constitutes an oligonucleotide perfectly complementing to the analysed sequence (perfect
match oligo) and an oligonucleotide with base pair exchange on the position 13 (mismatch oligo)
(Lipshutz et al., 1999).      
2.5.2. Generation and fragmentation of cDNA 
RNA from three independent isolations was pooled to minimize the influence of
handling. cDNA synthesis, fragmentation and labelling with Biotin-ddUTP were
performed as described in the protocol provided by Affymetrix. Briefly, 10 µg of RNA
was mixed together with 750 ng random primers Invitrogen and 8.67 pM from 10
nonpseudomonal control transcripts (kindly provided by S. Lory and co-workers,
Harvard) (Table 2.2) in a total volume of 30 µl. 
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Table 2.2. Nonpseudomonal control transcripts (S. Lory, Harvard). 
Gene Bacterial strain Length (bp) Final conc. (pM)
YEL002C/WBP1 Saccharomyces cerevisiae 1300 1
YEL018W Saccharomyces cerevisiae 840 2
YEL024W/RIP1 Saccharomyces cerevisiae 650 10
YER148W/SPT15 Saccharomyces cerevisiae 720 5
dapB Bacillus subtilis 740 1
lysA Bacillus subtilis 1320 5
pheB Bacillus subtilis 440 10
thrC Bacillus subtilis 1100 2
trpD Bacillus subtilis 1000 2
GAPDH Arabidopsis thaliana 1000 5
This reaction mixture was incubated for 10 min at 70 °C and 10 min at 25 °C and
subsequently chilled to 4 °C. The cDNA mixture was added to the reaction mixture
containing RNA. cDNA was generated by incubating this reaction mixture for 10 min
at 25 °C, for 60 min at 37 °C, for 60 min at 42 °C, and subsequently the enzyme was
inactivated by incubating for 10 min at 70 °C. 
RNA was hydrolyzed by the addition of 20 µl 1M NaOH and incubation for 30 min at
65 °C, followed by neutralization of the reaction by 20 µl of 1M HCl. The generated
cDNA was purified with a Qiaquick column from Qiagen and quantified by UV
absorption at 260 nm. 
The 3-5 µg of cDNA was fragmented with 0.5 U DNaseI µg-1 cDNA in One Phor-All
buffer in a total volume of 50 µl Amersham Pharmacia Biotech for 10 min at 37 °C
and the reaction was stopped by 10 min incubation at 98 °C. Gel electrophoresis of
the 5 µl of fragmented product and staining with 2 % SYBRGreen (Molecular probes)
for 50 min was performed to ensure that the majority of cDNA fragments was within
the required 50-200 bp range (Figure 2.5).
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Fig. 2.5. Representative SYBR-Green stained agarose gel with fragmented cDNA. 
For the hybridisation of GeneChips, cDNA fragments with a size of approximately 50-200 bp are
optimal, therefore the majority of the cDNA fragments after fragmentation has this required size.        
2.5.3. Labelling of fragmented cDNA with biotin
Enzo BioArrayTm Terminal Labelling Kit with Biotin-ddUTP was used for terminal
labelling of generated cDNA fragments. For this purpose, 3-5 µg of fragmentation
product was mixed with 5x Reaction Buffer, 10x CoCl2 solution, 1 µl Biotin-ddUTP
and 2 µl terminal deoxynucleotide transferase in a total volume of 60 µl and
incubated at 37 oC for 60 min. Subsequently, the reaction was stopped by addition of
2 µl of 0.5 M EDTA. Such labelled fragmented cDNA was ready for immediate
hybridisation onto GeneChips or could be stored for future use at – 20 oC.  
2.5.4. Hybridisation of biotin-labelled cDNA to GeneChips
GeneChips are normally stored at 4 oC, therefore it is necessary to equilibrate them
at room temperature before starting the hybridisation process. The hybridization 
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volume of 130 µl. This hybridization mixture was loaded onto a GeneChip and
incubated at 50 oC for 16 h at 60 rpm in an Affymetrix GeneChip hybridization oven
640. After hybridisation, this mixture was removed and the GeneChips were put into
the Affymetrix Fluidics station 400 for washing.   
Subsequently the microarrays were subjected to fluorescent labelling by antibody-
mediated signal amplification using Streptavidin-Phycoerythrin. The GeneChips were
washed 20 times with nonstringent buffer at 25 oC and afterwards 60 times with
stringent buffer at 50 oC. Subsequently, the hybridised and washed cDNA was
labelled with streptavidin mixture (primary stain solution) for 10 min at 25 oC and
washed again 40 times with nonstringent buffer at 30 oC. Afterwards, microarrays
were stained with biotin anti-streptavidin antibodies (secondary stain solution) at 25
oC for 10 min and subsequently with streptavidin-phycoerythrin antibodies (tertiary
stain solution) at 25 oC for 10 min. Finally, the excess of fluorescent label was
removed by 60 washings with nonstringent buffer at 30 oC. 
The schematic representation of all the individual steps performed during GeneChip
experiments are shown in Figure 2.6.
2.5.5. GeneChip analyses
All information for analyses of GeneChips can be found online at
http://www.affymetrix.com (Affymetrix, 2001a, 2001b, 2001c, 2001d). 
2.5.5.1. Data mining from the GeneChips 
The GeneChips were scanned with the Affymetrix Microarray Suite 5.0 Software
(MAS 5.0) controlled HP Affymetrix GeneChip scanner. All necessary information for
the experiment, including details about the hybridisation protocol were automatically
saved in the .exp file. The GeneChip scanner is based on confocal microscopy and
uses argon-ion laser to excite the fluorescence of phycoerythrin at 570 nm with 3 µm
resolution. 64 pixels were taken per single probe cell and saved as .dat file. The
corresponding gene sequence was found to each probe cell according to its
coordinates on the GeneChip and signal intensity was assigned to it. MAS 5.0
analysed the dat file and derived a single intensity value for each probe cell on the
array. These data were generated automatically and saved as .cel file (Figure 2.7). 
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Fig. 2.7. Example of the two probe pairs converted from .dat file to .cel file. 
Single intensity value is generated for each probe cell on the array from the 64 pixels in .dat file and
saved as .cel file (Affymetrix, 2001a; von Götz, 2003). 
2.5.5.2. Background subtraction and normalisation
The important step in analysis is to correct for background caused due to unspecific
binding of the streptavidin-phycoerythrin across the entire array. To achieve this, the
whole array is divided into 16 equally spaced zones and an average background is
assigned to the centre of each zone, which corresponds to 2 percent of the zone.
Subsequently, the weighting factor for each probe cell is computed from its relative
distance to neighbouring zone centres. Finally the background signal is computed for
each probe cell by applying the weighting factor to the zone average (Figure 2.8).        
Fig. 2.8. Array zones for computing background signal. The arrow lengths indicate the relative
weights.  
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Our study required comparison of a number of GeneChips in order to detect
alterations in the expression of individual genes in different mutants or growth
conditions. Small discrepancies between arrays due to variables such as the amount
and quality of labelling of hybridised cDNA, staining or probe array lot could cause a
serious problem, if the results were not subjected to the so called linear normalisation
afterwards. This mathematical technique allows comparison analysis of the
experimental results from different GeneChips via multiplication of all signal
intensities on the GeneChip by a certain number. This number is specific to each
array and when multiplied with the average signal intensity of the examined
GeneChips results in the permanently adjusted scaling factor (150). 
2.5.5.3. Four-comparison survival method  
RNA from three independent preparations was pooled together and hybridized onto
each chip to minimize the errors caused due to different handling. Experiments were
carried out in duplicate, thus a total of two GeneChips for each mutant and each wild
type were compared by four-comparison survival method (Chen et al., 2000; Bakay
et al., 2002) (Figure 2.9). Only genes regulated in all four independent comparisons
were considered to be differentially expressed.
2.5.5.4. Expression analysis 
The data were imported into the Microsoft Acces database and selected by Wilcoxon
rank test for genes with significant changes in their expression and at least two-fold
differential regulation in all the four comparisons. The arithmetic mean and the
standard deviation (SD) of the 4 comparisons were calculated. Finally, a Bonferroni
correction for multiple testing (the total number of 5900 ORFs on the GeneChip) was
applied as an independent rigorous criterion for significantly changed signal
intensities. When exploiting this method, firstly the ratio of calibrated hybridization
signals per gene Si from both GeneChips of the mutant or wild type grown under
identical condition was verified to follow a Gaussian distribution and subsequently the
variance  was calculated. The analysed genes were considered to be significantly
differentially expressed only in the case, if the ratio S(i)mutant / S(i)wild type or S(i)wild typel /
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S(i)mutant exceeds the threshold (1 + u ). The factor u defines that the upper
boundary of the normalized Gaussian integral 	(u) where 	(u) = xn matches the
Bonferroni-corrected 95 % confidence interval:
( 1-
 ) = xn ( n = 5900, 
 = 0.025, 0.975 << x < 1.0)
Significantly differentially expressed ORFs were classified using latest internet
annotation from the web site of the Pseudomonas Genome Project
(http://www.pseudomonas.com). 
Fig. 2.9. Four-comparison survival method as a tool to identify differentially expressed genes
(Chen et al., 2000; Bakay et al., 2002).   
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2.6. Phenotypic analyses 
2.6.1. Intracellular survival in PMNs
Fresh blood from a healthy donor was used as a source of PMNs. Human blood
serum was also added to the tube when examining the intracellular survival ability of
tested strains because PMNs require a functional complement system for
opsonization and recognition of bacteria. Due to decreasing activity of isolated
PMNs, special care was taken to complete the whole experiment within 6 hours. In
addition, to avoid unwanted apoptosis and escape of the intracellular bacteria, the
incubation period of bacteria with PMNs was no longer than 2 and half hours.  
The schematic representation of this phagocytosis assay is shown in Figure 2.10. 
Fig. 2.10. Overview of the individual steps of the intracellular survival assay. 
2.6.1.1. Isolation and determination of the concentration of PMNs 
1. 10 ml of blood with 100 µl of liquemin was added in the glass tube containing 5 ml
of 10 % hydroxyethyl starch (HES) and incubated for 45 min at room temperature
to separate the sedimented erythrocytes from the blood plasma.
2. Using a Pasteur pipette the supernatant was transferred in the 15 ml plastic
Falcon tube.
+
P. aeruginosa TB
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3. Using a Pasteur pipette 2 ml of the lymphocyte separation medium were added to
the bottom of the plasma in the tube and the tube was centrifuged at 3000 g for
15 min. 
4. The pellet of granulocytes was resuspended in 1 ml of RPMI1640 medium and
placed on ice.
5. The granulocyte concentration was determined by counting in a Neubauer
chamber. The number of PMNs was counted in 10 different squares to minimize
the probability of errors: One granulocyte counted in the large square represents
a concentration of 2.5 x 105 granulocytes in 1 ml and approximately 107 PMNs
were obtained from 1 ml of blood. 
2.6.1.2. Intracellular survival assay 
1. Approximately 107 of the freshly isolated PMNs from 10 ml of blood, together with
a 10 fold excess (108) of bacteria were added in the RPMI1640 medium
containing 10 % human blood AB-serum to final volume of 2 ml and cultivated at
200 rpm at 37°C for 2 hours. The same 2 ml mixture was also prepared in the
second tube, but without addition of PMNs that served as a control.
2. After the incubation period the tube was placed on ice for 10 min and
subsequently centrifuged at 400 g for 10 min to pellet the granulocytes with
internalised bacteria.
3. The pellet was resuspended in 200 µl RPMI1640 medium, applied on the
nitrocellulose filter with the size of pores 5 µM and washed with 5 ml of PBS. 
4. The filter was transferred in the plastic tube containing 3 ml of double distilled
water and vortexed for 5 min to lyse the PMNs and separate them from bacteria.
5. The mixture was transferred in the fresh plastic tube and centrifuged at 4000 g for
10 min. 
6. The pelleted bacteria were resuspended in 100 µl PBS buffer and plated on LB
agar. The plate was incubated at 37 oC overnight and the number of intracellularly
survived bacteria was determined by counting the cfu.
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2.6.2. Survival in serum
1. The examined bacterial strains were grown in 5 ml of LB medium in 15 ml Falcon
tubes on a rotatory shaker at 37 oC overnight.
2. The optical density at 600 nm for all strains was measured.
3. Approximately 108 of bacteria were added in 2 ml of RPMI1640 medium
containing 10 % human blood AB-serum and cultivated at 200 rpm at 37°C for 2
hours. 
4. The control mixture without serum was simultaneously prepared in the second
tube. 
5. After the incubation period the appropriate dilutions from the bacterial cultures
were taken and plated on LB agar. The plate was incubated at 37 oC overnight
and the number of bacteria which survived the serum stress was determined by
counting the cfu.
2.6.3. Secretion of quorum sensing controlled exoproducts 
2.6.3.1. Secretion of pyocyanin
For the secretion of pyocyanin by the investigated strains a special medium called
King’s medium A was used (King at al., 1954). This medium favours the secretion of
pyocyanin by P. aeruginosa and simultaneously inhibits the secretion of pyoverdin.
1. The examined bacterial strains were grown in 5 ml of LB medium in 15 ml Falcon
tubes on a rotatory shaker at 37 oC overnight.
2. The optical density at 600 nm for all strains was measured.
3. Bacteria were inoculated in the 15-25 ml of King’s medium in 125 ml Capsenberg
flasks to optical density 0.05 and cultivated at 300 rpm on a rotatory shaker at 37
oC for 12 hours. 
4. 2 ml of this bacterial culture were centrifuged at 14.000 g for 3 min at room
temperature.
5. The pelleted bacterial cells were discarded, whereas the absorbance of the
supernatant was measured at 695 nm.
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2.6.3.2. Secretion of proteases  
P. aeruginosa secretes a battery of extracellular virulence factors. The important
virulence extracellular factors whose secretion is controlled by quorum sensing are
proteases. The secretion of proteases was determined by growth of the investigated
P. aeruginosa mutants on M9 agar plates supplemented with 0.75 % casein. 
1. The examined bacterial strains were grown in 5 ml of LB medium in 15 ml Falcon
tubes on a rotatory shaker at 37 oC overnight.
2. The optical density at 600 nm for all strains was adjusted to 1.0 and 2 µl thereof
were inoculated on M9 agar plates. 
3. The plates were incubated at 37 oC for at least 24 hours and then checked for the
size of the transparent zone around bacteria indicating proteolytic lysis of the
casein. 
2.6.3.3. Secretion of elastase
For the examination of the elastase secretion the modified elastin-Congo red assay
was used (Rust et al., 1994). This assay exploits elastin covalently linked to a Congo
Red dye as substrate. Secreted elastase digests this substrate, thus releasing the
red dye which causes an easily measurable colorimetric reaction.
1. The examined bacterial strains were grown in 5 ml of LB medium in 15 ml Falcon
tubes on a rotatory shaker at 37 oC overnight.
2. The optical density at 600 nm for all strains was measured. 
3. Bacteria were inoculated in the 15-25 ml of LB medium in 125 ml Capsenberg
flasks to optical density 0.05 and cultivated at 300 rpm on a rotatory shaker at 37
oC for 12 hours. 
4. 5 ml of the 30 mM Tris buffer (pH 7.2) were added to 50 mg of elastin-Congo red
and vortexed to avoid clumping of substrate.
5. 0.5 ml of the bacterial culture supernatant were added to the mixture and
cultivated at 200 rpm on a rotatory shaker at 37 oC for 4-6 hours.
6. Undigested elastin-Congo red was pelleted by centrifugation at 1200 g for 10 min
at room temperature and the absorbance of the supernatant was measured at
495 nm.
Materials and methods
81
2.6.3.4. Secretion of hemolysins   
Hemolytic activity is another important virulence trait known to be controlled by
quorum sensing in P. aeruginosa. P. aeruginosa was shown to produce two different
hemolysins: phospholipase C and rhamnolipids. In order to analyse the hemolytic
activity the investigated P. aeruginosa strains were grown on Columbia blood agar
(Becton Dickinson).  
1. The examined bacterial strains were grown in 5 ml of LB medium in 15 ml Falcon
tubes on a rotatory shaker at 37 oC overnight.
2. The optical density at 600 nm for all strains was adjusted to 1.0 and 2 µl thereof
were inoculated on Columbia agar plates.
3. The plates were incubated at 37 oC for at least 48 hours and then checked for the
size of the transparent zone around bacteria indicating hemolytic activity of the
tested strains.
2.6.4. Determination of the protein concentration 
The Bradford method was used to determine the concentration of proteins secreted
by the analysed bacterial strains (Bradford, 1976; Schmidt et al., 1963). This
procedure exploits the binding of a dye, Coomassie brilliant blue to the proteins after
the NaOH mediated lysis of the cells to determine the protein concentration.
1. 1 ml of the bacterial culture was mixed with the equal volume of 2M NaOH and
incubated at 80 oC for 1 hour.
2. Lysed bacterial cells were placed on ice for 2 min, resuspended thoroughly and
mixed with 40 times larger volume of the Bradford solution. 
3. The suspension was incubated at room temperature for 40 min and the
absorbance was measured at 595 nm.  
2.6.5. Virulence towards C. elegans  
Nematode killing assays were performed in collaboration with D. Jordan and I.
Steinmetz from the Institute of Medical Microbiology and Hospital Epidemiology of
the Hannover Medical School. All C. elegans strains were maintained under standard
culturing conditions on nematode growth medium with Esccherichia coli OP50 as a
food source (Stiernagle, 1999). Bristol N2 (wild type), provided by the Caenorhabditis
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Genetics Centre (University of Minnesota, St Paul’s, MN, USA) was used throughout
this study. C. elegans killing experiments were performed in a liquid-medium-based
system using 24-well plates. Nematodes were exposed to a suspension (OD650 0.5)
of bacterial cells for each strain tested.    
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2.7. Internet databases and software
2.7.1. Databases
1.  Most frequently used Pseudomonas database comprising completely sequenced
genome of P. aeruginosa strain PAO1-PSEUDOMONAS GENOME PROJECT
(http://www.pseudomonas.com) (Benson et al., 2002).
2. Reannotation P. aeruginosa genome database-PSEURECA
(http://maine.ebi.ac.uk:8000/services/pseureca) (Weinel et al., 2003). 
3. Gene and protein database-GENBANK (http://www.ncbi.nlm.nih.gov) (Benson et
al., 2002).
4. Sequences and annotation of GeneChip probes-NETAFFX
(http://www.affymetrix.com/analysis/index.affx).
5. Kyoto encyclopedia of genes and genomes-KEGG
(http://www.genome.ad.jp/kegg) (Kanehisa et al., 2002).
6. Database of protein families-PFAM 
(http://www.sanger.ac.uk/Software/Pfam/index.html) (Bateman et al., 2002). 
7.  Database of the Institute for Genomic Research-TIGR (http://www.tigr.org).  
2.7.2. Software
1. The bendability/ curvature propensity plot was calculated with the BEND.IT server
(http://hydra.icgeb.trieste.it/~kristian/dna/bend_it.html), using Dnase I-based
bendability parameters and consensus bendability scale as described by Brukner
et al., 1995.
2. The restriction map of the shuttle vector pME6010, which was used for
complementation of analysed genes was created with the help of the freeware
pDRAW32 (http://www.acaclone.com).
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3. For the examination of homology between tested ORFs BLAST software was
used (http://www.ncbi.nlm.nih.gov or http://blast.genome.ad.jp) (Altschul et al.,
1990; Altschul et al., 1997). 
4. Restriction digests of target sequences were pre-designed in silico with the
WEBCUTTER 2.0 software (http://www.firstmarket.com/cutter/cut2.html).
5. PRIMER 3 software was usually used to facilitate the construction of primers
(http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi).
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3. Results and discussion
3.1. Global regulation of quorum sensing and
virulence by VqsR
3.1.1. Features of the vqsR (PA2591) gene 
The sequence of vqsR (807 bp = 268 amino acids) corresponds to the ORF PA2591
of the P. aeruginosa PAO1 genome (http://www.pseudomonas.com) (Figure 3.1).
According to the information stored in the PAO1 database, vqsR (PA2591) encodes
a putative transcriptional regulator with 46% homology to DMSO reductase
regulatory protein DorX of Rhodobacter sphaeroides. The vqsR is the first gene of an
operon, follows a promoter region and contains a palindromic terminator sequence at
the end of the ORF.       
Fig. 3.1. The map showing the part of the P. aeruginosa chromosome area around the
investigated vqsR (PA2591) gene (http://www.pseudomonas.com).  
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The G+C content of this gene (58.33 mol%) (Figure 3.2) is lower than the average
G+C content (66.6 mol%) of the P. aeruginosa genome (Stover et al., 2000), but its
codon adaptation index (0.688) calculated from codon usage is similar to that
typically found for P. aeruginosa transcriptional regulators (Kiewitz et al., 2002). This
suggests that despite its lower G+C content, vqsR was not acquired by
phylogenetically recent horizontal transfer, but is rather a part of the core P.
aeruginosa genome. 
Fig. 3.2. The scheme showing the G+C content of the whole P. aeruginosa genome. The position
of the vqsR (PA2591) gene is indicated (http://www.tigr.org).  
VqsR possesses a las box (5’-AACTACCAGTTCTGGTAGGT-3’) in its -157 to -138
upstream region (Wagner et al., 2003), which exhibits homology with the palindromic
lux box DNA elements identified in Vibrio fischeri. las boxes are usually located
upstream of LuxR-regulated genes and serve as binding sites for regulatory protein-
autoinducer complexes. A bendability/curvature propensity plot revealed a low
curvature DNA sequence in the upstream region of vqsR (Figure 3.3). Hence, binding
of a protein-autoinducer complex could promote more extensive bending of the
upstream sequence leading to the transcriptional activation of this gene. 
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Fig. 3.3. Curvature propensity plot. Curvature propensity plot of the vqsR (PA2591) gene (20-826)
and its upstream sequence (827-984) containing a las box (965-984) until the start of PA2592 gene
(980), which is transcribed in the opposite direction. The upstream region of vqsR contains a relatively
low curvature DNA sequence which suggests necessity of subsequent bending by a protein-
autoinducer complex for transcriptional activation of this gene
(http://hydra.icgeb.trieste.it/kristian/dna/bend_it.html).   
Fig. 3.4. The scheme showing the pfam domains of the vqsR (PA2591) gene (http://www.tigr.org).
vqsR maintains a DNA binding domain in its carboxyl-terminus that is typical for the LuxR group of
transcriptional regulators.    
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VqsR moreover harbours a DNA binding domain in its carboxyl-terminus that is
typical for the LuxR group of transcriptional regulators (Fuqua et al., 1996) (Figure
3.4). These in silico findings suggest that the vqsR gene plays an important role in
the P. aeruginosa quorum sensing cascade.   
3.1.2. Complementation of the vqsR gene 
The P. aeruginosa vqsR mutant was generated by Tn5 transposon mutagenesis as
described previously (Wiehlmann et al., 2002). This mutant was complemented in
trans to ensure that all the subsequently observed striking phenotypes (see chapters
3.1.3 – 3.1.5) were caused by the transposon inactivation of the respective gene and
not by any other secondary genetic event.
Fig. 3.5. Scheme of the cloning of the vqsR gene into pME6010 vector.
The PCR fragment with the length of 1254 bp comprising the analysed vqsR gene was cloned into the
broad host range vector pME6010 maintaining the tetracycline resistance. The recombinant plasmid
pME6010vqsR was used for complementation of the phenotype of the P. aeruginosa vqsR mutant.    
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The pME6010vqsR plasmid used for complementation in trans was constructed by
cloning the 1254 bp of the PA2591 (vqsR) gene generated by PCR with primers: 5’-
CTT GAA CAA GCT TTC GTC CTG CGC GTA-3’, 5’-GAT TAT AGA TCT GTG GAT
ATC GCA TTG CAC-3’ into the BglII/HindIII- restricted pME6010 shuttle vector
(Figure 3.5). 
Fig. 3.6. The restriction digest of the recombinant plasmid pME6010vqsR. pME6010vqsR was
isolated from the complemented P. aeruginosa TBvqsR(pME6010vqsR) strain. 
This plasmid, based on the minimal pVS1 replicon, was demonstrated to express
proteins in both E. coli and P. aeruginosa (Heeb et al., 2000). The recombinant
pME6010vqsR plasmid was introduced into E. coli OneShot®TOP10 chemically
competent cells (Invitrogen) by transformation and subsequently into the P.
aeruginosa vqsR mutant via electroporation (see chapter 2.3). The restriction digest
of the recombinant plasmid pME6010vqsR isolated from P. aeruginosa confirmed
genetic complementation of the vqsR mutation (Figure 3.6).
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3.1.3. VqsR is essential for the production of autoinducer
molecules  
Quorum sensing in P. aeruginosa employs acylhomoserine lactones (AHLs) as
autoinducer signalling molecules (Pearson et al., 1994). In order to examine the
effect of the investigated vqsR gene on AHL synthesis, we streaked the P.
aeruginosa TB wild type strain and its Tn5::vqsR transposon mutant close to the
GFP-based broad range AHL sensor E. coli JM105(pJBA89) (Andersen et al., 2001).
No AHL production was observed with the P. aeruginosa Tn5::vqsR transposon
mutant. 
P. aeruginosa possesses two different quorum sensing acylhomoserine lactones: N-
(3-oxododecanoyl) homoserine lactone (3-oxo-C12-HSL) and N-butyryl homoserine
lactone (C4-HSL), which are the major components of las and rhl systems
respectively (Wagner et al., 2003). Therefore, the cross-streak experiments were also
performed with the biosensor P. putida F117 (pKR-C12), which only detects a narrow
range of long chain AHLs, being most sensitive for 3-oxo-C12-HSL (Steidle et al.,
2001). As with E. coli (pJBA89), the vqsR mutant did not provoke a positive signal
(Figure 3.7.a and 3.7.b), supporting the view that VqsR plays a crucial role in P.
aeruginosa quorum sensing cascade. 
For more detailed analysis, thin-layer chromatography (TLC) was performed
exploiting AHL biosensors E. coli MT102 (pSB403) and Chromobacterium violaceum
CV026 (McClean et al., 1997; Shaw et al., 1997; Winson et al., 1998; Geisenberger
et al., 2000). Using this highly sensitive technique, the vqsR mutant was confirmed to
be significantly impaired in the production of AHLs, including both C4-HSL (Figure
3.7.c) and 3-oxo-C12-HSL (Figure 3.7.d).  
Complementation of Tn5::vqsR in trans was performed in order to verify that the
observed phenotype of the mutant was caused by the transposon mutation and not
by any other secondary genetic event (see chapter 3.1.2). Complementation in trans
restored the AHL molecules secretion ability of the vqsR mutant to levels comparable
to the wild type (Figure 3.7.a, 3.7.b, 3.7.c and 3.7.d). Hence these experiments
revealed the important role of VqsR in the initial steps of the quorum sensing
cascade: in the production and secretion of quorum sensing autoinducers.     
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Fig. 3.7. Secretion of AHLs by P. aeruginosa TB wild type (wt), its Tn5::vqsR transposon
mutant (vqsR-) and complemented mutant (vqsR+). 
a) tested P. aeruginosa strains were cultivated with P. putida F117 harbouring plasmid pKR-C12,
which contains a translational fusion of the lasB promoter to gfp and the lasR gene under
control of a lac-type promoter and illuminated with normal light. 
b) tested strains illuminated with blue light exciting green fluorescent protein. Notice the full
restoration of the ability to produce autoinducer molecules in the Tn5::vqsR complemented
mutant (vqsR+). 
c) TLC analysis of AHLs secreted by tested P. aeruginosa strains using AHL biosensor Ch.
violaceum CV026 which is able to detect C4-HSL. Note the significantly diminished ability to
secrete AHLs, including C4-HSL (upper spot) in the vqsR mutant (vqsR-). 
d) TLC analysis of AHLs secreted by tested P. aeruginosa strains using AHL biosensor E. coli
MT102 (pSB403) which is able to detect 3-oxo-C12-HSL. Notice the remarkably diminished
ability to secrete AHLs, including 3-oxo-C12-HSL, in the vqsR mutant (vqsR-). In Fig. 1c, d
lanes with AHL standards are indicated by s (B. Huber and L. Eberl).
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3.1.4. VqsR affects secretion of extracellular virulence
factors
Quorum sensing modulates the expression of a broad spectrum of virulence genes in
P. aeruginosa (Passador et al., 1993). To analyze the effect of the vqsR mutation on
the production of bacterial extracellular virulence factors, I have investigated its
impact on proteases, hemolysins and pyocyanin secretion. 
Proteases: 
The secretion of proteases was determined by growth of the investigated P.
aeruginosa strains on M9 agar plates, which were supplemented with 0.75 % casein
(see chapter 2.6.3.2). The easily visible halo on casein agar plates, indicating
proteolytic activity was observed for the TB wild type, but not for its vqsR mutant. On
the other side, in the complemented mutant, the secretion of proteases was restored
according to our expectations (Figure 3.8). 
Fig. 3.8. Secretion of proteases by the P. aeruginosa TB wild type strain (wt), its Tn5::vqsR
transposon mutant (vqsR-) and complemented mutant (vqsR+). No proteolytic activity of the
mutant strain was detected on casein agar. 
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Casein is known to be degraded mainly by activity of LasB protease, alkaline
protease and protease IV (Cowell et al., 2003). All these three proteases play an
important part in the infection process of P. aeruginosa (van Delden, 2004). Protease
IV is implicated in the degradation of the components of the complement C1q and
C3, fibrinogen, immunoglobulin G, plasmin and plasminogen (Engel et al., 1998a)
and in facilitation of the P. aeruginosa corneal infections (Engel et al., 1998b).
Alkaline protease was also proven to degrade complement components as well as
fibrin and fibrinogen (Shibuya et al., 1991) but its role in the tissue invasion is still
unclear. LasB is a highly efficient protease with the proteolytic activity about ten times
higher than P. aeruginosa alkaline protease and four times higher effectivity towards
casein than trypsin (Galloway, 1991). LasB protease constitutes one of the major
virulence determinants during acute infection due to its ability to destroy protein
elastin (van Delden, 2004). Expression of both, LasB elastase and alkaline protease
was shown to be controlled by the quorum sensing circuit in P. aeruginosa (Latifi et
al., 1995). 
Intriguingly, the proteolytic activity of the vqsR mutant was not inducible even after
exogenous addition of 0.3 µM 3-oxo-C12–HSL and 0.4 µM C4-HSL to the medium.
Using the same concentrations of autoinducers, the extracellular proteolytic activity of
a lasI rhlI PAO1 double mutant was restored to the level of the wild type. These data
indicate that, in contrast to the inactivation of lasI and rhlI, the lack of AHL synthesis
does not completely explain the phenotype of protease deficiency in the vqsR
mutant. 
To test specifically for elastase secretion, the modified elastin-Congo red assay was
used (Rust et al., 1994) (see chapter 2.6.3.3). This assay exploits elastin covalently
linked to a Congo Red dye as substrate. Secreted elastase digests elastin-Congo
red, thus releasing the red dye which causes an easily measurable colorimetric
reaction. Using this assay, the vqsR mutant was found to be impaired in the ability to
produce elastase which is known to be LasR-3-oxo-C12-HSL dependent, whereas the
ability of the complemented mutant to secrete elastase was restored almost to levels
comparable to the wild type (Figure 3.9.a and 3.9.b). 
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               a)
                b)
Fig. 3.9. Secretion of elastase by the P. aeruginosa TB wild type strain (wt), its Tn5::vqsR
transposon mutant (vqsR-) and complemented mutant (vqsR+). 
a) Elastase secreted by the wild type and the complemented mutant digests elastin-Congo red,
thus releasing the red dye and causing an easily distinguishable coloured reaction. The ability
of vqsR mutant to secrete elastase was reduced severely. The picture shows a result of a
representative experiment after 8 hours of growth of tested strains in LB medium.  
b) Kinetics of the secretion of elastase by examined P. aeruginosa strains. The amount of
released red dye in the supernatant was quantified by measuring absorbance at 495 nm
(A495). ○, wt; ∆, vqsR-; ▲, vqsR.
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Hemolysins:
The hemolytic activity was analysed by growth of the investigated P. aeruginosa
strains on the Columbia blood agar (Becton Dickinson) (see chapter 2.6.3.4). The
zone of clearance on Columbia agar plates was clearly visible in the wild type and in
the complemented mutant. On the other hand, the zone of clearance around the
analysed vqsR mutant was only small and hard to seen thus reflecting its significantly
reduced hemolytic activity (Figure 3.10). 
Fig. 3.10. Secretion of hemolysins by the P. aeruginosa TB wild type strain (wt), its Tn5::vqsR
transposon mutant (vqsR-) and complemented mutant (vqsR+) on the Columbia agar plates.
The mutant strains displayed significantly reduced hemolytic activity.
P. aeruginosa produces two different hemolysins: phospholipase C and rhamnolipids.
Rhamolipids represent very potent biosurfactants, which act in concert with
phospholipase C in order to dissolve lipids (for instance phospholipids of lung
surfactant) and lecithin (van Delden, 2004). Furthermore phospholipase C was
shown to induce release of the inflammatory mediators from human inflammatory
effector cells (platelets, granulocytes, and monocytes), whereas rhamnolipids were
shown to be crucial for the developments of biofilms (Konig et al., 1996; Davey et al.,
2003). Both hemolysins: phospholipase C as well as rhamolipids were shown to be
controlled by quorum sensing in P. aeruginosa (Passador et al., 1993, Hentzer et al.,
2003).       
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Pyocyanin:
For determination of the pyocyanin secretion ability of the wild type, vqsR mutant and
complemented mutant a special medium called King’s medium A was used which
favours the secretion of pyocyanin and simultaneously inhibits the secretion of
siderophores (King at al., 1954). 
As shown below, measuring the amount of pyocyanin in the supernatants of the
tested bacterial strains revealed a dramatic decrease of pyocyanin secretion in the
vqsR mutant when compared to the wild type and complemented mutant (Figure
3.11.a and 3.11.b), thus revealing the important role of VqsR for the pyocyanin
production by P. aeruginosa.  
Pyocyanin is a blue phenazine pigment. It represents an important P. aeruginosa
extracellular virulence factor due to its ability to generate reactive oxygen species
(superoxide and hydrogen peroxidase), thus exposing host cells to oxidative stress
(Muller, 2002). As a consequence, pyocyanin was shown to induce apoptosis of
human neutrophils and inhibit lymphocyte proliferation (Usher et al., 2002).
Furthermore, the secretion of pyocyanin in P. aeruginosa was also found to be
controlled by quorum sensing (Latifi et al., 1995).
In all the experiments described above the mutation of analysed vqsR reduced
significantly secretion of various exoproducts: proteases (including elastase),
hemolysins and pyocyanin. On the other hand, in the complemented mutant,
proteases, hemolysins as well as pyocyanin secretion ability were restored almost to
levels comparable to the wild type. All exoproducts, whose secretion was
investigated, are known to be implicated in the P. aeruginosa virulence and their
secretion was shown to be controlled by quorum sensing circuitry. Thus, these
experiments provided further evidence that VqsR constitutes an essential element of
the P. aeruginosa cell-to-cell communication network. 
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               a)
              
               b)
Fig. 3.11. Pyocyanin secretion by P. aeruginosa TB wild type (wt), its Tn5::vqsR transposon
mutant (vqsR-) and complemented mutant (vqsR+). Strains were cultivated in the King’s A
medium.
a) Pyocyanin secreted by the complemented mutant and wild type caused an easily detectable
coloured reaction, whereas the pyocyanin secretion ability of the vqsR mutant was reduced
dramatically. The picture shows a result of a representative experiment after 8 hours of growth
of tested strains in King’s medium A. 
b) Kinetics of the secretion of pyocyanin by examined P. aeruginosa strains. The amount of
pyocyanin in the supernatant was quantified by measuring absorbance at 695 nm (A695). ○, wt;
∆, vqsR-; ▲, vqsR.
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3.1.5. VqsR has an impact on virulence in a C. elegans
model 
The nematode C. elegans has been used as a bacterial pathogenesis model for the
identification of virulence-attenuated mutants in P. aeruginosa (Mahajan-Miklos et al.,
1999; Tan et al., 1999). In fact, it has been shown that the analysis of the interaction
with this invertebrate host has the potential to predict disease outcome in the
mammalian host. Testing of the wild type and its Tn5::vqsR transposon mutant in the
C. elegans killing model revealed a significant attenuation of the vqsR mutant
compared to the wild type (Figure 3.12). The killing activity of the complemented
mutant was restored to wild type levels (Figure 3.12), indicating an important role of
the vqsR gene in virulence towards C. elegans.     
Fig. 3.12. Kinetics of the killing of C. elegans by TB wild type strain (wt), its Tn5::vqsR
transposon mutant (vqsR-) and complemented mutant (vqsR+). 45 to 60 L4 larvae were placed in
each well and scored for dead worms by microscopic examination. E. coli DH5 served as a negative
control. Values are the mean  SD of a representative experiment with triplicate values. ○, wt; ∆,
vqsR-; ▲, vqsR+; ■, E. coli (D. Jordan).
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3.1.6. Transcriptional analysis of vqsR 
3.1.6.1. Expression of vqsR on Northern blot
The expression of VqsR mRNA was analyzed on Northern blots under various
growth conditions. Standard conditions like growth in LB medium to early and late
exponential phase were used as well as exposure to different stress conditions like
growth in ABC minimal mineral medium, growth in the presence of oxidative stress
generated by hydrogen peroxide, growth in the presence of serum and growth in the
presence of PMNs. 
Fig. 3.13. Northern blot of P. aeruginosa TB wild type strain (wt) and its Tn5::vqsR transposon
mutant (vqsR-) mRNA expression in the presence of 10% human blood serum. RNA isolated
from both strains was hybridised with the 615 bp probe prepared from the vqsR sequence. 
While exposing to the hydrogen peroxide generated stress, serum and PMNs,
bacteria were grown in a dialysis bag with appropriate pore diameter to ensure
continuous exchange of fluids. This was particularly convenient while growing
bacteria in the presence of PMNs due to difficulties in the separation of eukaryotic
and prokaryotic RNA. In addition to the degradation by bacteria, hydrogen peroxide
concentration in the medium is also decreasing spontaneously. Dialysis bags in
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combination with an excess of stressor (10 mM) were also used in order to measure
the steady state response of bacteria to hydrogen peroxide. Above 5 mM of
hydrogen peroxide was still present in the medium after 2 hours of incubation.  After
the incubation period, the cells were immediately recovered from the dialysis bag and
subjected to RNA isolation (see chapter 2.4.3). The expression pattern of vqsR was
examined by Northern blots.
Consistent with the hypothesis about its regulatory function, vqsR was found to be
expressed only very lowly on Northern blots. Hybridization with a genomic vqsR
probe gave a weak signal when P. aeruginosa TB had been cultured in the presence
of H2O2 or human serum (Figure 3.13), but only barely detectable signals under the
other tested conditions. The Tn5::vqsR mutant did not produce any detectable VqsR
transcript under all chosen conditions.   
3.1.6.2. GeneChip expression analysis of the VqsR regulon in the
presence of serum and H2O2
P. aeruginosa GeneChips were used to investigate the effect of VqsR on global
changes in the gene expression profile. Total RNA, extracted from bacterial cultures
cultivated in the presence of 10 % human blood serum or 10 mM H2O2, was
hybridized on the DNA microarrays in duplicate. The oligonucleotide-array comprises
the whole genome of P. aeruginosa PAO1 (5549 ORFs, 18 tRNA genes and 1 rRNA
operon, 199 probe sets for all intergenic regions exceeding 600 base pairs and 117
additional ORFs which are present in other P. aeruginosa strains). 
The signals on the arrays representing the expression levels of individual genes were
used to calculate the expression ratio between the wild type and mutant strain
cultivated in the presence of H2O2 and serum. Only those genes were considered to
be differentially expressed which exhibited a significant change according to
Wilcoxon rank test, showed at least two fold change in expression in all four
independent comparisons and passed through the Bonferroni correction for multiple
comparisons. The genes having signal intensities below 100 were discarded due to
large experimental variation. Numerous genes were differentially regulated in the
vqsR mutant when compared to the wild type strain (Figure 3.14).
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               a)
               b)
               
               c)
Fig. 3.14. Logarithmic scatter graph of absolute signal intensities of P. aeruginosa ORFs
represented by 5900 individual array spots. The graph indicates that the expression of many genes
was altered in the vqsR mutant under both tested conditions. 
a) Global expression profiles of two TB wild type cultures cultivated under the same growth
conditions. The absolute signal intensities of one replicate were plotted against the signal
intensities of a second replicate. 
b) Absolute signal intensities of TB wild type strain (wt) plotted against signal intensities of the
Tn5::vqsR transposon mutant (vqsR-) when both cultures were treated with H2O2. 
c) Signal intensities of the TB wild type (wt) plotted against Tn5::vqsR transposon mutant (vqsR-)
obtained after cultivation of both cultures in the presence of human blood serum. 
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By applying the stringent criteria outlined above, the mutation of vqsR significantly
influenced the expression of 151 genes in the presence of H2O2 and of 113 genes in
the presence of human blood serum. Out of 151 genes differentially regulated in the
presence H2O2, 55 genes were downregulated and 96 genes were upregulated in the
vqsR mutant. Out of 113 genes differentially regulated in the presence of serum, the
expression of 92 genes was repressed and the expression of remaining 21 genes
was promoted in the mutant. Only 26 genes were significantly regulated under both
conditions. 
The differences in the gene expression of the wild type and the mutant ranged from
2-fold up to 130-fold (Figure 3.15). The expression of the majority of the genes (112
genes) was modified 4 to 8-fold, whereas the expression of only five genes was
altered more than 64-fold. 
Fig. 3.15. Fold changes of the differentially regulated genes. Genes were separated according to
the magnitude of differential expression. 
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Interestingly, almost 90 % from the genes whose expression was altered more than
32-fold were previously identified as quorum sensing regulated genes (Hentzer et al.,
2003; Schuster et al., 2003; Wagner et al., 2003).       
Expression of a significant number of genes implicated in amino acid biosynthesis,
antibiotic resistance, cell wall and lipopolysaccharide biosynthesis, carbon compound
catabolism, central intermediary metabolism, chemotaxis, protein secretion, fatty acid
and phospholipid metabolism, translation and post-translational modification,
adaptation protection, biosynthesis of cofactors or those encoding putative enzymes
and two-component regulatory systems were found to be differentially regulated in
the examined vqsR mutant (Figure 3.16).
The largest proportion of all differentially regulated genes (43 %) belongs to the class
of hypotheticals with unknown function. Expression of 49 genes out of these genes
was upregulated in the mutant and expression of 64 genes was downregulated. 
Expression of 36 genes (11 upregulated in the mutant and 25 downregulated in the
mutant), which represent 24 % of the known ORFs and which are all involved in the
transport of small molecules in P. aeruginosa was found to be controlled by VqsR.
Other functional classes with the largest numbers of genes regulated by VqsR
included the genes encoding membrane proteins (22 %), energy metabolism (22 %),
secreted factors (22 %) and transcriptional regulators (19 %). Of particular interest
are genes encoding secreted factors and proteins involved in the transport of small
molecules due to their involvement in P. aeruginosa virulence (Stover et al., 2000).
The modulation of expression of a large number of other transcriptional regulators
suggested an important regulatory function for VqsR.     
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Fig. 3.16. Comparison of the transcriptome of P. aeruginosa TB and its vqsR Tn5 transposon
mutant during growth in the presence of serum and H2O2. The number of genes is classified by
metabolic category as defined in the original publication on the PAO genome sequence (Stover et al.,
2000). 
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3.1.6.2.1. vqsR regulates a broad spectrum of quorum sensing genes
Recently three independent transcriptome analyses were published with the ambition
to identify elements of the quorum sensing regulon in P. aeruginosa (Hentzer et al.,
2003; Schuster et al., 2003; Wagner et al., 2003). Comparison of the genes identified
in these studies with those regulated by vqsR revealed that a huge proportion of the
genes modulated by the investigated VqsR belong to the category of quorum sensing
regulated. From the genes found to be under the control of VqsR in the presence of
hydrogen peroxide and serum, nearly 40 % and 60 % respectively are previously
identified quorum sensing genes (Figure 3.17).     
Fig. 3.17. Proportion of quorum sensing (QS) regulated genes among all differentially
expressed genes in the P. aeruginosa vqsR mutant. 
Thus this transcriptome analysis revealed that VqsR modulates the expression of a
broad spectrum of quorum sensing and virulence genes and confirmed the
hypothesis about the key role of VqsR in the population density dependent gene
regulation in P. aeruginosa. Figures 3.18 and 3.19 represent an overview of all genes
whose expression was found to be significantly up- and downregulated in the
Tn5::vqsR mutant according to the results of the Genechip analyses, whereas Tables
3.1 and 3.2 list selectively only the previously identified quorum sensing genes giving
the detailed information about their products.    
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Fig. 3.18. Differential gene expression of the Tn5::vqsR transposon mutant compared to P.
aeruginosa wild type strain TB in the presence of 10 % human blood serum. Positive values
represent genes whose expression is upregulated in the mutant and negative numbers genes whose
expression is downregulated in the mutant compared to the TB wild type strain. Quorum sensing
regulated genes are indicated by black colour (Hentzer et al., 2003; Schuster et al., 2003; Wagner et
al., 2003).
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Fig. 3.19. Differential gene expression of the Tn5::vqsR transposon mutant compared to P.
aeruginosa wild type strain TB in the presence of 10 mM H2O2. Positive values represent genes
whose expression is upregulated in the mutant and negative numbers genes whose expression is
downregulated in the mutant compared to the TB wild type strain. Quorum sensing regulated genes
are indicated by black colour (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003). 
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Tab. 3.1. Quorum sensing genes with upregulated expression in the vqsR mutant in the
presence of serum and H2O2 (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003).
Fold change2ORF1 Gene
name Serum H2O2
Protein description
Nitrogen metabolism
PA0509 nirN 12.1 probable c-type cytochrome
PA0510 53.1 probable uroporphyrin-III c-methyltransferase
PA0511 nirJ 13.5 heme d1 biosynthesis protein NirJ
PA0512 17.3 conserved hypothetical protein
PA0513 22.6 probable transcriptional regulator
PA0514 nirL 45.9 heme d1 biosynthesis protein NirL
PA0515 129.7 probable transcriptional regulator
PA0516 nirF 32.0 heme d1 biosynthesis protein NirF
PA0517 nirC 51.5 probable c-type cytochrome precursor
PA0518 nirM 43.9 cytochrome c-551 precursor
PA0520 nirQ 7.3 regulatory protein NirQ
PA0521 5.9 probable cytochrome c oxidase subunit
PA0523 norC 54.3 nitric-oxide reductase subunit C
PA0524 norB 61.0 nitric-oxide reductase subunit B
PA0525 10.3 probable dinitrification protein NorD
PA3391 nosR 41.2 regulatory protein NosR
PA3392 nosZ 48.6 nitrous-oxide reductase precursor
PA3393 nosD 10.2 NosD protein
PA3394 nosF 7.5 NosF protein
PA3872 narI 13.0 respiratory nitrate reductase gamma chain
PA3873 narJ 21.6 respiratory nitrate reductase delta chain
PA3874 narH 26.2 respiratory nitrate reductase beta chain
PA3875 narG 117.1 respiratory nitrate reductase alpha chain
PA3876 narK2 42.2 nitrite extrusion protein 2
PA3877 narK1 20.5 nitrite extrusion protein 1
PA3914 moeA1 71.1 molybdenum cofactor biosynthetic protein A1
PA3915 moaB1 13.0 molybdopterin biosynthetic protein B1
Other genes
PA1559 15.5 hypothetical protein
PA2008 fahA 4.6 fumarylacetoacetase
PA2009 hmgA 8.3 homogentisate 1,2-dioxygenase
PA2446 gcvH2 9.8 glycine cleavage system protein H2
PA3337 rfaD 6.6 ADP-L-glycero-D-mannoheptose 6-epimerase
PA3871 7.8 prob. peptidyl-prolyl cis-trans isomerase, PpiC-type
PA3911 6.7 conserved hypothetical protein
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Fold change2ORF1 Gene
name Serum H2O2
Protein description
Other genes
PA3912 8.3 conserved hypothetical protein
PA4587 ccpR 10.2 cytochrome c551 peroxidase precursor
PA4916 5.5 hypothetical protein
PA4918 9.7 hypothetical protein
PA5230 13.5 probable permease of ABC transporter
PA5231 5.9 prob. ATP-binding/permease fusion ABC transporter
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
In the presence of serum, the vqsR mutant overexpressed only those genes that
belong to the category of amino acid metabolism or the category of conserved
hypotheticals, presumably just reflecting the serum as a protein-rich carbon source
(Table 3.1).
Exposure to H2O2 activated genes by more than 10-fold in the mutant that are either
conserved hypotheticals or encode components of anaerobic metabolism. Nitrite and
nitrate respiration have been also previously reported to be repressed by quorum
sensing  (Table 3.1) (Wagner et al., 2003). 
On the other hand, the inactivation of vqsR decreased mRNA levels of some of the
major regulators of the quorum sensing network in P. aeruginosa: LasI, RhlR, RsaL,
RpoS and MvfR (Table 3.2). LasI and RhlR are the major components of two quorum
sensing systems operating in this organism: the las system, which consists of the
transcriptional activator LasR and the AHL synthase LasI, which directs the synthesis
of N-3-oxo-dodecanoyl-homoserine lactone (3-oxo-C12-HSL) and the rhl system,
which consists of the transcriptional regulator RhlR and the AHL synthase RhlI, which
directs the synthesis of N-butanoyl-homoserine lactone (C4-HSL) (Passador et al.,
1993; Latifi et al., 1995; Pearson et al., 1995; Pesci et al., 1997). MvfR (PqsR) has
been proven to be responsible for the production of the P. aeruginosa quinolone
signal (PQS) molecule (Déziel et al., 2004).
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Tab. 3.2. Quorum sensing genes with downregulated expression in the vqsR mutant in the
presence of serum and H2O2 (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003).
Fold change2ORF1 Gene
name Serum H2O2
Protein description
las and rhl systems
PA1432 lasI 8.4 11.0 autoinducer synthesis protein LasI
PA3477 rhlR 5.4 transcriptional regulator RhlR
Global regulators of QS
PA1003 mvfR 3.0 transcriptional regulator
PA1431 rsaL 52.6 32.7 regulatory protein RsaL
PA3622 rpoS 3.5 sigma factor RpoS
PQS synthesis 
PA2587 pqsH 10.8 probable FAD-dependent monooxygenase
PA4190 pqsL 4.9 probable FAD-dependent monooxygenase
Proteases biosynthesis and secretion
PA1248 aprF 7.4 alkaline protease secretion protein AprF
PA1250 aprI 10.2 8.4 alkaline proteinase inhibitor AprI
PA1871 lasA 16.4 LasA protease precursor
PA1875 3.9 probable outer membrane protein precursor
PA3724 lasB 38.6 9.0 elastase LasB
PA4142 3.3 12.1 probable secretion protein
PA4175 prpL 5.6 probable endoproteinase Arg-C precursor
Phenazine biosynthesis
PA1900 phzB2 41.3 probable phenazine biosynthesis protein
PA1901 phzC2 6.2 phenazine biosynthesis protein PhzC
PA1902 phzD2 8.2 phenazine biosynthesis protein PhzD
PA1903 phzE2 9.8 phenazine biosynthesis protein PhzE
PA1904 phzF2 6.6 probable phenazine biosynthesis protein
PA1905 phzG2 7.1 probable pyridoxamine 5'-phosphate oxidase
PA4209 phzM 6.2 probable O-methyltransferase
PA4217 phzS 14.1 probable FAD-dependent monooxygenase
Rhamnolipid biosynthesis
PA3478 rhlB 7.4 rhamnosyltransferase chain B
PA3479 rhlA 26.3 8.2 rhamnosyltransferase chain A
Hydrogen cyanide biosynthesis
PA2193 hcnA 61.8 26.2 hydrogen cyanide synthase HcnA
PA2194 hcnB 16.6 hydrogen cyanide synthase HcnB
PA2195 hcnC 5.1 hydrogen cyanide synthase HcnC
Lectins
PA2570 pa1L 9.3 PA-I galactophilic lectin
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Fold change2ORF1 Gene
name Serum H2O2
Protein description
Lectins
PA3361 lecB 8.2 fucose-binding lectin PA-IIL 
Other genes
PA0027 6.6 PPI ase, chaperone
PA0122 9.1 conserved hypothetical protein
PA0263 hcpC 5.1 secreted protein Hcp
PA0284 6.1 hypothetical protein
PA0852 cpbD 9.7 chitin-binding protein CbpD precursor
PA1177 napE 4.2 periplasmic nitrate reductase protein NapE
PA1245 5.1 hypothetical protein
PA1657 3.9 conserved hypothetical protein
PA1784 7.9 hypothetical protein
PA1869 12.7 probable acyl carrier protein
PA1914 10.3 conserved hypothetical protein
PA2030 10.5 hypothetical protein
PA2146 5.5 conserved hypothetical protein
PA2321 7.2 gluconokinase
PA2331 9.7 hypothetical protein
PA2366 3.6 conserved hypothetical protein
PA2588 6.1 probable transcriptional regulator
PA2747 3.0 hypothetical protein
PA2939 15.7 probable aminopeptidase
PA3181 5.7 2-keto-3-deoxy-6-phosphogluconate aldolase
PA3326 7.0 probable Clp-family ATP-dependent protease
PA3331 4.9 cytochrome P450
PA3332 4.1 conserved hypothetical protein
PA3334 7.1 probable acyl carrier protein
PA3520 21.9 hypothetical protein
PA4078 4.8 probable nonribosomal peptide synthetase
PA4117 3.4 probable bacteriophytochrome
PA4133 4.3 9.5 cytochrome c oxidase subunit (cbb3-type)
PA4134 6.3 hypothetical protein
PA4139 63.6 71.4 hypothetical protein
PA4141 40.0 59.9 hypothetical protein
PA4296 4.7 probable two-component response regulator
PA4302 6.9 probable type II secretion system protein
PA4306 11.6 hypothetical protein
PA4359 3.8 conserved hypothetical protein
PA4443 cysD 5.5 ATP sulfurylase small subunit
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Fold change2ORF1 Gene
name Serum H2O2
Protein description
Other genes
PA4648 18.8 7.2 hypothetical protein
PA4677 16.4 hypothetical protein
PA4739 7.3 conserved hypothetical protein
PA4778 4.7 probable transcriptional regulator
PA5061 3.5 conserved hypothetical protein
PA5220 12.0 hypothetical protein
PA5482 12.6 hypothetical protein
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
The stationary sigma factor RpoS was demonstrated to be involved in the modulation
of expression of a large number of quorum sensing genes as well as the type III
secretion system and anti-host effector proteins (Hogardt et al., 2004; Schuster et al.,
2004). 
Downregulation of the expression of LasI encoding 3-oxo-C12-HSL autoinducer
molecules in the transcriptome assay confirmed the previously shown experimental
results with AHL biosensor strains (see chapter 3.1.3). 
Repressed in the vqsR mutant were also pqsH and pqsL, which are both involved in
the P. aeruginosa PQS signalling. Of particular interest is more than 10-fold
downregulation of pqsH which converts PQS precursor 4-hydroxy-2-heptylquinoline
into active PQS and whose expression is controlled by the las system (Gallagher et
al., 2004; Déziel et al., 2004).   
Also consistent with the results of the phenotypic assays shown above in chapter
3.1.4, mutation of vqsR led to the downregulation of the genes responsible for the
expression of different extracellular virulence factors (Table 3.2). 
These include various proteases (aprF, aprI, lasA, lasB, prpL), rhamnolipids (rhlA,
rhlB) which are one of the two known P. aeruginosa hemolysins (van Delden, 2004)
as well as the huge operon implicated in the biosynthesis of phenazine (phzB2,
phzC2, phzD2, phzE2, phzF2, phzG2, phzM, phzS). Phenazine is the precursor
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molecule of the blue P. aeruginosa pigment pyocyanin (Mavrodi et al., 2001) whose
expression was also proven to be repressed in the vqsR mutant by phenotypic
analyses. 
In addition to the number of genes hypotheticals of unknown function, mutation of
vqsR also negatively affected the expression of other known virulence genes: lectins
(pa1L, lecB) and hydrogen cyanide (hcnA, hcnB, hcnC).
The galactophilic lectin PA-IL, encoded by pa1L as well as the fucose-binding lectin
PA-II L encoded by lecB are involved in the adherence to epithelial cells and mucin
and for colonization of the host tissues and surfaces. Adherence of P. aeruginosa to
epithelial cells is mainly mediated by type IV pili, covered with the PA-1L or PA-IIL
lectins, which act as a ligands reacting with complementary sequences on host cells
(Hahn, 1997). The expression of both lectins was shown to be controlled by quorum
sensing in P. aeruginosa (Winzer et al., 2000). 
Hydrogen cyanide is a potent poison that blocks cytochrome oxidase, which in turn
leads to inhibition of mitochondrial respiration. This secondary metabolite was shown
to be responsible for rapid paralytic killing of the nematode C. elegans (Gallagher
and Manoil, 2001). Thus, rather massive downregulation of hydrogen cyanide
synthases (5 to more than 60-fold) would explain the significant attenuation of the
vqsR mutant virulence towards C. elegans compared to the wild type in this study
(see chapter 3.1.5). The role of hydrogen cyanide for human infections is still unclear,
but it is hypothesized that it could participate in tissue destruction and may contribute
to toxicity in P. aeruginosa infected burn wounds (Goldfarb and Margraf, 1967; van
Delden, 2004) 
 
Thus, in summary the vqsR mutant produced significantly less mRNA species of
genes that are necessary for the synthesis of quorum sensing quinolones and AHLs
and of virulence factors under control thereof.
As shown previously (Wagner et al., 2003), variable responses in the expression of
quorum sensing-regulated genes to different environmental stimuli may be caused by
alterations in the expression of the regulators themselves. When comparing mRNA
chip expression data with those of the known major regulators of AHL-mediated
quorum sensing (lasR, lasI, rhlR, rhlI), vqsR was the only gene with a comparatively
higher expression (2.5-fold) in the presence of serum than in LB medium (Table 3.3). 
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The GeneChip data confirm the results of the Northern blot experiments showing that
the expression of vqsR is more strongly activated by an environment that contains
human serum, as it happens in Pseudomonas septicaemia or burn wounds.   
Tab. 3.3. GeneChip normalized signal intensities of mRNA transcripts involved in quorum
sensing regulation in different environments. Numbers in brackets indicate relative expression
values in 10 mM H2O2 and 10 % serum compared to growth in LB medium. 
Expression of mRNA transcriptsGene ORF1
LB 10 mM H2O2 10 %  serum
lasR PA1430 722.3     360.4     (0.5) 456.4     (0.6)
lasI PA1432 377.1     239.7     (0.6) 335.7     (0.9)
rhlR PA3477 1754.2   221.9     (0.1) 769.8     (0.4)
rhlI PA3476 222.6     84.7       (0.4) 182.8     (0.8)
vqsR PA2591 120.1     65.2       (0.5) 293.5     (2.4)
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
3.1.6.2.2. vqsR links quorum sensing and iron uptake
The GeneChip analysis revealed an important role of VqsR for the modulation of
expression of many iron-regulated genes. 
In addition to the regulation of the production of the siderophores pyochelin and
pyoverdine, iron availability in P. aeruginosa modulates also the expression of some
virulence factors, including the extracellular protease PrpL and the exotoxin A. In
fluorescent pseudomonads, the expression of pyoverdine biosynthesis genes is
altered by the alternative sigma factor PvdS, the gene which is known to be
controlled by the general iron-co-factored repressor Fur (Lamont et al., 2002; Ravel &
Cornelis, 2003).
Recently, two independent microarray analyses (Ochsner et al., 2002; Palma et al.,
2003) identified genes induced by iron limitation in P. aeruginosa. Comparison of
these genes with those found to be VqsR dependent in this study, revealed that in
total, 25 genes found to be iron-regulated are also repressed in a vqsR mutant.
Interestingly, out of these iron-regulated genes, some are also regulated by quorum
sensing (Cornelis and Aendekerk, 2004) (Table 3.4).          
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In the vqsR mutant, the pvdS gene is downregulated together with other genes
belonging to the pyoverdine biosynthetic locus. In addition, the genes which are
responsible for the biosynthesis and uptake of the second siderophore, pyochelin,
are also downregulated in the vqsR mutant. 
An overlap of quorum sensing regulated functions and the iron regulon in P.
aeruginosa was also reported by Arevalo-Ferro et al., 2003 using proteomics, but
was not apparent in any of the three previous DNA microarray analyses (Hentzer et
al., 2003; Schuster et al., 2003; Wagner et al., 2003). The most plausible explanation
for these discrepancies is the fact that media used to grow the bacteria contained
iron above a concentration of 10 M resulting in repression of most of the iron-
limitation-induced genes (Vasil, 2003; Cornelis and Aendekerk, 2004). Another
reason for these discrepancies could be the usage of planctonic P. aeruginosa PAO1
in the previous three transcriptome analyses. In a recent study (Hentzer et al., 2004),
the quorum sensing regulon of sessile P. aeruginosa cells was mapped by
transcriptomics and in this study many genes were identified, which were previously
shown to be iron- regulated. According to authors of that study, quorum sensing
influences the response to iron-limitation when cells are in the biofilm mode of
growth. Because P. aeruginosa strain TB used in our work is known to form
microcolonies and biofilm-like structures even when growing in the planctonic culture,
this could be another explanation why the iron regulon was affected by the mutation
of vqsR, but was not apparent in the previous DNA microarray analyses.      
This genome-wide transcriptome analysis provided clear evidence that certain sets of
genes are only affected by quorum sensing when particular environmental conditions
prevail. The complexity of the quorum sensing circuitry may be therefore the result of
the demand for very precise regulation of certain sets of genes in response to both
environmental stimuli and population density. This genetic flexibility may be one of
the key elements responsible for the tremendous environmental versatility of P.
aeruginosa. 
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Tab. 3.4. QS and iron limitation. Genes known to be induced by iron limitation as detected by
transcriptome analyses (Ochsner et al., 2002; Palma et al., 2003) with downregulated expression in a
vqsR mutant in the presence of serum and H2O2 (Cornelis and Aendekerk, 2004).
Fold change2ORF1 Gene
name Serum H2O2
Protein description
PA00263 4.4 hypothetical protein
PA00273 6.6 PPIase, chaperone
PA10033 mvfR 3.0 transcriptional regulator
PA1245 5.1 hypothetical protein
PA12483 aprF 7.4 alkaline protease secretion protein AprF
PA14313 rsaL 52.6 32.7 regulatory protein RsaL
PA2384 4.6 Fur-like regulator
PA2405 3.2 pyoverdine biosynthesis
PA2406 3.1 pyoverdine biosynthesis
PA2412 mbtH 6.0 7.3 pyoverdine biosynthesis
PA2426 pvdS 7.3 4.8 sigma factor PvdS
PA41753 prpL 5.6 probable endoproteinase Arg-C precursor
PA4218 4.6 6.5 probable transporter
PA4219 21.9 hypothetical protein
PA4221 ftpA 16.8 17.8 Fe(III)-pyochelin receptor precursor
PA4223 6.7 probable ATP-binding component of ABC transporter
PA4224 pchG 8.9 pyochelin biosynthetic protein PchG
PA4225 pchF 7.5 9.9 pyochelin synthetase
PA4226 pchE 14.9 41.0 dihydroaeruginoic acid synthetase
PA4228 pchD 13.1 10.3 pyochelin biosynthesis protein PchD
PA4229 pchC 11.1 7.3 pyochelin biosynthetic protein PchC
PA4230 pchB 18.0 29.0 salicylate biosynthesis protein PchB
PA4231 pchA 5.3 9.3 salicylate biosynthesis isochorismate synthase
PA4359 FeoA 3.8 iron(II) uptake
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
3 Genes also known to be regulated by quorum sensing. 
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3.1.6.2.3. Additional genes regulated by vqsR 
Tables 3.5 and 3.6 list genes regulated by VqsR which were not previously identified
as being quorum sensing or iron regulated by transcriptome analyses (Hentzer et al.,
2003; Schuster et al., 2003; Wagner et al., 2003; Ochsner et al., 2002; Palma et al.,
2003). Out of these additional VqsR dependent genes, the major upregulated genes
in the vqsR mutant are implicated in the antimicrobial peptide resistance, chemotaxis,
proton pumping, arginine metabolism and transport of small molecules. On the other
hand, disruption of vqsR downregulated one multidrug efflux system, genes
responsible for the antimicrobial peptide resistance and transport. 
However, some of these, as for instance the multidrug efflux systems were already
proven to be involved in the quorum sensing in P. aeruginosa (Aendekerk et al.,
2002; Maseda et al., 2004). Consistent with that, MexEF-OprN, the multidrug efflux
system which affects cell-to-cell signalling (Kohler et al., 2001) was also
downregulated in the vqsR mutant (Table 3.6). 
Moreover, the nirS gene (PA0509), which is implicated in the denitrification was
upregulated in the presence of H2O2 in this study (Table 3.5). Even if nitrite and
nitrate respiration have been previously reported to be repressed by quorum sensing
(Wagner et al., 2003), the nirS gene was so far not identified in the transcriptome
analyses (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003). Therefore
many of these ORFs may represent an additional, novel quorum sensing genes
whose expression was not detected by the previous transcriptome analyses due to
their strict VqsR and/or environmental dependency. 
A good example of the importance of the environment for regulation of the quorum
sensing genes is the different modulation of the oprH-phoP-phoQ (PA1178-PA1179)
operon, which is known to be involved in the antimicrobial peptide resistance. In our
study, this operon was downregulated by VqsR in the presence of serum and
upregulated in the presence of oxidative stress. This is consistent with the
observation about the slightly different pools of quorum sensing regulated genes in
the independent transcriptome analyses (Vasil, 2003) and with the knowledge about
the fine tuning of the P. aeruginosa las and rhl quorum sensing systems by global
regulators.    
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Tab. 3.5. Genes with upregulated expression in the vqsR mutant.
 
Fold change2ORF1 Gene
name Serum H2O2
Protein description
Antimicrobial peptide resistance
PA1178 oprH 4.9 outer membrane protein H1 precursor
PA1179 phoP 6.1 two-component response regulator PhoP
PA1180 phoQ 5.7 two-component sensor PhoQ
PA3553 20.4 probable glycosyl transferase
PA3554 19.8 conserved hypothetical protein
PA3555 8.0 conserved hypothetical protein
PA3556 arnT 8.9 Prot.name: inner membr. L-Ara4N transferase ArnT
PA3557 15.3 conserved hypothetical protein
PA3558 8.1 hypothetical protein
Chemotactic transducers
PA1561 aer 4.8 aerotaxis receptor Aer
PA2788 4.8 probable chemotaxis transducer
Proton pumps, energy metabolism
PA1555 15.9 probable cytochrome c
PA1556 10.8 probable cytochrome c oxidase subunit
PA1560 12.7 hypothetical protein
PA2664 fhp 17.2 flavohemoprotein
PA4811 fdnH 6.3 nitrate-inducible formate dehydrogenase, beta subunit
PA4919 pcnB1 6.3 nicotinate phosphoribosyltransferase
PA4920 nadE 6.3 NH3-dependent NAD synthetase
Transport of small molecules
PA0073 4.2 probable ATP-binding component of ABC transporter
PA0783 putP 3.6 sodium/proline symporter PutP
PA1297 4.4 probable metal transporter
PA1429 4.8 probable cation-transporting P-type ATPase
PA3901 fecA 5.3 Fe(III) dicitrate transport protein FecA
Arginine metabolism
PA5170 arcD 5.1 arginine/ornithine antiporter
PA5171 arcA 21.3 arginine deiminase
PA5172 arcB 35.7 ornithine carbamoyltransferase, catabolic
PA5173 arcC 32.0 carbamate kinase
Denitrification
PA0519 nirS 19.8 nitrite reductase precursor
Other genes
PA0045 5.4 hypothetical protein
PA0522 6.3 hypothetical protein
Results and discussion
119
Fold change2ORF1 Gene
name Serum H2O2
Protein description
Other genes
PA0526 7.8 hypothetical protein
PA0835 pta 7.3 phosphate acetyltransferase
PA1137 17.2 probable oxidoreductase
PA1333 4.3 hypothetical protein
PA2085 3.8 probable ring-hydroxylating dioxygenase small subunit
PA2264 4.7 conserved hypothetical protein
PA2567 5.3 hypothetical protein
PA2662 27.1 conserved hypothetical protein
PA2663 16.0 hypothetical protein
PA2783 4.0 hypothetical protein
PA2794 37.9 hypothetical protein
PA2814 4.9 hypothetical protein
PA2862 lipA 4.7 lactonizing lipase precursor
PA2916 10.2 hypothetical protein
PA3006 psrA 4.3 transcriptional regulator PsrA
PA3160 wzz 4.8 O-antigen chain length regulator
PA3309 6.8 conserved hypothetical protein
PA3458 5.1 probable transcriptional regulator
PA3552 9.2 conserved hypothetical protein
PA3559 18.6 probable nucleotide sugar dehydrogenase
PA3586 25.5 5.7 probable hydrolase
PA3811 hscB 4.9 heat shock protein HscB
PA3814 iscS 4.6 L-cysteine desulfurase (pyridoxal phosph.-dependent)
PA3815 4.4 conserved hypothetical protein
PA3919 5.9 conserved hypothetical protein
PA3972 17.3 probable acyl-CoA dehydrogenase
PA3973 19.8 probable transcriptional regulator
PA4166 5.1 probable acetyltransferase
PA4352 4.9 conserved hypothetical protein
PA4596 4.6 6.7 probable transcriptional regulator
PA4610 6.6 hypothetical protein
PA4630 4.8 hypothetical protein
PA4683 13.5 hypothetical protein
PA4758 carA 3.6 carbamoyl-phosphate synthase small chain
PA4773 6.2 hypothetical protein
PA4774 15.1 hypothetical protein
PA4775 12.2 hypothetical protein
PA4776 10.3 probable two-component response regulator
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Fold change2ORF1 Gene
name Serum H2O2
Protein description
Other genes
PA4777 6.1 probable two-component sensor
PA4782 6.7 hypothetical protein
PA5098 hutH 15.4 histidine ammonia-lyase
PA5100 hutU 6.0 urocanase
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
Tab. 3.6. Genes with downregulated expression in the vqsR mutant. 
Fold change2ORF1 Gene
name Serum H2O2
Protein description
Multidrug efflux system
PA2493 mexE 12.6 RND multidrug efflux membr. fusion prot. MexE prec.
PA2494 mexF 14.0 RND multidrug efflux transporter MexF
PA2495 oprN 8.1 outer membrane protein OprN precursor
Antimicrobial peptide resistance
PA1178 oprH 13.5 outer membrane protein H1 precursor
PA1179 phoP 4.6 two-component response regulator PhoP
Transport of small molecules
PA2322 10.9 gluconate permease
PA4614 mscL 3.9 conductance mechanosensitive channel
PA5434 mtr 13.3 tryptophan permease
Other genes
PA0459 3.3 probable ClpA/B protease ATP binding subunit
PA0587 3.4 conserved hypothetical protein
PA0654 speD 5.3 S-adenosylmethionine decarboxylase proenzyme
PA0704 5.0 probable amidase
PA1159 2.9 6.8 probable cold-shock protein
PA1344 18.8 probable short-chain dehydrogenase
PA1790 7.2 hypothetical protein
PA1874 5.1 hypothetical protein
PA1970 6.7 hypothetical protein
PA2182 3.8 11.3 hypothetical protein
PA2203 4.9 probable amino acid permease
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Fold change2ORF1 Gene
name Serum H2O2
Protein description
Other genes
PA2208 10.6 hypothetical protein
PA2441 8.3 hypothetical protein
PA2622 cspD 3.0 cold-shock protein CspD
PA2659 3.4 hypothetical protein
PA2806 5.1 conserved hypothetical protein
PA2864 3.8 conserved hypothetical protein
PA3229 10.6 hypothetical protein
PA3291 7.5 hypothetical protein
PA4140 11.0 27.0 hypothetical protein
PA4220 73.1 hypothetical protein
PA4354 6.5 conserved hypothetical protein
PA4377 3.9 hypothetical protein
PA4482 gatC 5.7 Glu-tRNA(Gln) amidotransferase subunit C
PA4625 5.7 hypothetical protein
PA5180 8.7 conserved hypothetical protein
PA5181 9.9 probable oxidoreductase
PA5351 rubA1 7.4 rubredoxin
PA5404 12.7 hypothetical protein
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
3.1.6.3. GeneChip expression analysis of the VqsR regulon in the
ABC minimal medium
AB minimal medium was previously shown to induce the expression of the vir operon
of Agrobacterium tumefaciens, an operon which is known to be implicated in the
pathogenicity of that bacterium in different infection models (Gray et al., 1992;
Wirawan et al., 1993). Furthermore, the same medium supplemented with 10 mM
citrate (ABC minimal medium) was extensively used in previous studies when
investigating the quorum sensing dependent secretion of virulence factors and biofilm
formation of P. aeruginosa (Huber et al., 2001; Huber et al., 2003). The enhanced
virulence properties of P. aeruginosa in minimal medium were also reflected by the
large number of differentially expressed genes in the investigated VqsR mutant. The
differences in the gene expression of wild type and VqsR mutant ranged from 2-fold
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to up to more than 400-fold. In our experimental setting, the mutation of vqsR altered
the expression of 731 genes more than 5-fold, 457 of which were upregulated and
274 downregulated.
3.1.6.3.1. VqsR and modulation of general metabolism
Figure 3.20 depicts the number of differentially regulated genes classified by
metabolic categories (Stover et al., 2000). The largest proportion of all regulated
genes (43 %) belongs to the class of hypotheticals with unknown function.
Expression of 456 out of these hypothetical genes was upregulated in the mutant,
whereas the expression of 131 genes was downregulated. In the VqsR mutant the
expression of genes was downregulated that are involved in amino acid, energy and
fatty acid metabolism, nucleotide biosynthesis, transcription, translation and post-
translational processing and secretion of proteins. On the other hand the disruption of
vqsR led to the upregulation of genes implicated in carbon compound catabolism,
transport and membrane constituents. Moreover, numerous transcriptional
regulators, 70-factors and two-component systems were upregulated demonstrating
that VqsR is a key regulatory protein of the P. aeruginosa cell. In summary, the
central anabolic pathways were downregulated, whereas transport and catabolic
pathways were upregulated in the investigated VqsR mutant (Figure 3.20, Appendix
I). This observation suggests that besides the impact on virulence, quorum sensing
and iron homeostasis (Juhas et al., 2004), VqsR also plays an important role in the
regulation of the general metabolism of P. aeruginosa. 
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Fig. 3.20. Comparison of the transcriptome of P. aeruginosa TB and its vqsR Tn5 transposon
mutant during growth in ABC medium. The number of genes with significantly different cDNA
hybridization signals on the Affymetrix P. aeruginosa GeneChip is classified by metabolic category as
defined in the original publication on the PAO genome sequence (Stover et al., 2000). 
 
 
Upregulated in mutant 
 
Downregulated in mutant 
0         20        40         60        80       100       120      140  
     Number of genes 
                            Adaptation, protection 
Amino acid biosynthesis and metabolism 
    Antibiotic resistance and susceptibility 
                       Biosynthesis of cofactors 
                 Carbon compound catabolism 
                                           Cell division 
      Cell wall, lipopolysaccharide, capsule 
             
             Central intermediary metabolism 
          Chaperones & heat shock proteins 
                                           Chemotaxis 
        DNA repl., recombination and repair 
  
                               Energy metabolism 
  Fatty acid and phospholipid metabolism 
                               Membrane proteins 
                            Motility & attachment 
                         Nucleotide biosynthesis 
          Protein secretion/export apparatus 
                                  Putative enzymes 
              Related to phages and plasmids 
          Secreted factors(toxins, enzymes) 
               Transcription, RNA processing 
 
                       Transcriptional regulators 
  Translation and post-translational modif. 
                  Transport of small molecules 
        Two-component regulatory systems 
Results and discussion
124
3.1.6.3.2. VqsR regulates the expression of ECF sigma factors and additional
group of quorum sensing genes
Seven genes encoding different sigma factors (PA0149, PA0472, PA1350, PA1912,
PA2468, PA3899, PA4896) which belong to the extracytoplasmic function (ECF)
subfamily of the 70– factors were found to be upregulated more than 5-fold in the
VqsR mutant. Interestingly, six of them are adjacent to genes involved in the iron
metabolism, thus suggesting that VqsR partially exerts its impact on iron uptake and
metabolism through the direct antagonism on these ECF sigma factors. 
Disruption of vqsR differentially affected the expression of numerous genes of the las
and rhl quorum sensing network in the ABC minimal medium. Of the genes identified
as being quorum sensing regulated by previous transcriptome analyses (Hentzer et
al., 2003; Schuster et al., 2003; Wagner et al., 2003), 125 genes were upregulated
and 58 genes were downregulated in the VqsR mutant (Figure 3.21). The expression
of a few quorum sensing genes which were previously shown to belong to the VqsR
regulon was not altered in the ABC minimal medium. This group comprises genes
implicated in phenazine and pyocyanin biosynthesis (phzB, phzC, phzD, phzE, phzF,
phzG, phzM, phzS), in the synthesis of lectins (pa1L, lecB) and of the stationary
sigma factor RpoS as well as few genes involved in the biosynthesis of other
bacterial exoproducts. The most plausible explanation for these discrepancies is the
fact that for this study, the bacteria were grown into exponential phase (OD600 = 1.0),
whereas in previous transcriptome analyses the cultures were investigated in the
stationary phase (OD600 = 5.0). The stationary sigma factor RpoS as well as many
virulence exoproducts of P. aeruginosa, including pyocyanin and lectins are known to
be only produced at the high cell concentrations of the stationary phase. 
On the other side, a large number of previously undescribed VqsR-regulated quorum
sensing genes was identified. Tables 3.7 and 3.8 list those quorum sensing genes
which were not previously categorized in the VqsR-regulon but whose expression
was altered significantly in the VqsR mutant in the examined ABC minimal medium.
In addition to numerous hypotheticals of unknown function, the mutation of vqsR
affected positively the expression of components of a multidrug efflux pump mexG,
opmD as well as of lasR. 
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Fig. 3.21. VqsR-regulated quorum sensing genes in ABC minimal medium. The figure depicts the
subgroup of VqsR-regulated genes that in previous GeneChip analyses on lasRI rhlIR mutants had
been identified to be regulated by the las and rhl regulon (Hentzer et al., 2003; Schuster et al., 2003;
Wagner et al., 2003). Positive values represent quorum sensing genes whose expression is
upregulated in the mutant, whereas negative values represent quorum sensing genes whose
expression is downregulated in the mutant compared to the TB wild type strain. 
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The influence of VqsR on the expression of LasR, together with the presence of a las
box in the promoter region of VqsR, underlines the existence of an autoregulatory
feedback loop between VqsR and las quorum sensing circuit. Besides numerous
hypothetical genes, the disruption of vqsR negatively affected the expression of the
PQS biosynthesis operon (pqsA, pqsB, pqsC, pqsD, pqsE, phnA, phnB) that is
implicated in the modulation of quorum sensing and virulence and of the
transcriptional regulator Vfr that controls type III mediated secretion of virulence
factors (Wolfgang et al., 2003).  
In conclusion, this analysis identified novel genes belonging to the VqsR-regulon of
P. aeruginosa. Results presented show that VqsR plays an even more important role
in the virulence and quorum sensing network of P. aeruginosa than concluded from
GeneChip expression analysis in the presence of serum and H2O2. Furthermore,
VqsR was shown to be involved in the regulation of ECF sigma factors genes and
major metabolic pathways, such as nucleotide biosynthesis, transcription, protein
biosynthesis and processing. 
Tab. 3.7.  Upregulated quorum sensing genes. QS genes (Hentzer et al., 2003; Schuster et al.,
2003; Wagner et al., 2003) upregulated in the vqsR mutant cultured in ABC minimal medium, which
were not identified as being VqsR regulated in the presence serum and H2O2. 
ORF1 Gene
name
Fold
change2
Protein description
PA0105 coxB 31.5 cytochrome c oxidase, subunit II
PA0106 coxA 54.7 cytochrome c oxidase, subunit I
PA0107 49.6 conserved hypothetical protein
PA0108 coIII 46.2 cytochrome c oxidase, subunit III
PA0109 6.2 hypothetical protein
PA0132 10.8 beta-alanine-pyruvate transaminase
PA0175 5.0 probable chemotaxis protein methyltransferase
PA0176 5.8 probable chemotaxis transducer
PA0179 5.5 probable two-component response regulator
PA0355 pfpI 5.8 protease PfpI
PA0434 4.2 hypothetical protein 
PA0435 5.9 hypothetical protein
PA0447 gcdH 11.5 glutaryl-CoA dehydrogenase
PA0586 14.2 conserved hypothetical protein
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ORF1 Gene
name
Fold
change2
Protein description
PA0588 8.7 conserved hypothetical protein
PA0744 4.0 probable enoyl-CoA hydratase/ isomerase
PA0745 4.3 probable enoyl-CoA hydratase/ isomerase
PA0887 acsA 2.9 acetyl-coenzyme A synthetase
PA1131 3.0 probable MFS transporter
PA1173 napB 13.5 cytochrome c-type protein NapB precursor
PA1175 napD 8.1 NapD protein of periplasmic nitrate reductase
PA1176 napF 8.2 ferredoxin protein NapF
PA1219 4.5 hypothetical protein
PA1221 5.2 hypothetical protein
PA1247 aprE 3.4 alkaline protease secretion protein AprE
PA1289 7.0 hypothetical protein
PA1404 7.3 hypothetical protein
PA1430 lasR 4.2 transcriptional regulator LasR
PA1745 2.9 hypothetical protein
PA1930 21.2 probable chemotaxis transducer
PA1978 5.3 probable transcriptional regulator
PA1984 3.6 probable aldehyde dehydrogenase
PA2011 3.3 hydroxymethylglutaryl-CoA lyase
PA2014 6.7 probable acyl-CoA carboxyltransferase beta chain
PA2145 19.6 hypothetical protein
PA2151 14.9 conserved hypothetical protein
PA2158 7.0 probable alcohol dehydrogenase (Zn-dependent)
PA2163 14.2 hypothetical protein
PA2166 6.8 hypothetical protein
PA2170 4.1 hypothetical protein
PA2176 7.3 hypothetical protein
PA2180 4.3 hypothetical protein
PA2190 26.5 conserved hypothetical protein
PA2250 lpdV 13.1 lipoamide dehydrogenase-Val
PA2341 5.6 probable component of ABC maltose/mannitol transporter
PA2385 pvdQ 4.4 probable acylase
PA2414 5.9 L-sorbosone dehydrogenase
PA2433 18.0 hypothetical protein
PA2513 antB 4.3 anthranilate dioxygenase small subunit
PA2552 6.9 probable acyl-CoA dehydrogenase
PA2553 12.0 probable acyl-CoA thiolase
PA2554 8.4 probable short-chain dehydrogenase
PA2572 6.6 probable two-component response regulator
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ORF1 Gene
name
Fold
change2
Protein description
PA2573 7.3 probable chemotaxis transducer
PA2711 3.8 probable periplasmic spermidine/putrescine-binding protein
PA2717 9.1 chloroperoxidase precursor
PA3032 snr1 7.5 cytochrome c Snr1
PA3174 5.1 probable transcriptional regulator
PA3182 pgl 4.6 6-phosphogluconolactonase
PA3183 zwf 5.3 glucose-6-phosphate 1-dehydrogenase
PA3194 edd 5.6 phosphogluconate dehydratase
PA3195 gapA 13.5 glyceraldehyde 3-phosphate dehydrogenase
PA3233 4.8 hypothetical protein
PA3234 5.9 probable sodium:solute symporter
PA3235 13.8 conserved hypothetical protein
PA3369 10.1 hypothetical protein
PA3370 11.3 hypothetical protein
PA3371 7.1 hypothetical protein
PA3396 nosL 8.6 NosL protein
PA3416 397.8 probable pyruvate dehydrogenase E1 component, beta chain
PA3418 ldh 24.1 leucine dehydrogenase
PA3662 4.8 hypothetical protein
PA3688 11.0 hypothetical protein
PA3691 5.8 hypothetical protein
PA3692 7.0 probable outer membrane protein precursor
PA3721 4.9 probable transcriptional regulator
PA3923 4.8 hypothetical protein
PA3986 7.5 hypothetical protein
PA4128 4.8 hypothetical protein
PA4205 mexG 41.0 membrane protein MexG
PA4208 opmD 5.3 probable outer membrane protein precursor 
PA4293 44.2 probable two-component sensor
PA4294 10.8 hypothetical protein
PA4298 12.2 hypothetical protein
PA4299 12.6 hypothetical protein
PA4300 13.7 hypothetical protein
PA4303 9.4 hypothetical protein
PA4304 25.1 probable type II secretion system protein
PA4305 12.1 hypothetical protein
PA4311 5.8 conserved hypothetical protein
PA4649 8.8 hypothetical protein
PA4650 6.6 hypothetical protein
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ORF1 Gene
name
Fold
change2
Protein description
PA4651 6.0 probable pili assembly chaperone
PA4691 3.4 hypothetical protein
PA4692 4.4 conserved hypothetical protein
PA4703 7.3 hypothetical protein
PA4738 3.0 conserved hypothetical protein
PA4876 osmE 4.1 osmotically inducible lipoprotein OsmE
PA5352 12.2 conserved hypothetical protein
PA5353 glcF 12.0 glycolate oxidase subunit GlcF
PA5354 glcE 11.5 glycolate oxidase subunit GlcE
PA5355 glcD 9.0 glycolate oxidase subunit GlcD
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
Tab. 3.8.  Downregulated quorum sensing genes. QS genes (Hentzer et al., 2003; Schuster et al.,
2003; Wagner et al., 2003) downregulated in the vqsR mutant cultured in ABC minimal medium, which
were not identified as being VqsR regulated in the presence serum and H2O2. 
ORF1 Gene
name
Fold
change2
Protein description
PA0652 vfr 2.9 transcriptional regulator
PA0996 pqsA 15.7 probable coenzyme A ligase
PA0997 pqsB 23.2 hypothetical protein
PA0998 pqsC 55.2 hypothetical protein
PA0999 pqsD 12.2 3-oxoacyl-[acyl-carrier-protein] synthase III
PA1000 pqsE 12.0 hypothetical protein
PA1001 phnA 15.8 anthranilate synthase component I
PA1002 phnB 11.0 anthranilate synthase component II
PA1658 18.6 conserved hypothetical protein
PA1659 5.6 hypothetical protein
PA1664 5.9 hypothetical protein
PA1665 4.9 hypothetical protein
PA1667 4.0 hypothetical protein
PA1894 3.3 hypothetical protein
PA3328 3.5 probable FAD-dependent monooxygenase
PA3329 8.1 hypothetical protein
PA3330 10.0 probable short chain dehydrogenase
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ORF1 Gene
name
Fold
change2
Protein description
PA3333 fabH2 4.5 3-oxoacyl-acyl-carrier-protein-synthase II
PA3904 24.9 hypothetical protein
PA3905 18.4 hypothetical protein
PA3906 6.0 hypothetical protein
PA3907 5.9 hypothetical protein
PA3908 6.1 hypothetical protein
PA4129 5.9 hypothetical protein
PA4130 4.7 probable sulfite or nitrite reductase
PA4131 8.5 probable iron-sulfur protein
PA4132 3.6 conserved hypothetical protein
PA4242 rpmJ 21.9 50S ribosomal protein L36
PA4243 secY 15.5 secretion protein SecY
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com).
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
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3.2. Characterization of gltR and 47D7 
At this time, only one source of information is available about the function of gltR,
which presents this gene as a regulator implicated in the transport of glucose (Sage
et al., 1996). On the other hand there is nothing known about the product of the 47D7
gene. 
The disruption of gltR by Tn5 transposon mutagenesis by previous Ph.D. student
(Wiehlmann, 2001) led to decreased resistance of the mutant to human blood serum
and to the protease secretion deficiency. The disruption of 47D7 led to complete loss
of protease secretion ability of the mutant. These preliminary experiments suggested
an important role of the genes gltR and 47D7 in P. aeruginosa virulence.  
To confirm or refute this hypothesis, genes gltR and 47D7 were comprehensively
analysed.
3.2.1. Features of the gltR (PA3192) gene 
The sequence of gltR (729 bp = 242 amino acids) corresponds to the ORF PA3192
of the P. aeruginosa PAO1 genome (http://www.pseudomonas.com) (Figure 3.22). 
According to the information stored in the PAO1 database, gltR (PA3192) encodes a
two-component response regulator GltR which is involved in the carbon compound
catabolism and gluconeogenesis. gltR (PA3192) is placed in a cluster of genes which
encode other glucose phosphorylative pathway enzymes or genes which are
responsible for the regulation of this pathway. The end of gltR (PA3192) ORF could
possibly form a hairpin-like structure but due to its rather low AT-content it would
constitute a very weak terminator. Therefore it is more likely that the following ORFs
(PA3191, glk, edd) are transcribed together with gltR (PA3192) on one RNA
transcript.
gltR (PA3192) harbours a DNA binding domain in its carboxyl-terminus that is typical
for transcriptional regulators and one additional domain that corresponds to the
receiver domain of response regulators (Figure 3.23).
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Fig. 3.22. The map showing the part of the P. aeruginosa chromosome area around the
investigated gltR (PA3192) gene (http://www.pseudomonas.com).  
Fig. 3.23. The scheme showing the pfam domains of the gltR (PA3192) gene. gltR maintains a
DNA binding domain in its carboxyl-terminus that is typical for a transcriptional regulator and a domain
which corresponds to the receiver domain of response regulators (http://www.tigr.org).    
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3.2.2. Features of the 47D7 gene 
The 47D7 gene has no homologous ORF in the sequenced P. aeruginosa PAO1
genome. It shares only a very weak homology (2 e-19) on the protein level with the
hypothetical ORF from Salmonella typhimurium.     
Southern hybridisation revealed that this sequence is not specific only for strain TB,
but that it can be also found in two other P. aeruginosa isolates (CSGB8 and
SG17M) (Wiehlmann, 2001). Sequencing of the 47D7 gene revealed that it
comprises a 1308 bp long ORF (Figure 3.24). 
CTATTCGGTATCGGCTACAGATTCCGGTACGTCTTCGCCGGCGGTTTCTTCATTTTCTCTACTGCGGT
AATCGATCGTTCGTTCTGGGAAGCCTGGGATCCCCTCCCCTTTGGTATCGATGAAGGCATCCCAGTGC
CACCAGCCAGCGGAACCGAACTGACCGTTGTACCAACGAATCTTTCTCTGTCGGCGCGCCTGGTACGT
CGGCGTATTCATCCCGAATACCTCCAGGGGATATTGCGTGTCACGGCCCATGTCTAGCAGCCAGAAGT
CAGGAAAAATTTCATCCTCAGCTTCAAAGCGTGGGGGCTTGAAGAAGGCACGTCCCTCGGCGTGGAGC
TTTTCCTCAATTGTGGCTTCGTAGCCGGAGTCGAGCGGAATCATCCGGTCGCTGACGCGCATCAGCGC
CAAATCCAGGACATCCGCGTAGCGCCCCTTCTTCAGATTCAGCTGCGCGATCGCAATAACCTCGTGCC
CAGACTCCCACGCGACTAGCTCAGAAGCAAAGCTACGTTCAACTCGGCGCCGAACCTCCGCTCGAATG
TCCATCGTCGGCATCCCGAAGGGTCCCGAGACAGAAAGCGTCAAGAGATTGCGTCGTTCCGAGTTGAA
GGACGCCAGCGGCGACACCGCAATGAGCCTGCGCGAATGCTCCTGCGCCAGCTCCACGACCTCAGCAT
TGCGCTTCGCCATGCGGGAGTTCTTCTTGGCCGACATCAGCAAGACGTCGAACACCGTCATTCGGCTG
GCCCGGATACGCTTTGCGGCTTCAGATACCCAATAGGCAACATTCGCGGGCGTTCGCTTGCCTTCCAT
CAGTGGGTACCAGTTGGCCAGTCCAGCCTCTAACCACAGCAGCTGGAGCAGCCCGAGCAGACGTATCG
AAGGCTTCTTAACCCCCGGCGTACGCGGAACGTCGGCCACGTCATCGGCGGCGGGAGACGCTTCTTTG
ACTCGAAGGCCATGGGCTAGCCGGATGCGCAGGGTGTTGTCATCGGCCTCCTCTACAACTCCCTCAGC
GTAGCCCTGCAGGCCTGATCGCTCTGGGGCGTGAGCATGGAATCGGCAGTCGTTTGCATGCTCCGGAC
CGGTGTTGGCGTACCGGGCAAGGTGATAGTTGTCGCTCCCCTCCCGATGTTTCACCGAGAGATAGCGA
TTACCCTTGCCGGGGCACAGGCAGACCACAGGGGTACCGTGTGCTCGTTGCAGGACCGATTTCCAGCC
ATCCTCGAATTCGTTCTTGACCTGGAATTCCCTGGAATATTTCTTCTGGGTACTGACCACCCGTACTT
CGTAAGTTTTCGACAT
Fig. 3.24. Complete sequence of the investigated non-PAO1 gene 47D7.
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3.2.3. Complementation of the gltR and 47D7 mutants 
The P. aeruginosa gltR and 47D7 mutants were generated by Tn5 transposon
mutagenesis (Wiehlmann 2001). Subsequently these mutants were complemented in
trans to ensure that the observed phenotypes (decreased resistance to human blood
serum and protease secretion deficiency) were caused by the transposon inactivation
of the respective genes and not by any other secondary genetic event.
Fig. 3.25. Scheme of the cloning of the genes gltR and 47D7 into pME6010 vector.
The PCR fragments with the lengths of 737 bp and 1308 bp comprising the analysed genes gltR and
47D7, respectively were cloned in the broad host range vector pME6010 maintaining the tetracycline
resistance. The recombinant plasmids pME6010gltR and pME601047D7 were subsequently used for
complementation of the phenotypes of the investigated P. aeruginosa mutants.    
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The pME6010gltR plasmid used for complementation in trans was constructed by
cloning the 737 bp of the gltR gene generated by PCR with primers: 5’-GAT TAT
AGA TCT GTG AGC GCG AAC GGA CG-3’, 5’-GTC ATG AAT TCG CTC ATG GCT
GCA GGT-3’ into the BglII/EcoRI-restricted pME6010 shuttle vector. The
pME601047D7 plasmid was constructed by cloning the 1308 bp of the 47D7 gene
generated by PCR with primers: 5’-GAT TAT AGA TCT ATG TCG AAA ACT TAC-3’,
5’-GTA TAT AAG CTT CTA TTC GGT ATC GGC-3’ into the BglII/HindIII - restricted
pME6010 shuttle vector (Figure 3.25). The constructed recombinant plasmids
pME6010gltR and pME601047D7 were introduced into E. coli OneShot®TOP10
chemically competent cells (Invitrogen) by transformation and subsequently into the
P. aeruginosa mutant gltR and 47D7 via electroporation (see chapter 2.3.). The
restriction digest of the recombinant plasmids pME6010gltR and pME601047D7
isolated from the complemented P. aeruginosa strains confirmed genetic
complementation of the gltR and 47D7 mutations (Figures 3.26 and 3.27).
Fig. 3.26. The restriction digest of the recombinant plasmid pME6010gltR. pME6010gltR was
isolated from the complemented P. aeruginosa TBgltR(pME6010gltR) mutant strain. 
 
1. pME6010 (BglII digest) 
2. pME6010gltR (BglII digest) 
      3.   pME6010gltR (BglII/EcoRI digest) 
 /BstII 
 ladder  1    2    3 
pME6010
 
 
 
 
 
 
 
 
gltR 
Results and discussion
136
Fig. 3.27. The restriction digest of the recombinant plasmid pME601047D7. pME601047D7 was
isolated from the complemented P. aeruginosa TB47D7(pME601047D7) mutant strain. 
3.2.4. Phenotypic complementation of the gltR and 47D7
mutants
Disruption of gltR and 47D7 by Tn5 transposon mutagenesis (Wiehlmann, 2001)
caused decreased resistance to human blood serum as well as the significant
protease secretion deficiency of the gltR mutant and the complete loss of the
protease secretion ability of the 47D7 mutant. To test whether these striking
phenotypes were caused by transposon inactivation of the gltR and 47D7 genes or
by a secondary genetic event, the same experiments were performed with all five
strains: TB wild type, gltR and 47D7 mutants and both constructed complemented
mutants.
Susceptibility to serum: 
The tested P. aeruginosa strains were grown for 2 hours in the presence of human
AB serum and the number of survived bacteria was evaluated as described in the
chapter 2.6.2. 
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In this assay, gltR mutant showed decreased resistance to serum when comparing to
the wild type strain, but the phenotype of the complemented mutant was not restored
to the levels comparable to the wild type strain (Figure 3.28). In fact, the resistance of
the complemented mutant to serum was even lower than the resistance of the gltR
mutant, thus confirming that GltR is not important for the survival of P. aeruginosa in
serum.   
Fig. 3.28. Susceptibility to serum of the P. aeruginosa TB wild type strain (wt), its Tn5::gltR
transposon mutant (gltR-) and complemented mutant (gltR+). The survival ability of the
complemented mutant was not restored to the levels comparable to the wild type. 
Proteases: 
The secretion of proteases was determined by growth of the investigated P.
aeruginosa strains on M9 agar plates supplemented with 0.75 % casein (see chapter
2.6.3.2). 
The easily visible halo on casein agar plates, indicating proteolytic activity was
observed for the TB wild type strain and in the gltR mutant the secretion of proteases
was slightly reduced as expected (Figure 3.29). However, in the complemented
mutant strain the proteolytic activity was not restored as it would be expected in case
that the protease secretion deficiency was caused by mutation of gltR (Figure 3.29).  
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Thus this result revealed that reduced proteolytic activity of the gltR mutant was
caused by a secondary genetic event and not by the mutation of gltR as it was
hypothesized by Wiehlmann, 2001.
Fig. 3.29. Secretion of proteases by the P. aeruginosa TB wild type strain (wt), its Tn5::gltR
transposon mutant (gltR-) and complemented mutant (gltR+). Restoration of the proteolytic
activity was not detected for the complemented mutant strain on casein agar. 
The easily visible halo on casein agar plates was observed for the TB wild type and
in the 47D7 mutant the secretion of proteases was completely switched-off (Figure
3.30). However, in the complemented mutant the proteolytic activity was not restored
as it would be expected in case that the protease secretion deficiency was caused by
the mutation of 47D7 (Figure 3.30). Thus this experiment confirmed that reduced
proteolytic activity of the 47D7 mutant was not caused by mutation of 47D7, but by a
secondary genetic event elsewhere in the genome.  
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Fig. 3.30. Secretion of proteases by the P. aeruginosa TB wild type strain (wt), its Tn5::47D7
transposon mutant (47D7-) and complemented mutant (47D7+). Restoration of the proteolytic
activity was not detected for the complemented mutant on casein agar.
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3.3. Global regulation of oxidative stress response
by IcsF  
3.3.1. Features of the icsF (PA1572) gene 
The sequence of icsF (1146 bp = 382 amino acids) corresponds to the ORF PA1572
of the P. aeruginosa PAO1 genome (http://www.pseudomonas.com) (Figure 3.31).
According to the information stored in the PAO1 database, icsF (PA1572) encodes a
protein with 56 % homology to a hypothetical protein of Pyrococcus horikoshii with
the length of 377 amino acids. Like its homologue in P. horikoshii, the IcsF protein
also belongs to the class of hypotheticals with unknown function, therefore opening a
wide field for future investigations.   
icsF (PA1572) is placed in a cluster of genes which are implicated in the energy
metabolism of P. aeruginosa (Figure 3.31). The last 20 bp of the icsF (PA1572) build
together with the first bases of the following ORF PA1573 a typical terminator
structure. This suggests, that the following genes are not transcribed together with
icsF (PA1572) on a single RNA transcript. 
The G+C content of this gene (69,38 mol%) is in the range of average G+C content
of the P. aeruginosa genome (61,80 mol% - 70,14 mol%) (Stover et al., 2000), thus
suggesting that like the vqsR gene, icsF was not acquired by phylogenetically recent
horizontal transfer, but is rather a part of the core P. aeruginosa genome. 
A blast search revealed that icsF (PA1572) harbours a domain that is typical for ATP-
NAD kinases (Figure 3.32) and further investigation confirmed that IcsF shares
strong homology with the NAD kinase from E. coli. 
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Fig. 3.31. The map showing the part of the P. aeruginosa chromosome area around the
investigated icsF (PA1572) gene (http://www.pseudomonas.com).  
Fig. 3.32. The scheme showing the pfam domains of the icsF (PA1572) gene (http://www.tigr.org).
icsF (PA1572) maintains a domain that is typical for ATP-NAD kinases.     
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3.3.2. Complementation of the icsF gene 
The P. aeruginosa icsF mutant was generated by Tn5 signature transposon
mutagenesis as described previously (Wiehlmann et al., 2002). This mutant was
complemented in trans to ensure that all the subsequently observed striking
phenotypes (see chapters 3.3.3 – 3.3.6) were caused by the transposon inactivation
of the icsF gene and not by any other secondary genetic event.
Fig. 3.33. Scheme of the cloning of the icsF gene into pME6010 vector.
The PCR fragment with the length of 1414 bp comprising the analysed icsF gene was cloned into the
broad host range vector pME6010 maintaining the tetracycline resistance. The recombinant plasmid
pME6010icsF was used for complementation of the phenotype of the P. aeruginosa icsF mutant.    
The pME6010icsF plasmid used for complementation in trans was constructed by
cloning the 1414 bp of the icsF gene generated by PCR with primers: 5’-TAT TAG
ATC TAT GGA CAT GTT TCG CCT GG-3’, 5’-CTA TAT TAA GCT TCT GTA GAT
CCA GCC CC-3’ into the BglII/HindIII-restricted pME6010 shuttle vector (Figure
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3.33). The recombinant pME6010icsF plasmid was introduced into E. coli
OneShot®TOP10 chemically competent cells (Invitrogen) by transformation and
subsequently into the P. aeruginosa icsF mutant via electroporation (see chapter
2.3). The recombinant plasmid pME6010icsF was afterwards isolated from
electroporated P. aeruginosa cells and subjected to restriction digest in order to
confirm genetic complementation of the icsF mutation (Figure 3.34).
Fig. 3.34. The restriction digest of the recombinant plasmid pME6010icsF. pME6010icsF was
isolated from the complemented P. aeruginosa TBicsF(pME6010icsF) mutant strain. 
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3.3.3. IcsF is crucial for the intracellular survival in PMNs 
PMN-mediated phagocytosis is known as the host’s most proficient antipseudomonal
weapon (Döring et al., 1995). To investigate the impact of IcsF on the ability of P.
aeruginosa TB to survive intacellularly in PMNs, wild type strain, Tn5::icsF
transposon mutant and complemented mutant were cultivated for 2 hours in the
presence of PMNs. Subsequently PMNs were lysed and the number of intracellular
viable bacteria was determined by counting the cfu (see chapter 2.6.1). 
As shown in Figure 3.35, this experiment revealed that the ability of the investigated
icsF mutant to survive intracellularly in PMNs was significantly decreased when
compared to the wild type. In fact, the intracellular survival ability of the icsF mutant
was less than 10 % of the wild type. On the other hand, the intracellular survival
ability of the complemented mutant was completely restored and was even slightly
higher than that of the wild type (Figure 3.35). 
Fig. 3.35. Intracellular survival of the P. aeruginosa TB wild type strain (wt), its Tn5::icsF
transposon mutant (icsF-) and complemented mutant (icsF+) in PMNs. The investigated strains
were cultured for 2 hours in the presence of PMNs. Subsequently PMNs were lysed and the number
of intracellular viable bacteria was determined by counting of cfu. 
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TB (TBCF10839 isolate) is a highly virulent strain of P. aeruginosa, which was
isolated in 1983 from the sputum of a CF patient who had been suffering a severe
chronic infection with P. aeruginosa. The reason for the high virulence of this strain is
its ability to survive and replicate in PMNs (Miethke, 1985; Wiehlmann, 2001). All
known evidence indicated that some novel mechanisms operate in the P. aeruginosa
TB which allows this bacterium to thrive in PMNs. So far the genetic basis for the
intracellular survival of P. aeruginosa strain TB in PMNs remained an enigma;
however, the experimental results presented above suggests that the investigated
icsF gene constitutes one of the crucial elements responsible for this striking
phenotype.   
3.3.4. IcsF affects production of autoinducer molecules  
As mentioned before, quorum sensing in P. aeruginosa employs AHLs as
autoinducer signalling molecules (Pearson et al., 1994). In order to investigate the
impact of the analysed icsF gene on AHL production, we streaked the P. aeruginosa
TB wild type strain and its Tn5::icsF transposon mutant close to the GFP-based
broad range AHL sensor E. coli JM105(pJBA89) (Andersen et al., 2001) (Figure
3.36). The AHL secretion of the examined icsF mutant was reduced when comparing
to the wild type (Figure 3.36).  
Two different quorum sensing acylhomoserine lactones N-(3-oxododecanoyl)
homoserine lactone (3-oxo-C12-HSL) and N-butyryl homoserine lactone (C4-HSL)
constitute the major components of the P. aeruginosa las and rhl systems,
respectively (Wagner et al., 2003). Therefore, the cross-streak experiments were also
performed with the biosensor P. putida F117 (pKR-C12), which only detects a narrow
range of long chain AHLs, being most sensitive for 3-oxo-C12-HSL (Steidle et al.,
2001). As with E. coli (pJBA89), the investigated icsF mutant secreted remarkably
lower amounts of AHLs (Figure 3.37). 
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Fig. 3.36. AHLs secretion by P. aeruginosa TB wild type (wt), its Tn5::icsF transposon mutant
(icsF-) and complemented mutant (icsF+). The tested strains were cultivated with the GFP-based
broad range AHL sensor E. coli JM105 (pJBA89). 
a) tested P. aeruginosa strains were illuminated with normal light.
b) tested strains illuminated with blue light exciting GFP. icsF mutant showed diminished AHL
secretion when comparing to the wild type.
 
Fig. 3.37. AHLs secretion by P. aeruginosa TB wild type (wt), its Tn5::icsF transposon mutant
(icsF-) and complemented mutant (icsF+). All strains were cultivated with P. putida F117 (pKR-
C12), which contains a translational fusion of the lasB promoter to gfp and the lasR under control of a
lac-type promoter.
a) tested P. aeruginosa strains were illuminated with normal light.
b) tested strains illuminated with blue light exciting GFP. icsF mutant showed reduced AHL
secretion when comparing to the wild type.
 E. coli JM105 (pJBA89)
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For more detailed analysis, thin-layer chromatography (TLC) was performed with
AHL biosensors E. coli MT102 (pSB403) and Chromobacterium violaceum CV026
(McClean et al., 1997; Shaw et al., 1997; Winson et al., 1998; Geisenberger et al.,
2000). Using this technique, the icsF mutant was confirmed to be impaired in the
production of AHLs, including both C4-HSL and 3-oxo-C12-HSL (Figure 3.38).
Complementation in trans (see chapter 3.3.2) restored the AHL secretion ability of
the icsF mutant to levels comparable to the wild type thus providing further evidence
that in this case the phenotype of the mutant was caused by the transposon
inactivation of the icsF gene and not by any other secondary genetic event (Figures
3.36, 3.37 and 3.38). 
Fig. 3.38. TLC analysis of AHLs secreted by P. aeruginosa TB wild type (wt), its Tn5::icsF
transposon mutant (icsF-) and complemented mutant (icsF+). Lanes with standards are indicated
by s.
a) using AHL biosensor Ch. violaceum CV026 which is able to detect C4-HSL. Note the
significantly diminished ability to secrete AHLs, including C4-HSL (upper spot) in the icsF
mutant (icsF-).
b) using AHL biosensor E. coli MT102 (pSB403) which is able to detect 3-oxo-C12-HSL. Notice
the reduced ability to secrete AHLs, including 3-oxo-C12-HSL, in the icsF mutant (icsF-)
(B.Huber and L. Eberl).
Hence these experiments revealed the impact of IcsF on the production and
secretion of quorum sensing autoinducers. The disruption of icsF did not shut-down
the AHL secretion completely, as in the case of vqsR mutation (see chapter 3.1.3),
but the ability of bacterium to secrete AHLs was reduced significantly when
compared to the wild type.        
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3.3.5. IcsF affects secretion of extracellular virulence
factors
Evidence has accumulated over the last few years that quorum sensing modulates
the expression of a broad spectrum of virulence genes in P. aeruginosa (Passador et
al., 1993). As IcsF was shown to have an influence on the secretion of quorum
sensing AHL signalling molecules I hypothesized that the secretion of extracelular
virulence factors will be also diminished in the IcsF mutant. To investigate the effect
of the icsF mutation on the production of bacterial extracellular virulence factors, I
investigated its impact on protease and pyocyanin secretion. 
Proteases: 
The secretion of proteases was determined by growth of the investigated P.
aeruginosa strains on M9 agar plates which were supplemented with 0.75 % casein
(see chapter 2.6.3.2). The easily visible halo on casein agar plates, indicating
proteolytic activity was observed for the TB wild type and in the icsF mutant the
secretion of proteases was slightly reduced as expected (Figure 3.39). 
Fig. 3.39. Secretion of proteases by the P. aeruginosa TB wild type strain (wt), its Tn5::icsF
transposon mutant (icsF-) and complemented mutant (icsF+). In the mutant the secretion of
proteases was reduced when comparing to the wild type. 
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On the other side, in the complemented mutant, the secretion of proteases was
restored according to our expectations (Figure 3.39).  
All three casein degrading proteases, LasB elastase, alkaline protease and protease
IV, have an important part in the infection process of P. aeruginosa (van Delden,
2004). Moreover, the expression of LasB elastase and alkaline protease was shown
to be controlled by the quorum sensing in P. aeruginosa (Latifi et al., 1995). To test
specifically for elastase secretion, the modified elastin-Congo red assay was used
(Rust et al., 1994) (see chapter 2.6.3.3). Using this assay, the icsF mutant was found
to be slightly impaired in the ability to produce elastase, whereas the ability of the
complemented mutant to secrete elastase was restored almost to levels comparable
to the wild type (Figure 3.40). 
Fig. 3.40. Secretion of elastase by the P. aeruginosa TB wild type strain (wt), its Tn5::icsF
transposon mutant (icsF-) and complemented mutant (icsF+). The amount of released red dye in
the supernatant after 8 hours of growth of tested strains in LB medium was quantified by measuring
absorbance at 495 nm (A495). 
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Pyocyanin:
The special medium, King’s medium A, was used for investigation of the pyocyanin
secretion ability of the wild type, icsF mutant and the complemented mutant (see
chapter 2.6.3.1), which favours the secretion of pyocyanin and simultaneously
inhibits the secretion of siderophores (King at al., 1954). As mentioned before, the
secretion of pyocyanin in P. aeruginosa was also found to be controlled by quorum
sensing (Latifi et al., 1995).
As shown below, measuring the amount of pyocyanin in the supernatants of the
tested bacterial strains revealed a significant decrease of pyocyanin secretion in the
icsF mutant when compared to the wild type and complemented mutant (Figure 3.41)
thus revealing the role of IcsF for the pyocyanin production.  
Fig. 3.41. Pyocyanin secretion by P. aeruginosa TB wild type (wt), its Tn5::icsF transposon
mutant (icsF-) and complemented mutant (icsF+). Strains were cultivated in the King’s A medium
and the amount of pyocyanin in the supernatant was quantified by measuring absorbance at 695 nm
(A695). ○, wt; ∆, icsF-; ▲, icsF.
The mutation of icsF significantly reduced the secretion of proteases (including
elastase) and pyocyanin, whereas in the complemented mutant protease as well as
pyocyanin secretion ability were restored almost to levels comparable to the wild
type. These exoproducts are known to be implicated in the P. aeruginosa virulence
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and their secretion was shown to be controlled by quorum sensing circuitry. Thus,
these experiments provide further evidence that IcsF affects the P. aeruginosa cell-
to-cell communication network. 
3.3.6. IcsF influences virulence towards C. elegans 
As shown in the previous chapter, disruption of icsF decreased secretion of
extracellular virulence factors protease and pyocyanin, thus suggesting the
significant impact of IcsF on the overall virulence of P. aeruginosa. To prove this
hypothesis, wild type strain, Tn5::icsF transposon mutant and complemented mutant
were tested for their virulence towards the nematode C. elegans, which has been
frequently used before as a bacterial pathogenesis model for the identification of
virulence-attenuated mutants in P. aeruginosa (Mahajan-Miklos et al., 1999; Tan et
al., 1999). This experiment revealed a significant attenuation of virulence of the icsF
mutant when compared to the wild type (Figure 3.42). On the other hand, the killing
activity of the complemented mutant was restored to wild type levels (Figure 3.42),
confirming the important role of the icsF gene in P. aeruginosa virulence towards C.
elegans.     
Fig. 3.42. Kinetics of the killing of C. elegans by TB wild type strain (wt), its Tn5::icsF
transposon mutant (icsF-) and complemented mutant (icsF+). 45 to 60 L4 larvae were placed in
each well and scored for dead worms by microscopic examination. E. coli DH5 served as a negative
control. Values are the mean  SD of a representative experiment with triplicate values. ○, wt; ∆, icsF-
; ▲, icsF+; ■, E. coli (D. Jordan).
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3.3.7. Transcriptional analysis of icsF 
3.3.7.1. Northern blot expression analysis of icsF
The expression of IcsF mRNA was analyzed by Northern blots under various growth
conditions. Standard conditions like growth in LB medium to early and late
exponential phase were used as well as exposure to different stress conditions like
growth in the presence of oxidative stress generated by hydrogen peroxide, growth in
the presence of serum, growth in the presence of PMNs, and growth in ABC minimal
mineral medium. 
While exposing to the oxidative stress generated by hydrogen peroxide, blood serum
and PMNs, bacteria were cultivated in a dialysis bag with appropriate pore diameter
to ensure continuous exchange of fluids. After the incubation period, the cells were
immediately recovered from the dialysis bag and subjected to RNA isolation (see
chapter 2.4.3.). The expression pattern of icsF was examined by Northern blots.
Interestingly, icsF was found to be expressed only very lowly on Northern blots.
Hybridization with a genomic icsF probe gave a weak signal when P. aeruginosa TB
had been cultured in the presence of H2O2 or PMNs. Under all other examined
growth condition, icsF expression signal was completely undetectable on Northern
blots. The Tn5::icsF mutant did not produce any detectable IcsF transcript under all
chosen conditions.
3.3.7.2. GeneChip expression analysis of icsF
P. aeruginosa GeneChips from Affymetrix were used to investigate the impact of IcsF
on global changes in the gene expression profile. Total RNA, extracted from bacterial
cultures cultivated in the presence of 10 % human blood serum or PMNs, was
hybridized on the DNA microarrays in duplicate (see chapter 2.5). The signals on the
arrays representing the expression levels of individual genes were used to calculate
the expression ratio between the wild type and mutant strain cultivated in the
presence of H2O2 and serum. Numerous genes were differentially regulated in the
icsF mutant when compared to the wild type strain, particularly in the presence of
H2O2 (Figure 3.43).
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Fig. 3.43. Logarithmic scatter graph of absolute signal intensities of P. aeruginosa ORFs
represented by 5900 individual array spots. The graph indicates that the expression of a number of
genes was altered in the icsF mutant, particularly in the presence of H2O2.  
a) Global expression profiles of two TB wild type cultures cultivated under the same
growth conditions. The absolute signal intensities of one replicate were plotted against
the signal intensities of a second replicate.
b) Absolute signal intensities of TB wild type strain (wt) plotted against signal intensities
of the Tn5::icsF transposon mutant (icsF-) when both cultures were treated with H2O2.
c) Signal intensities of the TB wild type (wt) plotted against Tn5::icsF transposon mutant
(icsF-) obtained after cultivation of both cultures in the presence of PMNs.
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Confirming the results from Northern blots, icsF was found to be only very lowly
expressed on DNA microarrays under all examined growth conditions with signal
intensities ranging from 90 to 180. Such low expression combined with the large
number of differentially expressed genes in the investigated icsF mutant underlines
the important global regulatory function of IcsF. 
GeneChip expression analysis revealed that only few genes were differentially
expressed in the icsF mutant in the presence of PMNs, whereas a large number of
genes was differentially expressed in the presence of H2O2. By applying the stringent
criteria outlined above, the mutation of icsF significantly influenced the expression of
904 genes in the presence of H2O2 and of 110 genes in the presence of PMNs (see
Appendix III and IV). Out of 904 genes differentially regulated in the presence H2O2,
401 genes were downregulated and 503 genes were upregulated in the icsF mutant.
Out of 111 genes differentially regulated in the presence of PMNs, the expression of
53 genes was repressed and the expression of remaining 57 genes was promoted in
the mutant. The differences in the gene expression of the wild type and the mutant
ranged from 2-fold up to more than 1000-fold. 
Expression of a significant number of genes involved in amino acid biosynthesis,
biosynthesis of cofactors, carbon compound catabolism, central intermediary
metabolism, chemotaxis, and translation and post-translational modification was
found to be differentially regulated in the investigated icsF mutant (Figure 3.44). The
largest proportion of all differentially regulated genes (36 %) belongs to the class of
hypotheticals with unknown function. Expression of 259 genes out of these genes
was upregulated in the mutant and expression of 197 genes was downregulated.
Expression of 96 genes (69 upregulated in the mutant and 28 downregulated in the
mutant), which represent 8 % of the known ORFs and which are all involved in the
energy metabolism of P. aeruginosa was found to be controlled by IcsF. Other
functional classes with the largest numbers of genes regulated by IcsF included the
genes encoding membrane proteins (7 %), genes involved in transport of small
molecules (7 %), putative enzymes (5 %), genes involved in adaptation and
protection (5 %) and transcriptional regulators (4 %). 
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Fig. 3.44. Comparison of the transcriptome of P. aeruginosa TB and its icsF transposon mutant
grown in the presence of PMNs and H2O2. The number of genes is classified by metabolic category
as defined in the original publication on the PAO genome sequence (Stover et al., 2000). 
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3.3.7.2.1. icsF regulates a large number of oxidative stress response genes
As mentioned above, only few genes were differentially expressed in the icsF mutant
in the presence of PMNs, whereas a huge number of genes was differentially
expressed in the presence of H2O2. This result suggested that the expression of icsF
is not activated by cytokines released by PMNs, but rather that it needs a direct
contact with PMNs and that its expression is triggered with maximal intensity when
bacterium deals with the oxidative stress in the intracellular compartments of PMNs. 
Knowing this, the impact of IcsF on the expression of oxidative stress genes was
investigated. In the first step, the GeneChip expression profile of the wild type strain
P. aeruginosa TB cultured in the presence of 10 mM H2O2 was compared with the
GeneChip expression profile of the same strain grown in LB medium without addition
of H2O2. This experiment led to the identification of whole group of genes
differentially expressed by the wild type strain in the presence of H2O2, which are
responsible for dealing with the oxidative stress in P. aeruginosa. In the second step,
this gene array dataset was compared with the group of genes that was found to be
regulated by IcsF in the presence of H2O2 and PMNs. Intriguingly, almost all genes
controlled by IcsF are identified oxidative stress genes. Out of 110 genes regulated
by IcsF in the presence of PMNs, 55 % (61 genes) belong to oxidative stress genes
(see Appendix III) and in the presence of H2O2 this number is even higher. Out of 401
genes downregulated in the analysed icsF mutant in the presence of H2O2, about 80
% (317 genes) are oxidative stress genes. Similarly, out of 503 genes upregulated in
the icsF mutant in the presence of H2O2, about 80 % (405 genes) are oxidative stress
genes (see Appendix IV). Only 182 genes controlled by IcsF in the presence of H2O2
(98 upregulated and 84 downregulated) do not belong to the category of oxidative
stress genes. On the other hand, this comparison revealed that out of the whole
group of genes, which are implicated in the oxidative stress response of the P.
aeruginosa strain TB (1318 genes), 55 % are controlled by IcsF.
 
Figure 3.45 underlines IcsF as the major regulator of oxidative stress response in P.
aeruginosa showing that only 14 out of 164 more than 10-fold differentially regulated
genes in the investigated icsF mutant do not belong to oxidative stress genes. 
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Fig. 3.45. Differential gene expression of the Tn5::icsF transposon mutant compared to P.
aeruginosa wild type strain TB in the presence of 10 mM H2O2. Positive values represent genes
whose expression is upregulated in the mutant and negative numbers genes whose expression is
downregulated in the mutant compared to the TB wild type strain. Only genes whose expression is
regulated more than 10-fold are shown. Oxidative stress genes are indicated by black colour. 
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The most differentially expressed in the investigated icsF mutant grown in the
presence of H2O2 are large operons implicated in the nitrogen metabolism (Figure
3.45 and Table 3.9). Interestingly, all these genes were previously reported to be
controlled by quorum sensing in P. aeruginosa thus highlighting the importance of
quorum sensing as a switch for preferential usage of cellular pathways and for
anaerobic growth (Wagner et al., 2003). Results of the GeneChip expression
analysis presented in this thesis shows that besides quorum sensing, the nitrogen
metabolism is also implicated in the oxidative stress response of P. aeruginosa.
Moreover, this analysis provided evidence that the investigated icsF gene, which
influences both, intracellular survival and quorum sensing of P. aeruginosa, may be
the factor that has a major impact on the expression of these operons.      
Tab. 3.9.  Oxidative stress response genes involved in nitrogen metabolism whose expression
was found to be upregulated in the icsF mutant in the presence of H2O2. 
ORF1 Gene
name
Fold
change2
Protein description
PA05093 nirN 67.8 probable c-type cytochrome
PA05103 414.9 probable uroporphyrin-III c-methyltransferase
PA05113 nirJ 78.4 heme d1 biosynthesis protein NirJ
PA05123 111.0 conserved hypothetical protein
PA05133 138.1 probable transcriptional regulator
PA05143 nirL 224.0 heme d1 biosynthesis protein NirL
PA05153 1153.9 probable transcriptional regulator
PA05163 nirF 132.8 heme d1 biosynthesis protein NirF
PA05173 nirC 198.9 probable c-type cytochrome precursor
PA05183 nirM 148.6 cytochrome c-551 precursor
PA0519 nirS 45.5 nitrite reductase precursor
PA05203 nirQ 33.1 regulatory protein NirQ
PA05213 28.7 probable cytochrome c oxidase subunit
PA05223 10.6 hypothetical protein
PA05233 norC 175.4 nitric-oxide reductase subunit C
PA05243 norB 342.3 nitric-oxide reductase subunit B
PA05253 116.3 probable dinitrification protein NorD
PA11723 napC 20.1 cytochrome c-type protein NapC
PA11733 napB 16.5 cytochrome c-type protein NapB precursor
PA1174 napA 23.1 periplasmic nitrate reductase protein NapA
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ORF1 Gene
name
Fold
change2
Protein description
PA1175 napD 13.4 NapD protein of periplasmic nitrate reductase
PA1176 napF 23.6 ferredoxin protein NapF
PA1177 napE 22.8 periplasmic nitrate reductase protein NapE
PA30323 snr1 2.7 cytochrome c Snr1
PA33913 nosR 126.8 regulatory protein NosR
PA33923 nosZ 219.9 nitrous-oxide reductase precursor
PA33933 nosD 56.8 NosD protein
PA33943 nosF 54.2 NosF protein
PA33953 nosY 39.0 NosY protein
PA33963 nosL 59.4 NosL protein
PA38723 narI 12.9 respiratory nitrate reductase gamma chain
PA38733 narJ 15.8 respiratory nitrate reductase delta chain
PA38743 narH 14.1 respiratory nitrate reductase beta chain
PA38753 narG 30.8 respiratory nitrate reductase alpha chain
PA38763 narK2 5.5 nitrite extrusion protein 2
PA3879 narL 2.9 two-component response regulator NarL
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com). 
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
3 Quorum sensing regulated genes (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003).
3.3.7.2.2. icsF regulates the key oxidative stress response genes 
Bacteria have developed a variety of strategies to cope with the oxidative stress in
the intracellular compartments of PMNs. In particular, superoxid dismutase (SOD)
and catalase are implicated in these oxidative stress mediated reactions (Hassett
and Cohen, 1989). SOD generates hydrogen peroxide and molecular oxygen out of
superoxide anions and in subsequent reaction catalase converts toxic hydrogen
peroxide into water and molecular oxygen (Fridovich, 1978). Besides genes encoding
superoxid dismutases (sodB, sodM) and catalases (katA, katB, katE, katN) (Brown et
al., 1995; Hassett et al., 1995), the P. aeruginosa genome comprises also a few
genes for alkyl hydroperoxide reductases (ahpA, ahpB, ahpCF, ohr, PA0848) as well
as oxyR and soxR which encode the key modulators of the oxidative stress response
in bacteria (Ochsner et al., 2000; Ochsner et al., 2001).     
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Table 3.10 shows the GeneChip signal intensities of the major oxidative stress
response genes of P. aeruginosa in the wild type strain TB in the absence and
presence of H2O2 compared with the signal intensities of the investigated icsF mutant
grown in the presence of H2O2. 
Under the experimental conditions used in this study the alkylhydroperoxide
reductase AhpB, catalases KatE and KatN, regulator SoxR and the superoxid
dismutase SodM were constitutively expressed at low levels in wild type in the
absence and presence of H2O2, suggesting that under used experimental settings
these proteins do not play a role in the response of P. aeruginosa to oxidative stress
caused by H2O2. On the other hand, ahpC, bfrB, bfrA, or katA are already expressed
at such high levels in the wild type strain, even without addition of the H2O2 to growth
medium, that any further upregulation upon exposure to H2O2 would not be
biologically meaningful for the bacterium. Most interesting is therefore the last
category, which comprises the key oxidative stress response genes ahpF, PA0848,
trxB2, ohr, sodB, katB and oxyR, whose mRNA transcripts expression was increased
remarkably in the wild type strain after addition of 10 mM H2O2 to growth medium, but
their expression in the examined icsF mutant cultured under the same condition
remained almost completely unaltered. This is the group of genes whose expression
is strongly dependent on the presence of IcsF protein. The differences in the
expression of mRNA transcripts between wild type strain and icsF mutant cultivated
in the presence of H2O2 were best visible in the case of alkyl hydroperoxide
reductases ahpF, PA0848 and ohr (above 25-fold, 18-fold and 4-fold difference,
respectively), thioredoxin reductase trxB2 (15-fold difference) and catalase katB
(around 100-fold difference). Noteworthy is also the slight modulation of the OxyR
expression, which represents one of the well-conserved bacterial oxidative stress
response regulators. Moreover, the effect of the icsF mutation on the expression of
superoxide dismutase SodB suggests an important role of IcsF in the first step of
oxidative stress response of P. aeruginosa, in the conversion of superoxide anions
into H2O2. However, most striking is particularly the huge impact of IcsF on the
expression of catalase KatB, which pinpoints IcsF as a principal protein responsible
for regulation of H2O2 detoxification in P. aeruginosa. 
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Table 3.10. Expression of mRNA transcripts known to be involved in the oxidative stress
response. GeneChip normalized signal intensities in the P. aeruginosa strain TB wild type in the
absence (H2O2-) and presence (H2O2+) of 10 mM hydrogen peroxide and its Tn5::icsF transposon
mutant (IcsF-) in the presence of 10 mM hydrogen peroxide.
Signal intensityORF1 Gene name
H2O2- H2O2+ IcsF-
PA0139 ahpC 2320 3894 2510
PA0140 ahpF 63 1650 60
PA0847 ahpB 13 4 19
PA0848 66 1212 57
PA0849 trxB2 51 1227 82
PA2025 gor 392 330 334
PA2147 katE 4 4 7
PA2185 katN 11 12 21
PA2273 soxR 10 6 5
PA2850 ohr 56 201 55
PA3531 bfrB 2224 1710 1433
PA4235 bfrA 1964 710 1397
PA4236 katA 1770 2374 1406
PA4366 sodB 1490 2053 1250
PA4468 sodM 30 75 68
PA4613 katB 23 1736 17
PA5344 oxyR 229 378 207
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com). 
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4. Conclusions and perspectives
The objective of this work was to integrate four potential regulatory virulence genes
(vqsR, gltR, 47D7, icsF) from the STM library of P. aeruginosa TB (Wiehlmann, 2001)
into regulatory networks and pathways. To achieve this goal the mutants were
complemented in trans and comprehensively analysed using combined approach of
up-to-date technologies of functional genomics, genetics in silico and various
bioassays.      
4.1. vqsR 
In summary, the disruption of vqsR repressed the expression of genes that are
known to be promoted by quorum sensing and activated the expression of genes that
are known to be repressed by quorum sensing. Moreover, the vqsR mutant
harboured less mRNA transcript for the production of iron regulated genes and
membrane-bound elements of antibiotic resistance (Figure 4.1). Besides the
cytotoxicity caused by elements of the type III secretion system (Frank, 1997),
antibiotic resistance and extracellular virulence factors are the major determinants for
morbidity and prognosis of infections with P. aeruginosa in humans. The protein
encoded by vqsR (PA2591) regulates several traits of pathogenicity, hence the name
vqsR, (virulence and quorum sensing regulator), was assigned to PA2591.
Inactivation of vqsR abrogated the production of AHLs and decreased LasI mRNA by
about 10-fold. In addition, vqsR contains a las box in its upstream region.
Considering these data, I would like to conclude that vqsR is an essential element of
the quorum sensing hierarchy whose inactivation disrupts the production of AHLs,
including 3-oxo-C12-HSL and C4-HSL. On the other hand, the presence of the las box
located upstream of vqsR places this gene under the direct control of the regulatory
LasR-3-oxo-C12-HSL complex, thus creating an autoinducer feedback loop. The
influence of VqsR on the expression of LasR in ABC minimal medium further
underlines the existence of the autoregulatory feedback loop between vqsR and las
quorum sensing circuit. 
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This hypothesis is also supported by the GeneChip experiment performed by Wagner
et al. (2003) where transcription of the vqsR gene (PA2591) was found to be reduced
5.7 fold in the P. aeruginosa mutant strain deficient in the 3-oxo-C12-HSL and C4-HSL
synthesis.  
As 3-oxo-C12-HSL and C4-HSL are involved in the initiation of quorum sensing, the
disruption of 3-oxo-C12-HSL and C4-HSL production and secretion in the vqsR mutant
inevitably has a negative effect on the whole quorum sensing cascade. Indeed, the
GeneChip experiments revealed significant downregulation of the whole battery of
quorum sensing genes in the vqsR transposon mutant.
Fig. 4.1. Major gene categories and metabolic pathways regulated by VqsR in the presence of
10 mM H2O2 and 10 % serum. 
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Correspondingly the mutant was compromised in phenotypic traits that are under
quorum sensing control such as protease (elastase), hemolysin and pyocyanin
secretion and virulence in the C. elegans infection model. 
In summary, vqsR is a new member of the LuxR family that is involved in cell-to-cell
communication and virulence of P. aeruginosa. It constitutes an essential element of
the quorum sensing cascade, which, in concert with additional regulators, represents
a tool for the fine tuning of the quorum sensing in P. aeruginosa (Figure 4.2).
Fig. 4.2. Quorum sensing network in P. aeruginosa. Hierarchically arranged las and rhl systems
are subject to modulation by a number of additional regulators, including VqsR, which represent a tool
for the fine tuning of the quorum sensing in P. aeruginosa. 
It would be interesting to further investigate the exact position of vqsR in the quorum
sensing hierarchy and its delicate interplay with other key regulators of cell-to-cell
communication in P. aeruginosa.  
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4.2. gltR and 47D7
Disruption of gltR and 47D7 by Tn5 transposon mutagenesis (Wiehlmann, 2001)
caused decreased resistance to serum as well as the significant protease secretion
deficiency of the gltR mutant and the complete loss of the protease secretion ability
of the 47D7 mutant, thus suggesting an important role of these genes in P.
aeruginosa virulence.
Therefore, gltR and 47D7 mutants were complemented in trans to ensure that their
phenotypes were caused by the transposon inactivation of the respective genes.
However, the complemented mutants maintaining the recombinant plasmids
pME6010gltR and pME601047D7 did not show phenotypes that are typical for the
wild type strain. Complementation in trans did neither restore the protease secretion
ability nor the survival ability of the gltR mutant in the serum. Furthermore
complementation in trans did not restore the protease secretion ability of the 47D7
mutant, thus providing evidence that in this case, like in the case of the gltR mutant,
the observed phenotypes are most probably caused by a secondary genetic event
elsewhere in the genome. Therefore the results presented in this work suggest that
any further research on these two mutants would be meaningless. 
4.3. icsF
The disruption of icsF altered the expression of a number of genes that are known to
be implicated in the oxidative stress response of P. aeruginosa. As mentioned
before, prior to phagocytosis of bacteria, the PMN begins to consume oxygen, a
process known as oxidative burst, thus transforming the phagolysosomes into the
harsh and microorganisms-killing compartments. Therefore bacteria have developed
a variety of strategies to cope with oxidative stress in the intracellular compartments
of PMNs. One of the most important from these strategies exploits the antioxidant
enzymes (Staudinger et al., 2002), but so far this type of intracellular survival
mechanism was not reported for P. aeruginosa. In general, intracellular survival of P.
aeruginosa in PMNs is very rare, because PMN-mediated phagocytosis represents
one of the host’s most proficient antipseudomonal weapon (Döring et al., 1995) and
can be only seen in a minority of CF isolates. However, the investigated P.
aeruginosa strain TB was shown to be capable of survival and replication in PMNs
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irrespective of whether they were isolated from patients with CF or healthy donors
(Tümmler, 1987). 
The data presented in this work demonstrate that icsF is one of the key genes
responsible for the regulation of the expression of oxidative stress genes. As
oxidative stress response genes represent an effective tool to combat the harsh
conditions in phagolysosomes, the disruption of icsF inevitably has a negative effect
on the intracellular survival. The protein encoded by icsF (PA1572) has a large
impact on the intracellular survival of P. aeruginosa in PMNs and hence the name
icsF, (intracellular survival factor), was assigned to PA1572. Besides the intracellular
survival, the disruption of icsF also affects cell-to-cell communication and overall
virulence of P. aeruginosa against C. elegans. 
It was shown, that the oxidative burst is caused by a membrane-associated NADPH
oxidase (Rosen, 2004). Intriguingly, IcsF shares a strong homology with the NAD
kinase from E. coli. Further investigation in this direction would help to reveal the
exact enzymatic function of this protein and its dual role for the intracellular survival
and quorum sensing of P. aeruginosa.
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6. Abbreviations
A Absorbance Max. Maximum 
Aa   Amino acid Mb Megabases
AHL acylated homoserine lactones µ micro- (10-6)
bp Base pair min. Minute
approx. approximately MOPS Morpholinopropanesulfonic acid
oC Degree Celsius mRNA Messenger RNA
cDNA Complementary DNA n nano- (10-9)
CDS Coding sequence dNTP Deoxynucleotide triphosphate
CF Cystic fibrosis OD Optical Density
cfu Colony forming units ORF Open reading frame; possible gene
dATP Deoxyadenosine triphosphate p pico- (10-12)
dCTP Deoxycytosine triphosphate PAGE Polyacrylamide gel electrophoresis
ddH2O Double distilled water PCR Polymerase chain reaction
DEPC Diethylpyrocarbonate QS Quorum sensing
dGTP Deoxyguanosine triphosphate R,r Antibiotic resistance
DIG Digoxigenin RBS Ribosome binding sequence
DNase Deoxyribonuclease RNase Ribonuclease
dNTP Deoxynucleotide triphosphate rpm Revolutions per minute
dsDNA Double stranded DNA rRNA Ribosomal RNA
dTTP Deoxythymidine triphosphate RT Room temperature (23 oC)
EDTA Ethylenediaminetetraacetic acid s Second
e.g. For example SDS Sodium dodecyl sulfate
et. al., et alteri (and others) ssDNA Single stranded DNA
EtBr Ethidium bromide t Time
i.e. That means T Temperature
F Farad TE Tris-EDTA 
FCS Fetal calf serum Tris Tris(hydroxymethyl)aminomethane
x g Centrifugal acceleration TTSS Type III secretion system
h Hour U Unit (unit of enzymatic activity)
I.E. Injection units UV Ultra violet
Kb 1000 Base pairs V Volt
LB Luria-Bertani Vol. Unit volumes
M Molar v/v Percentage volume per total volume
M milli- (10-3); Meter, Mass w/v Prcentage by weight per total volume
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7. Appendices
Appendix I
Molecular weight standards used for DNA and RNA agarose gel electrophoresis in this work.
The fragment sizes are given in base pairs.
 DNA/BstE II 100 bp DNA ladder 0.16-1.77 Kb RNA ladder
8454 1517 1770
7242 1200 1520
6369 1000 1280
5686 900 780
4822 800 530
4324 700 400
3675 600 280
2323 517 155
1929 500
1371 400
1264 300
702 200
224 100
117
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Appendix II
Differential transcription profile of the vqsR mutant grown in the ABC minimal medium. 
ORF1 Gene
name
Fold
change2
Protein description
Genes upregulated in the vqsR mutant in the ABC minimal medium
PA0029 5.68 probable sulfate transporter
PA0038 6.37 hypothetical protein
PA0069 7.74 conserved hypothetical protein
PA01053 coxB 31.50 cytochrome c oxidase, subunit II
PA01063 coxA 54.70 cytochrome c oxidase, subunit I
PA01073 49.55 conserved hypothetical protein
PA01083 coIII 46.18 cytochrome c oxidase, subunit III
PA01093 6.16 hypothetical protein
PA0110 20.78 hypothetical protein
PA0111 41.62 hypothetical protein
PA0112 16.50 hypothetical protein
PA0113 15.05 probable cytochrome c oxidase assembly factor
PA0114 6.34 conserved hypothetical protein
PA01323 10.79 beta-alanine--pyruvate transaminase
PA0134 7.22 probable guanine deaminase
PA0136 6.46 probable ATP-binding component of ABC transporter
PA0138 17.07 probable permease of ABC transporter
PA0140 ahpF 6.98 alkyl hydroperoxide reductase subunit F
PA0149 5.27 probable sigma-70 factor, ECF subfamily
PA01763 5.80 probable chemotaxis transducer
PA0177 23.55 probable purine-binding chemotaxis protein
PA0178 5.98 probable two-component sensor
PA01793 5.49 probable two-component response regulator
PA0207 8.66 probable transcriptional regulator
PA0209 7.21 conserved hypothetical protein
PA0215 7.10 probable transporter
PA0216 28.47 probable transporter
PA0227 7.21 probable CoA transferase, subunit B
PA0235 pcaK 5.66 4-hydroxybenzoate transporter PcaK
PA0238 7.11 hypothetical protein
PA0249 6.35 probable acetyltransferase
PA0250 6.65 conserved hypothetical protein
PA0251 17.03 hypothetical protein
PA0326 6.78 probable ATP-binding component of ABC transporter
PA03553 pfpI 5.78 protease PfpI
PA0424 mexR 7.62 multidrug resistance operon repressor MexR
PA04353 5.85 hypothetical protein
PA0439 12.22 probable oxidoreductase
PA0440 47.67 probable oxidoreductase
PA0441 74.30 dihydropyrimidinase
PA0443 11.77 probable transporter
PA0444 26.68 N-carbamoyl-beta-alanine amidohydrolase
PA0446 6.14 conserved hypothetical protein
PA04473 gcdH 11.45 glutaryl-CoA dehydrogenase
PA0451 8.73 conserved hypothetical protein
PA0452 15.31 probable stomatin-like protein
PA0471 9.32 probable transmembrane sensor
PA0472 11.71 probable sigma-70 factor, ECF subfamily
PA0476 52.48 probable permease
PA0491 6.75 probable transcriptional regulator
PA0492 68.31 conserved hypothetical protein
PA0494 6.91 probable acyl-CoA carboxylase subunit
PA0499 28.37 probable pili assembly chaperone
PA05103 14.04 probable uroporphyrin-III c-methyltransferase
PA0531 15.22 probable glutamine amidotransferase
PA0532 5.65 hypothetical protein
PA0543 7.90 hypothetical protein
PA0545 6.96 hypothetical protein
PA0585 33.31 hypothetical protein
PA05863 14.20 conserved hypothetical protein
PA0587 14.10 conserved hypothetical protein
PA05883 8.66 conserved hypothetical protein
PA0610 prtN 6.31 transcriptional regulator PrtN
PA0613 13.86 hypothetical protein
PA0670 13.36 hypothetical protein
PA0671 21.98 hypothetical protein
PA0672 hemO 5.75 heme oxygenase
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ORF1 Gene
name
Fold
change2
Protein description
Genes upregulated in the vqsR mutant in the ABC minimal medium
PA0673 7.97 hypothetical protein
PA0680 7.25 probable type II secretion system protein
PA0718 11.60 hypothetical protein of bacteriophage Pf1
PA0722 5.78 hypothetical protein of bacteriophage Pf1
PA0726 9.81 hypothetical protein of bacteriophage Pf1
PA0737 52.08 hypothetical protein
PA0738 6.11 conserved hypothetical protein
PA0742 8.63 hypothetical protein
PA0743 13.33 probable 3-hydroxyisobutyrate dehydrogenase
PA0747 9.52 probable aldehyde dehydrogenase
PA0785 7.00 probable acyl carrier protein phosphodiesterase
PA0788 20.31 hypothetical protein
PA0816 7.20 probable transcriptional regulator
PA0821 6.75 hypothetical protein
PA0829 14.77 probable hydrolase
PA0845 15.23 conserved hypothetical protein
PA0865 hpd 417.72 4-hydroxyphenylpyruvate dioxygenase
PA0866 aroP2 25.84 aromatic amino acid transport protein AroP2
PA0872 phhA 21.65 phenylalanine-4-hydroxylase
PA0874 6.46 hypothetical protein
PA0875 11.84 conserved hypothetical protein
PA0882 7.30 hypothetical protein
PA0894 7.17 hypothetical protein
PA0907 9.52 hypothetical protein
PA0912 6.80 hypothetical protein
PA0931 38.93 siderophore receptor protein
PA0942 7.58 probable transcriptional regulator
PA1027 6.88 probable aldehyde dehydrogenase
PA1028 6.14 probable oxidoreductase
PA1029 8.72 hypothetical protein
PA1030 5.79 hypothetical protein
PA1135 8.62 conserved hypothetical protein
PA1136 5.20 probable transcriptional regulator
PA1137 5.41 probable oxidoreductase
PA1144 20.37 probable MFS transporter
PA1147 9.21 probable amino acid permease
PA1172 napC 14.43 cytochrome c-type protein NapC
PA11733 napB 13.46 cytochrome c-type protein NapB precursor
PA1174 napA 12.01 periplasmic nitrate reductase protein NapA
PA11753 napD 8.10 NapD protein of periplasmic nitrate reductase
PA11763 napF 8.15 ferredoxin protein NapF
PA11773 napE 6.11 periplasmic nitrate reductase protein NapE
PA1190 66.42 conserved hypothetical protein
PA1194 8.42 probable amino acid permease
PA1195 10.26 hypothetical protein
PA1231 8.08 conserved hypothetical protein
PA1240 19.08 probable enoyl-CoA hydratase/isomerase
PA1256 11.76 probable ATP-binding component of ABC transporter
PA1282 8.74 probable MFS transporter
PA1283 5.77 probable transcriptional regulator
PA12893 7.00 hypothetical protein
PA1297 15.75 probable metal transporter
PA1300 9.81 probable sigma-70 factor, ECF subfamily
PA1301 7.34 probable transmembrane sensor
PA1313 15.14 probable MFS transporter
PA1328 11.55 probable transcriptional regulator
PA1332 24.21 hypothetical protein
PA1333 8.73 hypothetical protein
PA1348 9.93 hypothetical protein
PA1350 16.36 hypothetical protein
PA1352 8.22 conserved hypothetical protein
PA1485 7.88 probable amino acid permease
PA1497 9.10 probable transporter
PA1503 8.18 hypothetical protein
PA1513 5.97 hypothetical protein
PA1514 5.55 conserved hypothetical protein
PA1515 alc 5.76 allantoicase
PA1517 9.60 conserved hypothetical protein
PA1518 5.39 conserved hypothetical protein
PA1519 8.87 probable transporter
PA1522 5.49 hypothetical protein
PA1523 xdhB 11.56 xanthine dehydrogenase
PA1524 xdhA 12.01 xanthine dehydrogenase
PA1538 7.48 probable flavin-containing monooxygenase
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ORF1 Gene
name
Fold
change2
Protein description
Genes upregulated in the vqsR mutant in the ABC minimal medium
PA1540 18.85 conserved hypothetical protein
PA1541 80.50 probable drug efflux transporter
PA1617 12.42 probable AMP-binding enzyme
PA1728 10.99 hypothetical protein
PA1761 12.14 hypothetical protein
PA1763 5.85 hypothetical protein
PA1785 22.11 conserved hypothetical protein
PA1786 6.57 conserved hypothetical protein
PA1851 10.19 hypothetical protein
PA1860 6.47 hypothetical protein
PA18743 6.65 hypothetical protein
PA18753 6.09 probable outer membrane protein precursor
PA1877 6.89 probable secretion protein
PA1885 6.76 conserved hypothetical protein
PA1911 7.01 probable transmembrane sensor
PA1912 6.33 probable sigma-70 factor, ECF subfamily
PA1920 7.35 conserved hypothetical protein
PA19303 21.15 probable chemotaxis transducer
PA1931 5.35 probable ferredoxin
PA1946 5.37 binding protein component precursor of ABC ribose transporter
PA1977 5.39 hypothetical protein
PA19783 5.30 probable transcriptional regulator
PA1992 6.22 probable two-component sensor
PA1997 6.31 probable AMP-binding enzyme
PA20093 hmgA 7.76 homogentisate 1,2-dioxygenase
PA20143 6.67 probable acyl-CoA carboxyltransferase beta chain
PA2015 5.96 probable acyl-CoA dehydrogenase
PA2016 11.00 probable transcriptional regulator
PA2017 7.59 hypothetical protein
PA2021 13.49 hypothetical protein
PA2024 27.89 probable ring-cleaving dioxygenase
PA2054 cynR 6.48 transcriptional regulator CynR
PA2094 6.13 probable transmembrane sensor
PA2120 6.01 hypothetical protein
PA2123 5.36 probable transcriptional regulator
PA2132 12.02 probable pili assembly chaperone
PA2137 19.34 hypothetical protein
PA2138 12.54 probable ATP-dependent DNA ligase
PA21453 19.58 hypothetical protein
PA21463 12.73 conserved hypothetical protein
PA2149 13.62 hypothetical protein
PA21513 14.88 conserved hypothetical protein
PA21583 7.02 probable alcohol dehydrogenase (Zn-dependent)
PA21633 14.16 hypothetical protein
PA21663 6.75 hypothetical protein
PA2174 10.06 hypothetical protein
PA2175 6.85 hypothetical protein
PA21763 7.25 hypothetical protein
PA2187 7.58 hypothetical protein
PA21903 26.47 conserved hypothetical protein
PA2210 13.82 probable MFS transporter
PA2211 15.21 conserved hypothetical protein
PA2247 bkdA1 46.12 2-oxoisovalerate dehydrogenase (alpha subunit)
PA2248 bkdA2 24.14 2-oxoisovalerate dehydrogenase (beta subunit)
PA2249 bkdB 15.94 branched-chain alpha-keto acid dehydrogenase 
PA22503 lpdV 13.07 lipoamide dehydrogenase-Val
PA2252 5.84 probable AGCS sodium/alanine/glycine symporter
PA2256 pvcC 5.26 pyoverdine biosynthesis protein PvcC
PA2282 5.97 hypothetical protein
PA2292 6.45 hypothetical protein
PA2313 5.29 hypothetical protein
PA2336 10.65 hypothetical protein
PA23413 5.62 probable component of ABC maltose/mannitol transporter
PA2376 5.71 probable transcriptional regulator
PA2381 6.13 hypothetical protein
PA24143 5.81 L-sorbosone dehydrogenase
PA2418 6.34 hypothetical protein
PA2422 8.23 hypothetical protein
PA24333 17.96 hypothetical protein
PA2468 15.16 probable sigma-70 factor, ECF subfamily
PA2481 7.33 hypothetical protein
PA2482 7.94 probable cytochrome c
PA2485 14.01 hypothetical protein
PA2486 19.34 hypothetical protein
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PA2504 7.96 hypothetical protein
PA2519 xylS 5.61 transcriptional regulator XylS
PA2523 20.07 probable two-component response regulator
PA2524 5.28 probable two-component sensor
PA2550 14.68 probable acyl-CoA dehydrogenase
PA25523 6.86 probable acyl-CoA dehydrogenase
PA25533 12.02 probable acyl-CoA thiolase
PA25543 8.37 probable short-chain dehydrogenase
PA25723 6.62 probable two-component response regulator
PA25733 7.26 probable chemotaxis transducer
PA2574 13.94 conserved hypothetical protein
PA2576 5.20 hypothetical protein
PA2578 9.37 probable acetyltransferase
PA2590 6.21 hypothetical protein
PA2600 6.27 hypothetical protein
PA2618 9.94 hypothetical protein
PA2674 7.24 probable type II secretion system protein
PA2675 7.36 probable type II secretion system protein
PA2676 10.73 probable type II secretion system protein
PA2680 18.40 probable quinone oxidoreductase
PA2686 pfeR 9.72 two-component response regulator PfeR
PA2687 pfeS 6.25 two-component sensor PfeS
PA2688 pfeA 53.86 ferric enterobactin receptor precursor PfeA
PA2691 6.39 conserved hypothetical protein
PA2717 9.13 chloroperoxidase precursor
PA2719 6.22 hypothetical protein
PA2746 9.06 hypothetical protein
PA2754 6.47 conserved hypothetical protein
PA2759 39.19 hypothetical protein
PA2776 9.43 conserved hypothetical protein
PA2777 7.80 conserved hypothetical protein
PA2778 6.40 hypothetical protein
PA2779 14.65 hypothetical protein
PA2799 10.20 hypothetical protein
PA2835 21.82 probable MFS transporter
PA2862 lipA 8.92 lactonizing lipase precursor
PA2863 lipH 8.38 lipase modulator protein
PA2881 15.38 probable two-component response regulator
PA2883 14.09 hypothetical protein
PA2898 9.63 hypothetical protein
PA2899 5.96 probable transcriptional regulator
PA2910 6.53 conserved hypothetical protein
PA2916 19.26 hypothetical protein
PA2920 6.78 probable chemotaxis transducer
PA2935 6.25 hypothetical protein
PA2937 35.53 hypothetical protein
PA2938 21.52 probable transporter
PA3017 6.07 conserved hypothetical protein
PA30323 snr1 7.51 cytochrome c Snr1
PA3044 5.97 probable two-component sensor
PA3045 6.03 probable two-component response regulator
PA3049 rmf 59.24 ribosome modulation factor
PA3067 12.42 probable transcriptional regulator
PA3089 13.39 hypothetical protein
PA3090 10.23 hypothetical protein
PA31743 5.08 probable transcriptional regulator
PA31833 zwf 5.30 glucose-6-phosphate 1-dehydrogenase
PA31943 edd 5.57 phosphogluconate dehydratase
PA31953 gapA 13.46 glyceraldehyde 3-phosphate dehydrogenase
PA3216 6.19 hypothetical protein
PA3231 17.84 hypothetical protein
PA32343 5.89 probable sodium:solute symporter
PA32353 13.76 conserved hypothetical protein
PA3237 40.51 hypothetical protein
PA3259 5.79 hypothetical protein
PA3273 23.86 hypothetical protein
PA3274 83.83 hypothetical protein
PA3277 5.31 probable short-chain dehydrogenase
PA3279 oprP 6.30 outer membrane porin OprP precursor
PA3323 6.34 conserved hypothetical protein
PA3324 13.12 probable short-chain dehydrogenase
PA3342 8.51 hypothetical protein
PA3343 6.60 hypothetical protein
PA3354 6.19 hypothetical protein
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PA3362 5.13 hypothetical protein
PA3368 9.05 probable acetyltransferase
PA33693 10.13 hypothetical protein
PA33703 11.26 hypothetical protein
PA33713 7.12 hypothetical protein
PA3383 13.85 binding protein component of ABC phosphonate transporter
PA3384 phnC 6.83 ATP-binding component of ABC phosphonate transporter
PA3386 8.24 conserved hypothetical protein
PA3390 5.77 hypothetical protein
PA33923 nosZ 10.10 nitrous-oxide reductase precursor
PA33963 nosL 8.61 NosL protein
PA3412 6.29 hypothetical protein
PA3415 64.25 probable dihydrolipoamide acetyltransferase
PA34163 397.78 probable pyruvate dehydrogenase E1 component, beta chain
PA3417 74.11 probable pyruvate dehydrogenase E1 component, alpha subunit
PA34183 ldh 24.06 leucine dehydrogenase
PA3421 15.64 conserved hypothetical protein
PA3422 83.72 hypothetical protein
PA3427 11.66 probable short-chain dehydrogenases
PA3428 28.79 hypothetical protein
PA3429 5.54 probable epoxide hydrolase
PA3430 9.45 probable aldolase
PA3432 10.35 hypothetical protein
PA3451 10.69 hypothetical protein
PA3546 algX 10.99 alginate biosynthesis protein AlgX
PA3568 8.74 probable acetyl-coa synthetase
PA3569 mmsB 6.59 3-hydroxyisobutyrate dehydrogenase
PA3570 mmsA 5.30 methylmalonate-semialdehyde dehydrogenase
PA3584 glpD 7.42 glycerol-3-phosphate dehydrogenase
PA3591 9.98 probable enoyl-CoA hydratase/isomerase
PA3630 11.46 probable transcriptional regulator
PA36883 10.95 hypothetical protein
PA36923 7.02 probable outer membrane protein precursor
PA3710 8.08 probable GMC-type oxidoreductase
PA3719 9.13 hypothetical protein
PA3720 13.44 hypothetical protein
PA3723 11.15 probable FMN oxidoreductase
PA3765 6.12 hypothetical protein
PA3865 11.72 probable amino acid binding protein
PA38723 narI 6.71 respiratory nitrate reductase gamma chain
PA38753 narG 11.26 respiratory nitrate reductase alpha chain
PA3899 7.92 probable sigma-70 factor, ECF subfamily
PA3900 6.71 probable transmembrane sensor
PA39193 18.29 conserved hypothetical protein
PA3957 13.99 probable short-chain dehydrogenase
PA39863 7.49 hypothetical protein
PA4027 7.23 hypothetical protein
PA4038 38.79 hypothetical protein
PA4039 8.03 hypothetical protein
PA4070 37.96 probable transcriptional regulator
PA4081 11.39 probable fimbrial protein
PA4084 cupB3 20.06 probable fimbrial biogenesis usher protein
PA4093 5.59 hypothetical protein
PA4094 8.30 probable transcriptional regulator
PA4096 5.26 probable MFS transporter
PA4097 6.08 probable alcohol dehydrogenase (Zn-dependent)
PA4104 6.65 conserved hypothetical protein
PA4108 6.70 hypothetical protein
PA4111 7.01 hypothetical protein
PA4115 6.04 conserved hypothetical protein
PA4120 6.07 probable transcriptional regulator
PA4121 7.31 conserved hypothetical protein
PA4124 hpcB 14.12 homoprotocatechuate 2,3-dioxygenase
PA4126 5.50 probable MFS transporter
PA4146 5.96 hypothetical protein
PA4147 acoR 15.15 transcriptional regulator AcoR
PA4149 5.68 conserved hypothetical protein
PA4152 6.94 probable hydrolase
PA4158 fepC 20.26 ferric enterobactin transport protein FepC
PA4160 fepD 10.09 ferric enterobactin transport protein FepD
PA4173 8.77 conserved hypothetical protein
PA4185 6.67 probable transcriptional regulator
PA4205 41.01 hypothetical protein
PA4221 fptA 27.22 Fe(III)-pyochelin receptor precursor
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PA4227 pchR 19.31 transcriptional regulator PchR
PA4229 pchC 14.90 pyochelin biosynthetic protein PchC
PA4231 pchA 30.45 salicylate biosynthesis isochorismate synthase
PA4289 5.54 probable transporter
PA4290 5.87 probable chemotaxis transducer
PA42933 44.23 probable two-component sensor
PA42943 10.75 hypothetical protein
PA42963 7.61 probable two-component response regulator
PA42983 12.21 hypothetical protein
PA42993 12.56 hypothetical protein
PA43003 13.66 hypothetical protein
PA4301 10.57 hypothetical protein
PA43023 19.26 probable type II secretion system protein
PA43033 9.40 hypothetical protein
PA43043 25.06 probable type II secretion system protein
PA43053 12.11 hypothetical protein
PA43063 23.64 hypothetical protein
PA43113 5.79 conserved hypothetical protein
PA4344 8.45 probable hydrolase
PA4350 7.05 conserved hypothetical protein
PA4364 20.94 hypothetical protein
PA4365 11.94 probable transporter
PA4469 8.08 hypothetical protein
PA4470 fumC1 13.34 fumarate hydratase
PA4471 145.86 hypothetical protein
PA4507 10.64 hypothetical protein
PA4523 31.54 hypothetical protein
PA4540 31.97 hypothetical protein
PA4541 14.90 hypothetical protein
PA4570 18.32 hypothetical protein
PA4573 12.01 hypothetical protein
PA4575 13.63 hypothetical protein
PA4596 5.90 probable transcriptional regulator
PA4608 7.99 hypothetical protein
PA4612 5.66 conserved hypothetical protein
PA4613 9.88 catalase
PA4616 5.41 probable c4-dicarboxylate-binding protein
PA4623 6.86 hypothetical protein
PA4630 14.88 hypothetical protein
PA4641 7.51 still frameshift hypothetical protein
PA46483 11.94 hypothetical protein
PA46493 8.82 hypothetical protein
PA46503 6.64 hypothetical protein
PA46513 6.00 probable pili assembly chaperone
PA4653 7.35 hypothetical protein
PA4654 34.62 probable MFS transporter
PA4658 9.05 hypothetical protein
PA4659 5.52 probable transcriptional regulator
PA4680 6.09 hypothetical protein
PA4702 10.24 hypothetical protein
PA47033 7.27 hypothetical protein
PA4704 5.68 hypothetical protein
PA4709 6.53 probable hemin degrading factor
PA4711 6.04 hypothetical protein
PA4810 fdnI 5.37 nitrate-inducible formate dehydrogenase, gamma subunit
PA4811 fdnH 13.11 nitrate-inducible formate dehydrogenase, beta subunit
PA4812 fdnG 6.62 formate dehydrogenase-O, major subunit
PA4844 6.79 probable chemotaxis transducer
PA4859 5.28 probable permease of ABC transporter
PA4861 20.01 probable ATP-binding component of ABC transporter
PA4877 8.44 hypothetical protein
PA4879 5.42 conserved hypothetical protein
PA4881 9.77 hypothetical protein
PA4883 13.01 hypothetical protein
PA4892 ureF 5.79 urease accessory protein UreF
PA4895 9.62 probable transmembrane sensor
PA4896 25.59 probable sigma-70 factor, ECF subfamily
PA4897 5.40 hypothetical protein
PA4898 24.92 probable porin
PA4908 8.38 hypothetical protein
PA4910 5.80 probable ATP-binding component of ABC transporter
PA4912 6.49 probable ABC branched chain amino acid transporter
PA4913 10.75 probable binding protein component of ABC transporter
PA4914 13.24 probable transcriptional regulator
Appendices
194
ORF1 Gene
name
Fold
change2
Protein description
Genes upregulated in the vqsR mutant in the ABC minimal medium
PA4915 11.19 probable chemotaxis transducer
PA4977 5.13 probable acetolactate synthase large subunit
PA4978 7.45 hypothetical protein
PA4995 7.30 probable acyl-CoA dehydrogenase
PA5020 5.94 probable acyl-CoA dehydrogenase
PA5023 5.20 conserved hypothetical protein
PA5085 5.03 probable transcriptional regulator
PA5087 12.73 hypothetical protein
PA5098 hutH 5.13 histidine ammonia-lyase
PA5100 hutU 6.71 urocanase
PA5106 12.39 conserved hypothetical protein
PA5313 32.15 probable pyridoxal-dependent aminotransferase
PA5314 5.51 hypothetical protein
PA5325 18.87 hypothetical protein
PA5328 6.54 probable cytochrome c(mono-heme type)
PA53523 12.20 conserved hypothetical protein
PA53533 glcF 12.03 glycolate oxidase subunit GlcF
PA53543 glcE 11.50 glycolate oxidase subunit GlcE
PA53553 glcD 9.01 glycolate oxidase subunit GlcD
PA5372 betA 7.22 choline dehydrogenase
PA5379 sdaB 5.69 L-serine dehydratase
PA5384 9.75 probable lipolytic enzyme
PA5385 7.13 hypothetical protein
PA5391 6.94 hypothetical protein
PA5418 soxA 16.85 sarcosine oxidase alpha subunit
PA5419 soxG 13.89 sarcosine oxidase gamma subunit
PA5431 5.18 probable transcriptional regulator
PA5446 12.35 hypothetical protein
PA5473 6.74 conserved hypothetical protein
PA5510 5.41 probable transporter
PA5522 15.83 probable glutamine synthetase
PA5523 8.59 probable aminotransferase
PA5531 tonB 9.07 TonB protein
PA5546 13.94 conserved hypothetical protein
Genes downregulated in the vqsR mutant in the ABC minimal medium
PA0046 19.50 hypothetical protein
PA0070 5.28 hypothetical protein
PA02633 hcpC 6.33 secreted protein Hcp
PA0281 cysW 10.59 sulfate transport protein CysW
PA0283 sbp 5.59 sulfate-binding protein precursor
PA0284 13.24 hypothetical protein
PA0291 oprE 6.65 outer membrane porin OprE precursor
PA0390 metX 7.23 homoserine O-acetyltransferase
PA0423 7.94 conserved hypothetical protein
PA0456 5.25 probable cold-shock protein
PA0546 metK 11.54 methionine adenosyltransferase
PA0547 10.05 probable transcriptional regulator
PA0548 tktA 12.98 transketolase
PA0552 pgk 14.96 phosphoglycerate kinase
PA0579 rpsU 18.19 30S ribosomal protein S21
PA0594 surA 5.30 peptidyl-prolyl cis-trans isomerase SurA
PA0595 ostA 7.34 organic solvent tolerance protein OstA precursor
PA0654 speD 6.40 S-adenosylmethionine decarboxylase proenzyme
PA0668 tyrZ 7.61 tyrosyl-tRNA synthetase 2
PA0751 14.96 conserved hypothetical protein
PA0752 16.98 conserved hypothetical protein
PA0753 15.94 hypothetical protein
PA0754 12.71 hypothetical protein
PA0755 19.18 probable porin
PA0779 6.52 probable ATP-dependent protease
PA0837 slyD 5.29 peptidyl-prolyl cis-trans isomerase SlyD
PA0856 8.31 hypothetical protein
PA0857 bolA 5.06 morphogene protein BolA
PA0904 lysC 9.67 aspartate kinase alpha and beta chain
PA0956 proS 6.90 prolyl-tRNA synthetase
PA0963 aspS 8.89 aspartyl-tRNA synthetase
PA0964 5.50 conserved hypothetical protein
PA0973 oprL 7.92 outer membrane protein OprL precursor
PA0974 6.57 conserved hypothetical protein
PA09963 pqsA 15.70 probable coenzyme A ligase
PA09973 pqsB 23.17 hypothetical protein
PA09983 pqsC 55.21 hypothetical protein
PA09993 pqsD 12.18 3-oxoacyl-[acyl-carrier-protein] synthase III
PA10003 pqsE 11.98 hypothetical protein
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PA10013 phnA 15.77 anthranilate synthase component I
PA10023 phnB 10.96 anthranilate synthase component II
PA1010 dapA 5.80 dihydrodipicolinate synthase
PA1011 6.17 hypothetical protein
PA1013 purC 5.87 phosphoribosylaminoimidazole-succinocarboxamide synthase
PA1155 nrdB 6.99 ribonucleoside reductase, small chain
PA1159 18.80 probable cold-shock protein
PA1170 7.51 conserved hypothetical protein
PA12503 aprI 8.58 alkaline proteinase inhibitor AprI
PA14313 rsaL 17.17 regulatory protein RsaL
PA1481 ccmG 6.62 cytochrome C biogenesis protein CcmG
PA1552 9.73 probable cytochrome c
PA1553 11.75 probable cytochrome c oxidase subunit
PA1554 10.66 probable cytochrome oxidase subunit (cbb3-type)
PA1574 14.98 conserved hypothetical protein
PA1581 sdhC 8.47 succinate dehydrogenase (C subunit)
PA1582 sdhD 8.88 succinate dehydrogenase (D subunit)
PA1583 sdhA 21.89 succinate dehydrogenase (A subunit)
PA1584 sdhB 10.96 succinate dehydrogenase (B subunit)
PA1585 sucA 6.33 2-oxoglutarate dehydrogenase (E1 subunit)
PA1586 sucB 6.61 dihydrolipoamide succinyltransferase (E2 subunit)
PA1587 lpdG 6.07 lipoamide dehydrogenase-glc
PA1588 sucC 15.31 succinyl-CoA synthetase beta chain
PA1589 sucD 12.71 succinyl-CoA synthetase alpha chain
PA1596 hptG 10.37 heat shock protein HtpG
PA1609 fabB 5.25 beta-ketoacyl-ACP synthase I
PA1610 fabA 7.53 beta-hydroxydecanoyl-ACP dehydrase
PA16573 24.31 conserved hypothetical protein
PA16583 18.65 conserved hypothetical protein
PA16593 5.63 hypothetical protein
PA16643 5.88 hypothetical protein
PA1674 folE2 6.59 GTP cyclohydrolase I precursor
PA1750 9.63 phospho-2-dehydro-3-deoxyheptonate aldolase
PA1776 5.79 probable sigma-70 factor, ECF subfamily
PA1787 acnB 11.38 aconitate hydratase 2
PA1800 tig 28.46 trigger factor
PA1812 mltD 7.23 membrane-bound lytic murein transglycosylase D precursor
PA1837 8.47 hypothetical protein
PA1838 cysI 6.41 sulfite reductase
PA1969 5.99 hypothetical protein
PA21933 hcnA 13.66 hydrogen cyanide synthase HcnA
PA2204 19.18 probable binding protein component of ABC transporter
PA2441 18.86 hypothetical protein
PA2619 infA 8.90 initiation factor
PA2629 purB 23.91 adenylosuccinate lyase
PA2740 pheS 5.37 phenylalanyl-tRNA synthetase, alpha-subunit
PA2741 rplT 5.31 50S ribosomal protein L20
PA2742 rpmI 5.22 50S ribosomal protein L35
PA2760 9.26 probable outer membrane protein precursor
PA2800 5.23 conserved hypothetical protein
PA2851 efp 23.23 translation elongation factor P
PA2950 10.45 hypothetical protein
PA2951 etfA 6.40 electron transfer flavoprotein alpha-subunit
PA2966 acpP 5.87 acyl carrier protein
PA2967 fabG 6.83 3-oxoacyl-[acyl-carrier-protein] reductase
PA2968 fabD 5.45 malonyl-CoA-[acyl-carrier-protein] transacylase
PA2970 rpmF 24.06 50S ribosomal protein L32
PA2971 13.20 conserved hypothetical protein
PA2993 8.34 conserved hypothetical protein
PA3000 aroP1 13.62 aromatic amino acid transport protein AroP1
PA3001 11.18 probable glyceraldehyde-3-phosphate dehydrogenase
PA3019 9.32 probable ATP-binding component of ABC transporter
PA3126 lbpA 13.09 heat-shock protein IbpA
PA3162 rpsA 13.76 30S ribosomal protein S1
PA3262 12.65 probable peptidyl-prolyl cis-trans isomerase, FkbP-type
PA3313 6.04 hypothetical protein
PA33263 6.00 probable Clp-family ATP-dependent protease
PA33293 8.09 hypothetical protein
PA33303 9.89 probable short chain dehydrogenase
PA33313 5.40 cytochrome P450
PA33323 6.17 conserved hypothetical protein
PA33343 7.58 probable acyl carrier protein
PA3397 für 64.55 ferredoxin--NADP+ reductase
PA3441 29.77 probable molybdopterin-binding protein
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PA3480 5.39 probable deoxycytidine triphosphate deaminase
PA3525 argG 20.15 argininosuccinate synthase
PA3529 5.52 probable peroxidase
PA3537 argF 5.52 ornithine carbamoyltransferase, anabolic
PA3621 fdxA 6.17 ferredoxin I
PA3635 eno 12.68 enolase
PA3645 fabZ 5.84 (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase
PA3646 lpxD 5.30 UDP-3-O-[3-hydroxylauroyl] glucosamine N-acyltransferase
PA3647 5.47 probable outer membrane protein precursor
PA3648 6.96 probable outer membrane protein precursor
PA3653 frr 7.55 ribosome recycling factor
PA3655 tsf 14.79 elongation factor Ts
PA3656 rpsB 16.10 30S ribosomal protein S2
PA3686 adk 11.21 adenylate kinase
PA3700 lysS 9.61 lysyl-tRNA synthetase
PA3742 rplS 14.01 50S ribosomal protein L19
PA3743 trmD 20.14 tRNA (guanine-N1)-methyltransferase
PA3744 rimM 19.92 16S rRNA processing protein
PA3745 rpsP 40.89 30S ribosomal protein S16
PA3746 ffh 17.95 signal recognition particle protein Ffh
PA3770 guaB 7.81 inosine-5'-monophosphate dehydrogenase
PA3801 6.20 conserved hypothetical protein
PA3803 gcpE 5.74 probable isoprenoid biosynthetic protein GcpE
PA3806 5.69 conserved hypothetical protein
PA3807 12.40 nucleoside diphosphate kinase
PA3820 secF 6.97 secretion protein SecF
PA3821 secD 5.21 secretion protein SecD
PA3822 9.43 conserved hypothetical protein
PA3827 5.81 conserved hypothetical protein
PA3834 valS 7.90 valyl-tRNA synthetase
PA3861 rhlB 5.48 ATP-dependent RNA helicase RhlB
PA39043 24.94 hypothetical protein
PA39053 18.37 hypothetical protein
PA39063 6.00 hypothetical protein
PA39073 5.87 hypothetical protein
PA39083 6.09 hypothetical protein
PA3931 7.57 conserved hypothetical protein
PA3940 9.35 probable DNA binding protein
PA3992 8.29 hypothetical protein
PA4031 ppa 26.46 inorganic pyrophosphatase
PA41293 5.89 hypothetical protein
PA41313 8.49 probable iron-sulfur protein
PA41333 8.45 cytochrome c oxidase subunit (cbb3-type)
PA41343 9.65 hypothetical protein
PA41393 78.04 hypothetical protein
PA4140 16.50 hypothetical protein
PA41413 22.36 hypothetical protein
PA4237 rplQ 8.26 50S ribosomal protein L17
PA4238 rpoA 16.61 DNA-directed RNA polymerase alpha chain
PA4239 rpsD 22.65 30S ribosomal protein S4
PA4240 rpsK 19.46 30S ribosomal protein S11
PA4241 rpsM 27.92 30S ribosomal protein S13
PA42423 rpmJ 21.92 50S ribosomal protein L36
PA42433 secY 15.54 secretion protein SecY
PA4244 rplO 28.66 50S ribosomal protein L15
PA4245 rpmD 39.48 50S ribosomal protein L30
PA4246 rpsE 35.21 30S ribosomal protein S5
PA4247 rplR 22.19 50S ribosomal protein L18
PA4248 rplF 20.89 50S ribosomal protein L6
PA4249 rpsH 14.57 30S ribosomal protein S8
PA4250 rpsN 11.22 30S ribosomal protein S14
PA4251 rplE 9.33 50S ribosomal protein L5
PA4252 rplX 19.18 50S ribosomal protein L24
PA4253 rplN 13.10 50S ribosomal protein L14
PA4254 rpsQ 26.99 30S ribosomal protein S17
PA4255 rpmC 27.32 50S ribosomal protein L29
PA4256 rplP 19.82 50S ribosomal protein L16
PA4257 rpsC 22.08 30S ribosomal protein S3
PA4258 rplV 19.46 50S ribosomal protein L22
PA4259 rpsS 15.91 30S ribosomal protein S19
PA4260 rplB 12.55 50S ribosomal protein L2
PA4261 rplW 43.24 50S ribosomal protein L23
PA4262 rplD 30.54 50S ribosomal protein L4
PA4263 rplC 17.52 50S ribosomal protein L3
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PA4264 rpsJ 16.56 30S ribosomal protein S10
PA4265 tufA 10.78 elongation factor Tu
PA4266 fusA1 17.17 elongation factor G
PA4267 rpsG 10.58 30S ribosomal protein S7
PA4268 rpsL 24.02 30S ribosomal protein S12
PA4269 rpoC 8.16 DNA-directed RNA polymerase beta* chain
PA4270 rpoB 11.02 DNA-directed RNA polymerase beta chain
PA4271 rplL 15.19 50S ribosomal protein L7 / L12
PA4272 rplJ 33.78 50S ribosomal protein L10
PA4273 rplA 22.87 50S ribosomal protein L1
PA4274 rplK 24.31 50S ribosomal protein L11
PA4275 nusG 6.57 transcription antitermination protein NusG
PA4276 secE 9.85 secretion protein SecE
PA4385 groEL 26.65 GroEL protein
PA4386 groES 19.39 GroES protein
PA4429 14.57 probable cytochrome c1 precursor
PA4430 10.04 probable cytochrome b
PA4431 9.07 probable iron-sulfur protein
PA4432 rpsI 33.79 30S ribosomal protein S9
PA4433 rplM 46.85 50S ribosomal protein L13
PA4442 cysN 13.73 ATP sulfurylase GTP-binding subunit/APS kinase
PA4443 cysD 13.91 ATP sulfurylase small subunit
PA4449 hisG 5.11 ATP-phosphoribosyltransferase
PA4450 murA 6.28 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
PA4451 11.00 conserved hypothetical protein
PA4481 mreB 7.23 rod shape-determining protein MreB
PA4482 gatC 12.40 Glu-tRNA(Gln) amidotransferase subunit C
PA4563 rpsT 35.87 30S ribosomal protein S20
PA4567 rpmA 6.13 50S ribosomal protein L27
PA4568 rplU 13.44 50S ribosomal protein L21
PA4569 ispB 5.62 octaprenyl-diphosphate synthase
PA4572 flkB 5.38 peptidyl-prolyl cis-trans isomerase FklB
PA4602 glyA3 12.07 serine hydroxymethyltransferase
PA4670 prs 8.10 ribose-phosphate pyrophosphokinase
PA4671 18.59 probable ribosomal protein L25
PA4672 5.22 peptidyl-tRNA hydrolase
PA4694 ilvC 17.54 ketol-acid reductoisomerase
PA4695 ilvH 11.86 acetolactate synthase isozyme III small subunit
PA4696 ilvI 6.21 acetolactate synthase large subunit
PA4723 dksA 7.88 suppressor protein DksA
PA4740 pnp 9.86 polyribonucleotide nucleotidyltransferase
PA4741 rpsO 17.80 30S ribosomal protein S15
PA4744 infB 6.74 translation initiation factor IF-2
PA4746 5.32 conserved hypothetical protein
PA4747 secG 7.84 secretion protein SecG
PA4748 tpiA 10.84 triosephosphate isomerase
PA4761 dnaK 6.01 DnaK protein
PA4762 grpE 8.36 heat shock protein GrpE
PA4765 omlA 7.37 outer membrane lipoprotein OmlA
PA4768 smpB 18.40 SmpB protein
PA4846 aroQ1 6.06 3-dehydroquinate dehydratase
PA4847 arccB 9.29 biotin carboxyl carrier protein (BCCP)
PA4848 accC 7.96 biotin carboxylase
PA4932 rplI 7.97 50S ribosomal protein L9
PA4933 29.71 hypothetical protein
PA4934 rpsR 24.37 30S ribosomal protein S18
PA4935 rpsF 37.87 30S ribosomal protein S6
PA4938 purA 6.17 adenylosuccinate synthetase
PA5046 8.90 malic enzyme
PA5049 rpmE 9.72 50S ribosomal protein L31
PA5053 hslV 6.30 heat shock protein HslV
PA5054 hslU 10.85 heat shock protein HslU
PA5076 12.81 probable binding protein component of ABC transporter
PA5117 typA 6.13 regulatory protein TypA
PA5119 glnA 6.13 glutamine synthetase
PA5128 secB 10.76 secretion protein SecB
PA5129 grx 9.40 glutaredoxin
PA5130 5.48 conserved hypothetical protein
PA5192 pckA 8.04 phosphoenolpyruvate carboxykinase
PA5300 cycB 7.59 cytochrome c5
PA5315 rpmG 10.77 50S ribosomal protein L33
PA5316 rpmB 42.33 50S ribosomal protein L28
PA5339 7.51 conserved hypothetical protein
PA5468 15.29 probable citrate transporter
Appendices
198
ORF1 Gene
name
Fold
change2
Protein description
Genes downregulated in the vqsR mutant in the ABC minimal medium
PA5469 11.81 conserved hypothetical protein
PA5479 gltP 5.66 proton-glutamate symporter
PA5490 cc4 6.28 cytochrome c4 precursor
PA5491 7.42 probable cytochrome
PA5505 8.95 probable TonB-dependent receptor
PA5553 atpC 7.47 ATP synthase epsilon chain
PA5554 atpD 18.09 ATP synthase beta chain
PA5555 atpG 34.95 ATP synthase gamma chain
PA5556 atpA 23.67 ATP synthase alpha chain
PA5557 atpH 38.17 ATP synthase delta chain
PA5558 atpF 20.27 ATP synthase B chain
PA5559 atpE 25.74 atp synthase C chain
PA5560 atpB 11.81 ATP synthase A chain
PA5569 rnpA 16.72 ribonuclease P protein component
PA5570 rpmH 34.85 50S ribosomal protein L34
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com). 
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. Only genes
with 5-fold and higher differential expression are shown. 
3 Quorum sensing regulated genes (Hentzer et al., 2003; Schuster et al., 2003; Wagner et al., 2003). 
Appendix III
Differential transcription profile of the icsF mutant grown in the presence of PMNs. 
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PA0236 2.8 probable transcriptional regulator
PA0237 4.5 probable oxidoreductase
PA03403 3.3 conserved hypothetical protein
PA05223 4.8 hypothetical protein
PA06143 3.6 hypothetical protein
PA0813 3.4 hypothetical protein
PA1127 3.7 probable oxidoreductase
PA1145 3.3 probable transcriptional regulator
PA1214 4.2 hypothetical protein
PA13213 cyoE 4.4 cytochrome o ubiquinol oxidase protein CyoE
PA1435 3.3 probable RND efflux membrane fusion protein precursor
PA1467 4.0 hypothetical protein
PA1697 4.9 ATP synthase in type III secretion system
PA1723 pscJ 3.6 type III export protein PscJ
PA1910 3.4 probable tonB-dependent receptor protein
PA1911 2.8 probable transmembrane sensor
PA1928 rimJ 3.2 ribosomal protein alanine acetyltransferase
PA1952 4.7 hypothetical protein
PA19703 8.7 hypothetical protein
PA19843 4.5 probable aldehyde dehydrogenase
PA2022 5.5 probable nucleotide sugar dehydrogenase
PA2089 3.3 hypothetical protein
PA2169 3.3 hypothetical protein
PA2278 arsB 3.2 ArsB protein
PA2344 mtlZ 3.1 fructokinase
PA23853 pvdQ 3.1 probable acylase
PA2390 3.0 probable ATP-binding/permease fusion ABC transporter
PA23943 pvdN 3.1 probable aminotransferase
PA24863 3.1 hypothetical protein
PA2488 3.8 probable transcriptional regulator
PA2506 3.5 hypothetical protein
PA2534 3.6 probable transcriptional regulator
PA27363 3.7 hypothetical protein
PA2759 9.4 hypothetical protein
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Genes upregulated in the icsF mutant grown in the presence of PMNs
PA32293 9.5 hypothetical protein
PA3293 8.3 hypothetical protein
PA3318 6.1 hypothetical protein
PA3384 phnC 3.3 ATP-binding component of ABC phosphonate transporter
PA3492 3.0 conserved hypothetical protein
PA3690 13.7 probable metal-transporting P-type ATPase
PA3774 2.9 probable acetylpolyamine aminohydrolase
PA38143 iscS 3.9 L-cysteine desulfurase (pyridoxal phosphate-dependent)
PA3815 4.9 conserved hypothetical protein
PA38883 5.0 probable permease of ABC transporter
PA38893 3.1 probable binding protein component of ABC transporter
PA4160 fepD 3.4 ferric enterobactin transport protein FepD
PA4208 opmD 4.5 probable outer membrane protein precursor
PA43233 2.8 hypothetical protein
PA4355 3.4 probable MFS transporter
PA43563 xenB 4.8 xenobiotic reductase
PA46233 14.9 hypothetical protein
PA4774 3.9 hypothetical protein
PA4783 5.4 conserved hypothetical protein
PA48813 9.9 hypothetical protein
PA48883 3.4 conserved hypothetical protein
PA5072 43.3 probable chemotaxis transducer
PA54073 3.6 hypothetical protein
Genes downregulated in the icsF mutant grown in the presence of PMNs
PA01223 2.9 conserved hypothetical protein
PA0527 dnr 6.7 transcriptional regulator Dnr
PA05873 2.8 conserved hypothetical protein
PA0761 nadB 3.9 L-aspartate oxidase
PA0820 2.9 hypothetical protein
PA09813 18.7 hypothetical protein
PA1159 4.8 probable cold-shock protein
PA11773 napE 3.5 periplasmic nitrate reductase protein NapE
PA1178 oprH 14.4 outer membrane protein H1 precursor
PA1179 phoP 6.2 two-component response regulator PhoP
PA1196 4.0 probable transcriptional regulator
PA1343 3.9 hypothetical protein
PA13443 10.8 probable short-chain dehydrogenase
PA15573 3.8 probable cytochrome oxidase subunit (cbb3-type)
PA16043 3.3 hypothetical protein
PA1617 3.3 probable AMP-binding enzyme
PA16573 3.1 conserved hypothetical protein
PA16643 4.2 hypothetical protein
PA1769 3.0 conserved hypothetical protein
PA17893 3.8 hypothetical protein
PA42113 phzB1 2.9 probable phenazine biosynthesis protein
PA19143 4.7 conserved hypothetical protein
PA21463 3.8 conserved hypothetical protein
PA21933 hcnA 3.1 hydrogen cyanide synthase HcnA
PA23813 2.8 hypothetical protein
PA26223 cspD 4.7 cold-shock protein CspD
PA32783 3.5 hypothetical protein
PA33613 lecB 2.8 hypothetical protein
PA34513 3.7 hypothetical protein
PA34793 rhlA 4.9 rhamnosyltransferase chain A
PA35203 4.0 hypothetical protein
PA36003 6.4 conserved hypothetical protein
PA36013 8.0 conserved hypothetical protein
PA36153 3.1 hypothetical protein
PA37243 lasB 4.2 elastase LasB
PA38753 narG 3.3 respiratory nitrate reductase alpha chain
PA41333 3.1 cytochrome c oxidase subunit (cbb3-type)
PA41343 6.3 hypothetical protein
PA4139 6.2 hypothetical protein
PA41413 4.4 hypothetical protein
PA42213 ftpA 2.9 Fe(III)-pyochelin receptor precursor
PA42263 pchE 2.8 dihydroaeruginoic acid synthetase
PA42303 pchB 3.5 salicylate biosynthesis protein PchB
PA42963 2.7 probable two-component response regulator
PA43063 3.9 hypothetical protein
PA43593 3.6 conserved hypothetical protein
PA43773 3.0 hypothetical protein
PA46113 3.0 hypothetical protein
PA46483 3.9 hypothetical protein
PA51703 arcD 3.3 arginine/ornithine antiporter
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Protein description
Genes downregulated in the icsF mutant grown in the presence of PMNs
PA54363 2.8 probable biotin carboxylase subunit of a transcarboxylase
PA54823 3.7 hypothetical protein
PA5501 znuB 2.9 permease of ABC zinc transporter ZnuB
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com). 
2 Numbers represent the arithmetic average of four independent GeneChip comparisons.  
3 Oxidative stress response genes. 
Appendix IV
Differential transcription profile of the icsF mutant grown in the presence of H2O2. 
ORF1 Gene
name
Fold
change2
Protein description
Genes upregulated in the icsF mutant grown in the presence of H2O2 
PA00073 25.4 hypothetical protein
PA00253 aroE 3.5 shikimate dehydrogenase
PA00273 3.2 hypothetical protein
PA00283 2.5 hypothetical protein
PA00503 5.7 hypothetical protein
PA00523 11.4 hypothetical protein
PA01053 coxB 10.5 cytochrome c oxidase, subunit II
PA01063 coxA 5.7 cytochrome c oxidase, subunit I
PA01073 7.2 conserved hypothetical protein
PA01083 collI 8.4 cytochrome c oxidase, subunit III
PA01093 11.4 hypothetical protein
PA01223 27.6 conserved hypothetical protein
PA01413 7.1 conserved hypothetical protein
PA01433 3.0 probable nucleoside hydrolase
PA01443 7.6 hypothetical protein
PA01733 38.3 probable methylesterase
PA01753 12.7 probable chemotaxis protein methyltransferase
PA01763 31.2 probable chemotaxis transducer
PA01773 14.3 probable purine-binding chemotaxis protein
PA01783 19.9 probable two-component sensor
PA01793 28.2 probable two-component response regulator
PA01803 6.0 probable chemotaxis transducer
PA01953 pntA 3.4 still frameshift pyridine nucleotide transhydrog. alpha subunit
PA02003 2.7 hypothetical protein
PA0209 4.1 conserved hypothetical protein
PA0210 mdcC 4.4 malonate decarboxylase delta subunit
PA02133 10.6 hypothetical protein
PA02693 2.8 conserved hypothetical protein
PA02703 4.1 hypothetical protein
PA02713 3.0 hypothetical protein
PA0387 2.7 conserved hypothetical protein
PA0413 2.7 still frameshift prob. component of chemotact. signal transd. syst.
PA0427 oprM 2.9 outer membrane protein OprM precursor
PA04413 dht 16.8 dihydropyrimidinase
PA0443 22.3 probable transporter
PA04443 9.9 N-carbamoyl-beta-alanine amidohydrolase
PA04463 3.8 conserved hypothetical protein
PA04473 gcdH 7.2 glutaryl-CoA dehydrogenase
PA0451 6.3 conserved hypothetical protein
PA04593 21.2 probable ClpA/B protease ATP binding subunit
PA04603 10.2 hypothetical protein
PA0468 3.6 hypothetical protein
PA04843 5.8 conserved hypothetical protein
PA04923 4.5 conserved hypothetical protein
PA05053 3.3 hypothetical protein
PA05093 nirN 67.8 probable c-type cytochrome
PA05103 414.9 probable uroporphyrin-III c-methyltransferase
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PA05113 nirJ 78.4 heme d1 biosynthesis protein NirJ
PA05123 111.0 conserved hypothetical protein
PA05133 138.1 probable transcriptional regulator
PA05143 nirL 224.0 heme d1 biosynthesis protein NirL
PA05153 1153.9 probable transcriptional regulator
PA05163 nirF 132.8 heme d1 biosynthesis protein NirF
PA05173 nirC 198.9 probable c-type cytochrome precursor
PA05183 nirM 148.6 cytochrome c-551 precursor
PA05193 nirS 45.5 nitrite reductase precursor
PA05203 nirQ 33.1 regulatory protein NirQ
PA05213 28.7 probable cytochrome c oxidase subunit
PA05223 10.6 hypothetical protein
PA05233 norC 175.4 nitric-oxide reductase subunit C
PA05243 norB 342.3 nitric-oxide reductase subunit B
PA05253 116.3 probable dinitrification protein NorD
PA05263 7.9 hypothetical protein
PA0534 27.2 conserved hypothetical protein
PA05433 2.9 hypothetical protein
PA05673 6.9 conserved hypothetical protein
PA05853 7.3 hypothetical protein
PA05863 38.6 conserved hypothetical protein
PA05873 22.4 conserved hypothetical protein
PA05883 16.8 conserved hypothetical protein
PA07043 4.6 probable amidase
PA07093 3.4 hypothetical protein
PA0710 gloA2 4.8 lactoylglutathione lyase
PA07133 8.7 hypothetical protein
PA0714 14.7 hypothetical protein
PA07373 3.3 hypothetical protein
PA07433 14.7 probable 3-hydroxyisobutyrate dehydrogenase
PA07633 mucA 3.3 anti-sigma factor MucA
PA07883 8.8 hypothetical protein
PA0792 prpD 3.0 propionate catabolic protein PrpD
PA0798 pmtA 4.2 probable methyltransferase
PA08033 3.7 hypothetical protein
PA08103 2.8 probable haloacid dehalogenase
PA08353 8.4 phosphate acetyltransferase
PA08363 3.5 probable acetate kinase
PA08403 4.1 probable oxidoreductase
PA08523 cpbD 4.6 chitin-binding protein CbpD precursor
PA08533 2.5 probable oxidoreductase
PA08543 3.4 fumarate hydratase
PA08613 5.7 hypothetical protein
PA0865 hpd 2.5 4-hydroxyphenylpyruvate dioxygenase
PA0870 phhC 3.1 aromatic amino acid aminotransferase
PA08723 phhA 2.6 phenylalanine-4-hydroxylase
PA09183 7.3 cytochrome b561
PA10033 3.0 probable transcriptional regulator
PA1016 2.8 hypothetical protein
PA10413 11.7 probable outer membrane protein precursor
PA1061 2.5 conserved hypothetical protein
PA1062 2.7 hypothetical protein
PA10653 5.7 conserved hypothetical protein
PA10773 flgB 4.6 flagellar basal-body rod protein FlgB
PA10783 flgC 4.6 flagellar basal-body rod protein FlgC
PA1079 flgD 4.6 flagellar basal-body rod modification protein FlgD
PA10803 flgE 4.7 flagellar hook protein FlgE
PA10823 flgG 4.2 flagellar basal-body rod protein FlgG
PA10833 flgH 3.7 flagellar L-ring protein precursor FlgH
PA10853 flgJ 3.0 flagellar protein FlgJ
PA10873 flgL 4.2 flagellar hook-associated protein type 3 FlgL
PA10883 4.5 hypothetical protein
PA10893 3.7 conserved hypothetical protein
PA1091 2.9 hypothetical protein
PA10923 fliC 5.2 flagellin type B
PA10933 13.8 hypothetical protein
PA10943 fliD 5.1 flagellar capping protein FliD
PA10953 4.2 hypothetical protein
PA10963 5.4 hypothetical protein
PA10983 fleS 2.9 two-component sensor
PA11003 fliE 3.3 flagellar hook-basal body complex protein FliE
PA11143 2.9 hypothetical protein
PA11183 3.6 hypothetical protein
PA11213 3.5 conserved hypothetical protein
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PA11233 13.0 hypothetical protein
PA11313 4.0 probable MFS transporter
PA1137 4.0 probable oxidoreductase
PA11663 4.7 hypothetical protein
PA11723 napC 20.1 cytochrome c-type protein NapC
PA11733 napB 16.5 cytochrome c-type protein NapB precursor
PA11743 napA 23.1 periplasmic nitrate reductase protein NapA
PA11753 napD 13.4 NapD protein of periplasmic nitrate reductase
PA11763 napF 23.6 ferredoxin protein NapF
PA11773 napE 22.8 periplasmic nitrate reductase protein NapE
PA1246 aprD 4.6 alkaline protease secretion protein AprD
PA1247 aprE 4.1 alkaline protease secretion protein AprE
PA12893 12.3 hypothetical protein
PA13243 3.4 hypothetical protein
PA13273 4.4 probable protease
PA1333 2.8 hypothetical protein
PA13483 3.6 hypothetical protein
PA13493 3.2 conserved hypothetical protein
PA14143 5.3 hypothetical protein
PA14153 3.1 hypothetical protein
PA14293 3.8 probable cation-transporting P-type ATPase
PA14313 rsaL 4.4 regulatory protein RsaL
PA1441 4.5 hypothetical protein
PA14533 flhF 3.3 flagellar biosynthesis protein FlhF
PA14573 cheZ 4.0 chemotaxis protein CheZ
PA14583 3.3 probable two-component sensor
PA14593 5.7 probable methyltransferase
PA14603 3.6 probable chemotaxis transmembrane proton channel
PA1463 4.0 hypothetical protein
PA14643 4.0 probable purine-binding chemotaxis protein
PA14653 3.9 hypothetical protein
PA14703 3.6 probable short-chain dehydrogenase
PA1471 2.6 hypothetical protein
PA14733 4.3 hypothetical protein
PA14743 3.5 hypothetical protein
PA15213 2.7 probable guanine deaminase
PA15223 4.2 hypothetical protein
PA15233 xdhB 7.4 xanthine dehydrogenase
PA1540 5.1 conserved hypothetical protein
PA1541 7.7 probable drug efflux transporter
PA15453 5.1 hypothetical protein
PA1547 2.6 hypothetical protein
PA1549 3.7 probable cation-transporting P-type ATPase
PA15503 3.2 hypothetical protein
PA15513 3.2 probable ferredoxin
PA15553 10.9 probable cytochrome c
PA15563 7.0 probable cytochrome c oxidase subunit
PA15613 aer 8.6 aerotaxis receptor Aer
PA15623 acnA 6.8 aconitate hydratase 1
PA1601 3.3 probable aldehyde dehydrogenase
PA16413 3.6 hypothetical protein
PA16563 5.0 hypothetical protein
PA16793 6.0 hypothetical protein
PA17283 7.9 hypothetical protein
PA1729 3.4 conserved hypothetical protein
PA17313 3.7 conserved hypothetical protein
PA17323 9.9 conserved hypothetical protein
PA17333 4.8 conserved hypothetical protein
PA17453 6.6 hypothetical protein
PA17463 10.4 hypothetical protein
PA17533 5.5 conserved hypothetical protein
PA17603 3.3 probable transcriptional regulator
PA17613 4.0 hypothetical protein
PA17843 13.0 hypothetical protein
PA17893 3.5 hypothetical protein
PA1828 2.6 probable short-chain dehydrogenase
PA18333 2.6 probable oxidoreductase
PA18603 7.9 hypothetical protein
PA1869 2.6 probable acyl carrier protein
PA18713 lasA 12.5 LasA protease precursor
PA18803 4.5 probable oxidoreductase
PA18813 6.2 probable oxidoreductase
PA42113 phzB2 3.5 probable phenazine biosynthesis protein
PA19013 phzC 27.7 phenazine biosynthesis protein PhzC
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PA1905 phzG2 3.2 probable pyridoxamine 5'-phosphate oxidase
PA19303 18.2 probable chemotaxis transducer
PA19313 3.8 probable ferredoxin
PA19673 2.8 hypothetical protein
PA2003 bdhA 4.3 3-hydroxybutyrate dehydrogenase
PA2004 2.5 conserved hypothetical protein
PA20073 maiA 13.0 maleylacetoacetate isomerase
PA20083 fahA 8.5 fumarylacetoacetase
PA20093 hmgA 5.4 homogentisate 1,2-dioxygenase
PA2011 2.9 hydroxymethylglutaryl-CoA lyase
PA2013 2.8 probable enoyl-CoA hydratase/isomerase
PA2014 3.8 probable acyl-CoA carboxyltransferase beta chain
PA2015 2.8 probable acyl-CoA dehydrogenase
PA2016 3.8 probable transcriptional regulator
PA2017 2.6 hypothetical protein
PA20243 19.5 probable ring-cleaving dioxygenase
PA20673 3.1 probable hydrolase
PA20713 fusA2 4.9 elongation factor G
PA2075 3.6 hypothetical protein
PA21193 3.6 alcohol dehydrogenase (Zn-dependent)
PA21263 4.0 conserved hypothetical protein
PA21373 8.8 hypothetical protein
PA21463 4.8 conserved hypothetical protein
PA21743 8.6 hypothetical protein
PA21833 12.3 hypothetical protein
PA21903 4.5 conserved hypothetical protein
PA21933 hcnA 4.8 hydrogen cyanide synthase HcnA
PA21943 hcnB 10.6 hydrogen cyanide synthase HcnB
PA21953 hcnC 18.4 hydrogen cyanide synthase HcnC
PA2197 3.3 conserved hypothetical protein
PA22313 3.2 probable glycosyl transferase
PA22473 bkdA1 5.4 2-oxoisovalerate dehydrogenase (alpha subunit)
PA22483 bkdA2 6.7 2-oxoisovalerate dehydrogenase (beta subunit)
PA22493 bkdB 6.1 branched-chain alpha-keto acid dehydrog. (lipoamide comp.)
PA22503 lpdV 5.1 lipoamide dehydrogenase-Val
PA2345 2.4 conserved hypothetical protein
PA23643 4.3 hypothetical protein
PA23653 4.6 conserved hypothetical protein
PA23753 16.6 hypothetical protein
PA23813 6.9 hypothetical protein
PA24143 11.7 L-sorbosone dehydrogenase
PA24233 4.3 hypothetical protein
PA24333 4.0 hypothetical protein
PA25043 7.9 hypothetical protein
PA25503 5.1 probable acyl-CoA dehydrogenase
PA2552 10.8 probable acyl-CoA dehydrogenase
PA2553 19.0 probable acyl-CoA thiolase
PA2554 8.9 probable short-chain dehydrogenase
PA2555 4.3 probable AMP-binding enzyme
PA2561 2.7 probable chemotaxis transducer
PA25623 7.4 hypothetical protein
PA25673 4.0 hypothetical protein
PA25713 17.4 probable two-component sensor
PA25723 10.4 probable two-component response regulator
PA25733 14.4 probable chemotaxis transducer
PA25883 4.1 probable transcriptional regulator
PA25913 3.0 probable transcriptional regulator
PA25923 2.8 probable periplasmic spermidine/putrescine-binding protein
PA26183 5.7 hypothetical protein
PA26333 3.5 hypothetical protein
PA26543 5.0 probable chemotaxis transducer
PA26623 104.1 conserved hypothetical protein
PA26633 35.2 hypothetical protein
PA26643 fhp 22.4 Flavohemoprotein
PA27223 3.2 hypothetical protein
PA27463 16.8 hypothetical protein
PA27533 4.0 hypothetical protein
PA27543 3.7 conserved hypothetical protein
PA2759 3.8 hypothetical protein
PA27713 2.9 conserved hypothetical protein
PA27783 3.7 hypothetical protein
PA27793 9.3 hypothetical protein
PA27883 28.0 probable chemotaxis transducer
PA2790 3.3 hypothetical protein
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PA28143 3.0 hypothetical protein
PA28153 4.1 probable acyl-CoA dehydrogenase
PA2841 3.5 probable enoyl-CoA hydratase/isomerase
PA29203 10.0 probable chemotaxis transducer
PA29373 22.1 hypothetical protein
PA29393 3.8 probable aminopeptidase
PA30173 4.2 conserved hypothetical protein
PA30323 snr1 2.7 cytochrome c Snr1
PA30403 6.3 conserved hypothetical protein
PA30413 9.7 hypothetical protein
PA30423 6.4 hypothetical protein
PA30493 rmf 5.9 ribosome modulation factor
PA30893 9.1 hypothetical protein
PA31033 xcpR 2.8 general secretion pathway protein E
PA31043 xcpP 3.0 secretion protein XcpP
PA3105 xcpQ 2.8 general secretion pathway protein D
PA3119 2.5 conserved hypothetical protein
PA31233 2.4 conserved hypothetical protein
PA3195 gapA 3.5 glyceraldehyde 3-phosphate dehydrogenase
PA32163 3.7 hypothetical protein
PA32253 3.9 probable transcriptional regulator
PA32263 3.8 probable hydrolase
PA32283 2.8 probable ATP-binding/permease fusion ABC transporter
PA32773 3.7 probable short-chain dehydrogenase
PA33073 6.8 hypothetical protein
PA33093 7.1 conserved hypothetical protein
PA33113 23.0 conserved hypothetical protein
PA3325 4.9 conserved hypothetical protein
PA33263 5.2 probable Clp-family ATP-dependent protease
PA33373 rfaD 3.5 ADP-L-glycero-D-mannoheptose 6-epimerase
PA33463 7.4 probable two-component response regulator
PA33473 6.3 hypothetical protein
PA33483 3.8 probable chemotaxis protein methyltransferase
PA33493 4.6 probable chemotaxis protein
PA33513 4.4 hypothetical protein
PA33523 4.5 hypothetical protein
PA3353 2.8 hypothetical protein
PA33543 4.0 hypothetical protein
PA33613 52.4 hypothetical protein
PA33623 5.5 hypothetical protein
PA33633 amiR 6.0 aliphatic amidase regulator
PA33643 amiC 4.2 aliphatic amidase expression-regulating protein
PA3365 4.3 probable chaperone
PA33663 amiE 3.6 aliphatic amidase
PA3369 3.0 hypothetical protein
PA3385 4.3 hypothetical protein
PA33913 nosR 126.8 regulatory protein NosR
PA33923 nosZ 219.9 nitrous-oxide reductase precursor
PA33933 nosD 56.8 NosD protein
PA33943 nosF 54.2 NosF protein
PA33953 nosY 39.0 NosY protein
PA33963 nosL 59.4 NosL protein
PA34153 26.8 probable dihydrolipoamide acetyltransferase
PA34163 70.8 probable pyruvate dehydrogenase E1 component, beta chain
PA34173 22.3 probable pyruvate dehydrogenase E1 component, alpha subunit
PA34183 ldh 39.0 leucine dehydrogenase
PA34273 4.8 probable short-chain dehydrogenases
PA34283 3.1 hypothetical protein
PA3429 3.0 probable epoxide hydrolase
PA34303 8.0 probable aldolase
PA34313 7.1 conserved hypothetical protein
PA34513 4.8 hypothetical protein
PA34613 7.0 conserved hypothetical protein
PA34653 6.2 conserved hypothetical protein
PA34773 rhlR 4.9 transcriptional regulator RhlR
PA34783 rhlB 16.8 rhamnosyltransferase chain B
PA34793 rhlA 20.3 rhamnosyltransferase chain A
PA35203 16.1 hypothetical protein
PA35263 7.0 probable outer membrane protein precursor
PA35723 3.3 hypothetical protein
PA35763 4.8 hypothetical protein
PA3581 glpF 2.6 glycerol uptake facilitator protein
PA35823 glpK 3.6 glycerol kinase
PA35843 glpD 3.5 glycerol-3-phosphate dehydrogenase
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PA36003 10.5 conserved hypothetical protein
PA36133 4.9 hypothetical protein
PA36143 3.0 hypothetical protein
PA3662 3.4 hypothetical protein
PA36883 9.0 hypothetical protein
PA36913 4.5 hypothetical protein
PA36923 2.8 probable outer membrane protein precursor
PA3704 wspE 4.2 probable chemotaxis sensor/effector fusion protein
PA37083 2.4 probable chemotaxis transducer
PA37123 4.1 hypothetical protein
PA37233 16.7 probable FMN oxidoreductase
PA37243 lasB 7.1 elastase LasB
PA37843 3.0 hypothetical protein
PA37853 2.7 conserved hypothetical protein
PA3790 oprC 2.8 outer membrane protein OprC
PA37963 3.0 hypothetical protein
PA38193 3.3 conserved hypothetical protein
PA38443 2.4 hypothetical protein
PA38463 3.5 hypothetical protein
PA38723 narI 12.9 respiratory nitrate reductase gamma chain
PA38733 narJ 15.8 respiratory nitrate reductase delta chain
PA38743 narH 14.1 respiratory nitrate reductase beta chain
PA38753 narG 30.8 respiratory nitrate reductase alpha chain
PA38763 narK2 5.5 nitrite extrusion protein 2
PA38793 narL 2.9 two-component response regulator NarL
PA38803 7.5 conserved hypothetical protein
PA3881 2.9 hypothetical protein
PA39113 11.6 conserved hypothetical protein
PA39123 11.9 conserved hypothetical protein
PA39133 6.1 probable protease
PA39193 2.8 conserved hypothetical protein
PA39213 3.5 probable transcriptional regulator
PA3930 cioA 2.6 cyanide insensitive terminal oxidase
PA39453 15.1 conserved hypothetical protein
PA39573 12.2 probable short-chain dehydrogenase
PA39713 7.7 hypothetical protein
PA39723 12.7 probable acyl-CoA dehydrogenase
PA39733 12.0 probable transcriptional regulator
PA39863 10.2 hypothetical protein
PA40173 3.6 conserved hypothetical protein
PA4027 2.9 hypothetical protein
PA40493 2.7 hypothetical protein
PA4063 3.1 hypothetical protein
PA40673 oprG 3.2 outer membrane protein OprG precursor
PA40783 6.3 probable nonribosomal peptide synthetase
PA41083 4.6 hypothetical protein
PA4111 3.6 hypothetical protein
PA41123 6.3 probable sensor/response regulator hybrid
PA41173 6.9 probable bacteriophytochrome
PA4137 10.6 probable porin
PA41753 prpL 3.9 probable endoproteinase Arg-C precursor
PA4181 3.0 hypothetical protein
PA41963 2.5 probable two-component response regulator
PA42093 3.2 probable O-methyltransferase
PA42933 4.0 probable two-component sensor
PA42943 5.1 hypothetical protein
PA42963 5.8 probable two-component response regulator
PA42993 3.8 hypothetical protein
PA43003 3.3 hypothetical protein
PA43023 3.1 probable type II secretion system protein
PA43033 3.0 hypothetical protein
PA43043 7.4 probable type II secretion system protein
PA43053 5.8 hypothetical protein
PA43063 6.8 hypothetical protein
PA43093 pctA 13.7 chemotactic transducer PctA
PA43103 pctB 3.3 chemotactic transducer PctB
PA43113 9.5 conserved hypothetical protein
PA43263 5.9 hypothetical protein
PA43493 7.5 hypothetical protein
PA4351 3.7 probable acyltransferase
PA43573 5.4 conserved hypothetical protein
PA43583 7.4 probable ferrous iron transport protein
PA43593 5.0 conserved hypothetical protein
PA43623 3.3 hypothetical protein
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PA4364 14.0 hypothetical protein
PA4365 16.1 probable transporter
PA44723 pmbA 4.0 PmbA protein
PA4474 10.4 conserved hypothetical protein
PA4493 2.6 probable two-component response regulator
PA45063 2.4 probable ATP-binding component of ABC dipeptide transporter
PA4520 3.9 probable chemotaxis transducer
PA45233 10.4 hypothetical protein
PA45733 14.8 hypothetical protein
PA45753 2.8 hypothetical protein
PA45773 7.3 hypothetical protein
PA45873 ccpR 9.7 cytochrome c551 peroxidase precursor
PA45963 10.9 probable transcriptional regulator
PA46073 13.1 hypothetical protein
PA46083 5.5 hypothetical protein
PA46103 13.1 hypothetical protein
PA4620 3.5 hypothetical protein
PA4621 2.5 probable oxidoreductase
PA4623 5.9 hypothetical protein
PA46333 11.8 probable chemotaxis transducer
PA46413 6.4 still frameshift hypothetical protein
PA46483 3.6 hypothetical protein
PA46573 5.6 hypothetical protein
PA46773 3.3 hypothetical protein
PA47023 5.6 hypothetical protein
PA47033 8.2 hypothetical protein
PA47133 3.1 hypothetical protein
PA47143 2.9 conserved hypothetical protein
PA47173 2.5 conserved hypothetical protein
PA47383 3.3 conserved hypothetical protein
PA47393 4.6 conserved hypothetical protein
PA47783 4.4 probable transcriptional regulator
PA47813 6.7 probable two-component response regulator
PA4809 fdhE 2.6 FdhE protein
PA48103 fdnI 4.8 nitrate-inducible formate dehydrogenase, gamma subunit
PA48113 fdnH 6.8 nitrate-inducible formate dehydrogenase, beta subunit
PA48123 fdnG 4.6 formate dehydrogenase-O, major subunit
PA4825 mgtA 4.9 Mg(2+) transport ATPase, P-type 2
PA4843 2.6 probable two-component response regulator
PA48763 osmE 3.0 osmotically inducible lipoprotein OsmE
PA4878 3.5 probable transcriptional regulator
PA48803 3.5 probable bacterioferritin
PA49153 15.7 probable chemotaxis transducer
PA49163 7.1 hypothetical protein
PA49173 4.2 hypothetical protein
PA49253 3.6 conserved hypothetical protein
PA49293 7.4 hypothetical protein
PA50203 2.5 probable acyl-CoA dehydrogenase
PA50273 3.4 hypothetical protein
PA5052 2.6 hypothetical protein
PA50563 phaC1 3.1 poly(3-hydroxyalkanoic acid) synthase 1
PA50573 phaD 3.0 poly(3-hydroxyalkanoic acid) depolymerase
PA50583 phaC2 5.2 poly(3-hydroxyalkanoic acid) synthase 2
PA50603 phaF 3.2 polyhydroxyalkanoate synthesis protein PhaF
PA50913 hutG 3.2 N-formylglutamate amidohydrolase
PA51013 5.5 hypothetical protein
PA51703 arcD 4.3 arginine/ornithine antiporter
PA51713 arcA 30.9 arginine deiminase
PA51723 arcB 78.3 ornithine carbamoyltransferase, catabolic
PA51733 arcC 104.6 carbamate kinase
PA52133 gcvP1 2.7 glycine cleavage system protein P1
PA52203 2.4 hypothetical protein
PA52303 13.1 probable permease of ABC transporter
PA52313 4.6 probable ATP-binding/permease fusion ABC transporter
PA5232 3.6 conserved hypothetical protein
PA5242 ppk 3.2 polyphosphate kinase
PA5272 cyaA 2.5 adenylate cyclase
PA53593 9.4 hypothetical protein
PA5374 betI 2.6 transcriptional regulator BetI
PA53953 4.2 conserved hypothetical protein
PA54243 3.8 conserved hypothetical protein
PA54273 adhA 8.9 alcohol dehydrogenase
PA54353 10.5 probable transcarboxylase subunit
PA54363 8.8 probable biotin carboxylase subunit of a transcarboxylase
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PA5446 2.9 hypothetical protein
PA54603 6.9 hypothetical protein
PA54753 5.9 hypothetical protein
PA54823 4.6 hypothetical protein
PA5495 thrB 3.1 homoserine kinase
PA54963 3.6 hypothetical protein
PA54973 3.8 hypothetical protein
PA5498 3.3 probable adhesin
PA54993 np20 6.1 transcriptional regulator np20
PA5500 znuC 3.0 zinc transport protein ZnuC
PA5531 tonB 5.1 TonB protein
Genes downregulated in the icsF mutant grown in the presence of H2O2
PA00463 5.2 hypothetical protein
PA00473 3.6 hypothetical protein
PA00693 4.1 conserved hypothetical protein
PA00703 6.8 hypothetical protein
PA0076 17.2 hypothetical protein
PA0077 3.6 hypothetical protein
PA00783 5.1 hypothetical protein
PA0080 4.6 hypothetical protein
PA00823 3.0 hypothetical protein
PA00833 10.5 conserved hypothetical protein
PA00843 8.1 conserved hypothetical protein
PA00853 10.9 conserved hypothetical protein
PA00873 13.0 hypothetical protein
PA00893 9.9 hypothetical protein
PA00903 4.7 probable ClpA/B-type chaperone
PA0091 3.3 conserved hypothetical protein
PA00933 6.9 hypothetical protein
PA0094 3.9 hypothetical protein
PA0126 4.1 hypothetical protein
PA01403 ahpF 25.7 alkyl hydroperoxide reductase subunit F
PA01653 3.5 hypothetical protein
PA01673 3.8 probable transcriptional regulator
PA01693 15.1 hypothetical protein
PA01703 8.2 hypothetical protein
PA01713 12.6 hypothetical protein
PA01723 2.8 hypothetical protein
PA02013 5.3 hypothetical protein
PA0263 hcpC 4.8 secreted protein Hcp
PA0277 4.9 conserved hypothetical protein
PA02803 cysA 13.7 sulfate transport protein CysA
PA02813 cysW 29.9 sulfate transport protein CysW
PA02823 cysT 9.4 sulfate transport protein CysT
PA02833 sbp 5.5 sulfate-binding protein precursor
PA02843 9.9 hypothetical protein
PA02933 aguA 2.7 probable hydratase
PA0320 2.5 conserved hypothetical protein
PA03413 lgt 3.5 prolipoprotein diacylglyceryl transferase
PA03503 folA 3.2 dihydrofolate reductase
PA03633 coaD 5.0 phosphopantetheine adenylyltransferase
PA03893 2.7 hypothetical protein
PA03903 metX 3.3 homoserine O-acetyltransferase
PA04213 2.8 hypothetical protein
PA0449 2.7 hypothetical protein
PA0456 2.6 probable cold-shock protein
PA0461 2.4 conserved hypothetical protein
PA05383 dsbB 14.2 disulfide bond formation protein
PA05633 5.3 conserved hypothetical protein
PA05793 rpsU 2.9 30S ribosomal protein S21
PA05823 folB 2.4 dihydroneopterin aldolase
PA05933 pdxA 3.7 pyridoxal phosphate biosynthetic protein PdxA
PA05943 surA 3.0 peptidyl-prolyl cis-trans isomerase SurA
PA06033 6.5 probable ATP-binding component of ABC transporter
PA06043 4.9 probable binding protein component of ABC transporter
PA06053 8.1 probable permease of ABC transporter
PA06063 7.5 probable permease of ABC transporter
PA06103 prtN 4.2 transcriptional regulator PrtN
PA06113 prtR 3.6 transcriptional regulator PrtR
PA06123 19.1 hypothetical protein
PA06133 21.9 hypothetical protein
PA06143 15.0 hypothetical protein
PA06153 5.2 hypothetical protein
PA06163 6.8 hypothetical protein
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PA06173 45.0 probable bacteriophage protein
PA06183 6.6 probable bacteriophage protein
PA06193 6.4 probable bacteriophage protein
PA06223 14.0 probable bacteriophage protein
PA06233 7.6 probable bacteriophage protein
PA06243 8.8 hypothetical protein
PA06253 13.8 hypothetical protein
PA06263 6.0 hypothetical protein
PA06273 9.3 conserved hypothetical protein
PA06283 11.9 conserved hypothetical protein
PA06293 12.2 conserved hypothetical protein
PA06303 6.6 hypothetical protein
PA06313 48.3 hypothetical protein
PA06543 sped 7.4 S-adenosylmethionine decarboxylase proenzyme
PA06633 2.6 hypothetical protein
PA06703 3.6 hypothetical protein
PA06713 2.7 hypothetical protein
PA07503 ung 4.8 uracil-DNA glycosylase
PA07823 putA 2.4 proline dehydrogenase PutA
PA07833 putP 3.2 sodium/proline symporter PutP
PA07893 3.5 probable amino acid permease
PA0802 2.7 hypothetical protein
PA08483 17.3 probable alkyl hydroperoxide reductase
PA08493 trxB2 13.2 thioredoxin reductase 2
PA09043 lysC 4.8 aspartate kinase alpha and beta chain
PA09213 2.6 hypothetical protein
PA09223 5.6 hypothetical protein
PA09373 3.0 conserved hypothetical protein
PA09613 5.3 probable cold-shock protein
PA0964 2.6 conserved hypothetical protein
PA09683 3.0 conserved hypothetical protein
PA09693 tolQ 2.4 TolQ protein
PA0970 tolR 2.8 TolR protein
PA09753 4.6 probable radical activating enzyme
PA09763 8.0 conserved hypothetical protein
PA0979 2.5 conserved hypothetical protein
PA0985 88.9 pyocin S5
PA0996 pqsA 2.8 probable coenzyme A ligase
PA10063 3.9 conserved hypothetical protein
PA10093 3.9 hypothetical protein
PA10133 purC 2.6 phosphoribosylaminoimidazole-succinocarboxamide synthase
PA1034 3.7 hypothetical protein
PA1035 3.7 hypothetical protein
PA1159 6.4 probable cold-shock protein
PA11833 dctA 4.5 C4-dicarboxylate transport protein
PA1192 2.6 conserved hypothetical protein
PA12283 17.0 hypothetical protein
PA12713 2.7 probable tonB-dependent receptor
PA12743 3.2 conserved hypothetical protein
PA12753 cobD 2.9 cobalamin biosynthetic protein CobD
PA12763 cobC 3.6 cobalamin biosynthetic protein CobC
PA12773 4.8 cobyric acid synthase
PA12783 cobP 3.0 cobinamide kinase
PA1281 cobV 3.0 cobalamin (5'-phosphate) synthase
PA12883 3.0 probable outer membrane protein precursor
PA12933 2.5 hypothetical protein
PA12953 3.1 conserved hypothetical protein
PA13173 cyoA 3.9 cytochrome o ubiquinol oxidase subunit II
PA13183 cyoB 3.7 cytochrome o ubiquinol oxidase subunit I
PA13193 cyoC 4.3 cytochrome o ubiquinol oxidase subunit III
PA13203 cyoD 6.4 cytochrome o ubiquinol oxidase subunit IV
PA13213 cyoE 2.6 cytochrome o ubiquinol oxidase protein CyoE
PA13773 2.4 conserved hypothetical protein
PA1395 10.4 hypothetical protein
PA14663 11.2 hypothetical protein
PA14933 cysP 5.0 sulfate-binding protein of ABC transporter
PA15043 4.5 probable transcriptional regulator
PA15333 2.6 conserved hypothetical protein
PA15343 recR 2.7 recombination protein RecR
PA15543 2.6 probable cytochrome oxidase subunit (cbb3-type)
PA17193 pscF 3.8 type III export protein PscF
PA17503 3.9 phospho-2-dehydro-3-deoxyheptonate aldolase
PA1756 cysH 2.7 3'-phosphoadenosine-5'-phosphosulfate reductase
PA17573 thrH 3.2 homoserine kinase
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PA17663 2.6 hypothetical protein
PA17673 3.3 hypothetical protein
PA17713 12.7 probable esterase/lipase
PA1790 13.5 hypothetical protein
PA1791 2.6 hypothetical protein
PA17923 2.8 conserved hypothetical protein
PA1793 ppiB 4.2 peptidyl-prolyl cis-trans isomerase B
PA18053 ppiD 2.8 peptidyl-prolyl cis-trans isomerase D
PA18063 fabI 2.8 NADH-dependent enoyl-ACP reductase
PA18113 5.9 probable solute-binding protein
PA18123 mltD 2.7 membrane-bound lytic murein transglycosylase D precursor
PA18373 7.0 hypothetical protein
PA18383 cysI 5.0 sulfite reductase
PA1859 4.7 probable transcriptional regulator
PA19713 braZ 4.2 branched chain amino acid transporter BraZ
PA20233 galU 2.8 UTP--glucose-1-phosphate uridylyltransferase
PA20383 2.5 hypothetical protein
PA20423 2.6 probable transporter (membrane subunit)
PA22043 21.2 probable binding protein component of ABC transporter
PA2230 3.0 hypothetical protein
PA22523 3.1 probable AGCS sodium/alanine/glycine symporter
PA22533 ansA 3.2 L-asparaginase I
PA2279 arsC 3.2 ArsC protein
PA22883 2.9 hypothetical protein
PA2321 2.7 gluconokinase
PA23223 5.0 gluconate permease
PA23273 5.4 probable permease of ABC transporter
PA23283 3.8 hypothetical protein
PA23293 4.3 probable ATP-binding component of ABC transporter
PA23303 2.8 hypothetical protein
PA23313 9.2 hypothetical protein
PA2359 8.0 probable transcriptional regulator
PA23843 2.7 hypothetical protein
PA23853 pvdQ 2.6 probable acylase
PA23863 pvdA 5.8 L-ornithine N5-oxygenase
PA23943 pvdN 2.4 probable aminotransferase
PA24093 5.6 probable permease of ABC transporter
PA24123 13.2 conserved hypothetical protein
PA24413 5.0 hypothetical protein
PA2453 4.3 hypothetical protein
PA2536 2.9 probable phosphatidate cytidylyltransferase
PA2539 9.3 conserved hypothetical protein
PA2542 2.7 conserved hypothetical protein
PA2543 7.1 conserved hypothetical protein
PA25453 xthA 2.9 exodeoxyribonuclease III
PA2579 2.4 hypothetical protein
PA2581 4.1 hypothetical protein
PA2619 infA 2.7 initiation factor
PA26603 2.4 hypothetical protein
PA2667 9.3 conserved hypothetical protein
PA27483 3.3 probable methionine aminopeptidase
PA27573 4.0 hypothetical protein
PA27603 4.4 probable outer membrane protein precursor
PA2800 3.6 conserved hypothetical protein
PA28283 3.1 probable aminotransferase
PA28433 3.1 probable aldolase
PA28503 ohr 3.5 organic hydroperoxide resistance protein
PA28513 efp 4.1 translation elongation factor P
PA28763 pyrF 2.8 orotidine 5'-phosphate decarboxylase
PA2905 cobH 2.6 precorrin isomerase CobH
PA29113 11.4 probable TonB-dependent receptor
PA2929 4.5 hypothetical protein
PA29503 3.8 hypothetical protein
PA2953 2.5 electron transfer flavoprotein-ubiquinone oxidoreductase
PA2957 3.5 probable transcriptional regulator
PA2966 acpP 3.1 acyl carrier protein
PA29703 rpmF 2.5 50S ribosomal protein L32
PA2983 2.4 probable tolQ-type transport protein
PA29863 3.0 conserved hypothetical protein
PA29943 nqrF 2.8 Na+-translocating NADH:quinone oxidoreductase, subunit Nqr6
PA30073 lexA 5.7 repressor protein LexA
PA30083 4.2 hypothetical protein
PA30463 2.4 conserved hypothetical protein
PA31343 gltX 2.5 glutamyl-tRNA synthetase
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PA3181 3.2 2-keto-3-deoxy-6-phosphogluconate aldolase
PA32373 67.1 hypothetical protein
PA32433 minC 4.7 cell division inhibitor MinC
PA32453 mine 4.5 cell division topological specificity factor MinE
PA32623 3.6 probable peptidyl-prolyl cis-trans isomerase, FkbP-type
PA32633 3.4 conserved hypothetical protein
PA32663 capB 3.1 cold acclimation protein B
PA32683 2.8 probable TonB-dependent  receptor
PA32803 oprO 18.6 outer membrane porin OprO precursor
PA32843 4.3 hypothetical protein
PA32873 11.2 conserved hypothetical protein
PA32953 3.2 probable HIT family protein
PA33133 3.3 hypothetical protein
PA33973 fpr 2.9 ferredoxin--NADP+ reductase
PA3402 3.9 hypothetical protein
PA3410 6.0 probable sigma-70 factor, ECF subfamily
PA34133 3.8 conserved hypothetical protein
PA34143 2.8 hypothetical protein
PA3438 folE1 2.4 GTP cyclohydrolase I precursor
PA34503 4.8 probable antioxidant protein
PA34523 mqoA 4.4 malate:quinone oxidoreductase
PA34803 2.6 probable deoxycytidine triphosphate deaminase
PA3496 3.9 hypothetical protein
PA35393 3.9 conserved hypothetical protein
PA36103 potD 5.3 polyamine transport protein PotD
PA3611 2.5 hypothetical protein
PA3612 2.4 conserved hypothetical protein
PA36163 3.4 conserved hypothetical protein
PA36203 mutS 2.8 DNA mismatch repair protein MutS
PA3621 fdxA 4.2 ferredoxin I
PA36413 5.0 probable amino acid permease
PA36423 rnhB 4.9 ribonuclease HII
PA36443 lpxA 2.4 UDP-N-acetylglucosamine acyltransferase
PA3645 fabZ 3.2 (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase
PA36463 lpxD 2.7 UDP-3-O-[3-hydroxylauroyl] glucosamine N-acyltransferase
PA36553 tsf 3.2 elongation factor Ts
PA36753 2.7 hypothetical protein
PA36863 adk 2.9 adenylate kinase
PA37133 3.9 hypothetical protein
PA37283 4.2 hypothetical protein
PA37293 3.5 conserved hypothetical protein
PA37303 5.7 hypothetical protein
PA3731 2.7 conserved hypothetical protein
PA37323 3.9 conserved hypothetical protein
PA37353 thrC 2.7 threonine synthase
PA37373 dsbC 2.8 thiol:disulfide interchange protein DsbC
PA37433 trmD 2.5 tRNA (guanine-N1)-methyltransferase
PA37463 ffh 2.8 signal recognition particle protein Ffh
PA37473 2.8 conserved hypothetical protein
PA3798 3.3 probable aminotransferase
PA38203 secF 3.1 secretion protein SecF
PA38213 secD 2.4 secretion protein SecD
PA38223 4.2 conserved hypothetical protein
PA38873 nhaP 6.6 Na+/H+ antiporter NhaP
PA39313 2.8 conserved hypothetical protein
PA3940 2.9 probable DNA binding protein
PA39673 5.0 hypothetical protein
PA39843 int 3.2 apolipoprotein N-acyltransferase
PA40023 rodA 3.4 rod shape-determining protein
PA40313 ppa 3.2 inorganic pyrophosphatase
PA40353 3.4 hypothetical protein
PA40423 xseB 3.9 exodeoxyribonuclease VII small subunit
PA41333 4.2 cytochrome c oxidase subunit (cbb3-type)
PA4139 2.8 hypothetical protein
PA41403 4.9 hypothetical protein
PA42183 5.9 probable transporter
PA42193 15.6 hypothetical protein
PA42203 75.4 hypothetical protein
PA42213 fptA 28.7 Fe(III)-pyochelin receptor precursor
PA42233 7.4 probable ATP-binding component of ABC transporter
PA42243 pchG 8.4 pyochelin biosynthetic protein PchG
PA42253 pchF 9.8 pyochelin synthetase
PA42263 pchE 35.9 dihydroaeruginoic acid synthetase
PA42283 pchD 44.2 pyochelin biosynthesis protein PchD
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PA42293 pchC 20.6 pyochelin biosynthetic protein PchC
PA42303 pchB 23.5 salicylate biosynthesis protein PchB
PA42313 pchA 10.6 salicylate biosynthesis isochorismate synthase
PA42553 rpmC 3.3 50S ribosomal protein L29
PA42713 rplL 2.5 50S ribosomal protein L7 / L12
PA43143 purU1 3.4 formyltetrahydrofolate deformylase
PA43173 7.8 hypothetical protein
PA43183 4.0 hypothetical protein
PA43193 4.1 conserved hypothetical protein
PA43203 2.7 hypothetical protein
PA43213 2.9 hypothetical protein
PA43543 6.2 conserved hypothetical protein
PA43903 2.6 hypothetical protein
PA44283 sspA 2.9 stringent starvation protein A
PA44323 rpsI 2.8 30S ribosomal protein S9
PA44423 cysN 11.9 ATP sulfurylase GTP-binding subunit/APS kinase
PA44433 cysD 14.3 ATP sulfurylase small subunit
PA44553 3.7 probable permease of ABC transporter
PA44563 3.0 probable ATP-binding component of ABC transporter
PA4482 gatC 5.5 Glu-tRNA(Gln) amidotransferase subunit C
PA45123 lpxO1 2.5 lipopolysaccharide biosynthetic protein LpxO1
PA4545 comL 3.1 competence protein ComL
PA45693 ispB 3.2 octaprenyl-diphosphate synthase
PA45743 2.5 conserved hypothetical protein
PA46023 glyA3 2.8 serine hydroxymethyltransferase
PA46123 3.3 conserved hypothetical protein
PA46133 katB 65.8 catalase
PA4625 3.9 hypothetical protein
PA46283 lysP 2.8 lysine-specific permease
PA46293 4.3 hypothetical protein
PA46323 4.2 hypothetical protein
PA46363 2.8 hypothetical protein
PA46373 3.4 hypothetical protein
PA46423 6.4 hypothetical protein
PA46453 3.6 probable purine/pyrimidine phosphoribosyl transferase
PA46683 2.8 probable lipoprotein localization protein LolB
PA46693 ipk 2.7 isopentenyl monophosphate kinase
PA46713 2.6 probable ribosomal protein L25
PA46723 3.1 peptidyl-tRNA hydrolase
PA46753 2.9 probable TonB-dependent receptor
PA46853 2.7 hypothetical protein
PA46933 pssA 2.8 phosphatidylserine synthase
PA4695 ilvH 3.1 acetolactate synthase isozyme III small subunit
PA47233 dksA 3.4 suppressor protein DksA
PA47293 panB 2.5 3-methyl-2-oxobutanoate hydroxymethyltransferase
PA47303 panC 2.6 pantoate--beta-alanine ligase
PA47413 rpsO 3.2 30S ribosomal protein S15
PA4747 secG 3.1 secretion protein SecG
PA47633 recN 2.7 DNA repair protein RecN
PA47703 lldP 3.9 L-lactate permease
PA48013 4.2 hypothetical protein
PA48463 aroQ1 2.9 3-dehydroquinate dehydratase
PA48513 2.5 hypothetical protein
PA48543 purH 2.4 phosphoribosylaminoimidazolecarboxamide formyltransferase
PA49233 3.1 conserved hypothetical protein
PA49333 2.8 hypothetical protein
PA49673 parE 2.9 topoisomerase IV subunit B
PA50013 2.6 hypothetical protein
PA50213 3.5 probable sodium/hydrogen antiporter
PA50243 18.5 conserved hypothetical protein
PA50463 2.7 malic enzyme
PA50493 rpmE 8.9 50S ribosomal protein L31
PA50743 2.8 probable ATP-binding component of ABC transporter
PA50753 2.7 probable permease of ABC transporter
PA50763 4.4 probable binding protein component of ABC transporter
PA51173 typA 4.1 regulatory protein TypA
PA5121 2.5 hypothetical protein
PA5131 pgm 3.0 phosphoglycerate mutase
PA5136 8.4 hypothetical protein
PA5138 4.7 hypothetical protein
PA5154 3.1 probable permease of ABC transporter
PA51573 3.4 probable transcriptional regulator
PA51813 3.6 probable oxidoreductase
PA51923 pckA 2.9 phosphoenolpyruvate carboxykinase
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PA51943 5.4 hypothetical protein
PA52023 4.9 hypothetical protein
PA5215 gcvT1 2.5 glycine-cleavage system protein T1
PA5240 trxA 2.6 thioredoxin
PA52503 3.2 conserved hypothetical protein
PA5285 2.5 hypothetical protein
PA52863 3.6 conserved hypothetical protein
PA52983 3.3 xanthine phosphoribosyltransferase
PA5300 cycB 2.6 cytochrome c5
PA53083 lrp 2.6 leucine-responsive regulatory protein
PA5315 rpmG 2.6 50S ribosomal protein L33
PA5351 rubA1 10.1 rubredoxin
PA5366 pstB 3.0 ATP-binding component of ABC phosphate transporter
PA53703 3.7 probable MFS transporter
PA54023 4.2 hypothetical protein
PA54033 2.8 probable transcriptional regulator
PA54043 8.0 hypothetical protein
PA54063 3.0 hypothetical protein
PA54073 3.3 hypothetical protein
PA54143 3.1 hypothetical protein
PA54253 purK 2.4 phosphoribosylaminoimidazole carboxylase
PA5441 3.6 hypothetical protein
PA54453 3.1 probable coenzyme A transferase
PA5470 2.9 probable peptide chain release factor
PA5505 3.7 probable TonB-dependent receptor
PA55303 14.5 probable MFS dicarboxylate transporter
PA55493 glmS 4.4 glucosamine--fructose-6-phosphate aminotransferase
PA55503 3.4 probable transcriptional regulator
PA55533 atpC 3.8 ATP synthase epsilon chain
PA55603 atpB 2.7 ATP synthase A chain
PA5564 gidB 2.7 glucose inhibited division protein B
PA55683 3.0 conserved hypothetical protein
1 PA numbers are from Pseudomonas genome project (www.pseudomonas.com). 
2 Numbers represent the arithmetic average of four independent GeneChip comparisons. 
3 Oxidative stress response genes.  
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